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ABSTRACT OF THE DISSERTATION 
 
Learning Quantitative Sequence-Function Relationships using 
Massively Parallel Reporter Assays 
by 
 
Kimberly Danielle Insigne 
Doctor of Philosophy in Bioinformatics 
University of California, Los Angeles, 2019 
Professor Sriram Kosuri, Chair 
 
The field of genomics has grown rapidly over the past decade due to the advent of high-
throughput sequencing technologies. Genomics relies on this wealth of information to draw 
biological inferences, but using inference to establish causality can be challenging as many 
genetic factors correlate with one another. Due to the declining cost of both reading and writing 
DNA, new techniques known as massively parallel reporter assays (MPRAs) provide the ability 
to test the function of a large library of tens to hundreds of thousands of designed DNA 
sequences simultaneously in a single experiment. Testing designed libraries allows us to 
explore beyond natural sequence variation to directly test thousands of sequence-function 
hypotheses simultaneously. In this dissertation I discuss two projects that explore sequence-
function relationships in different biological systems. 
 
The first project is focused on how human genetic variation affects exon recognition, as mis-
splicing is a major mechanism through which variants exert their influence. We developed a 
Multiplexed Functional Assay of Splicing using Sort-seq (MFASS) and assayed 27,333 variants 
 iii 
in the Exome Aggregation Consortium within or adjacent to 2,198 human exons. We found that 
3.8% (1,050) led to large splicing disruptions, many of which are extremely rare, located outside 
of canonical splice sites, distributed evenly across intronic and exonic regions, and are difficult 
to predict. MFASS enables direct functional measurement of large-effect splicing defects at 
scale.  
 
The second project is focused on promoters and transcriptional regulation in Escherichia coli. 
Promoter sequence space in bacteria is vast and difficult to study genome-wide due to external 
factors that influence transcription. We developed a genomically-encoded MPRA to characterize 
the global promoter landscape and dissect active promoters for regulatory motifs. We measure 
promoter activity of over 300,000 sequences spanning the entire genome and identify 3,321 
active promoter regions in glucose minimal media and 3,477 in rich LB media. Furthermore, we 
perform a scanning mutagenesis of 2,057 E. coli promoters to identify regulatory sequences. 
Lastly, we implement a variety of machine learning models to classify promoters and 
quantitatively predict their activity. We present a series of approaches to rapidly characterize 
promoter sequences within the E. coli  genome. 
  
 iv 
 
The dissertation of Kimberly Danielle Insigne is approved. 
 
Jason Ernst 
Leonid Kruglyak 
Xinshu Grace Xiao 
Sriram Kosuri, Committee Chair 
 
 
 
 
 
 
 
University of California, Los Angeles 
2019 
  
 v 
 
 
 
 
 
 
To my family, the boyfriend, and our dog.  
 
 vi 
TABLE OF CONTENTS 
 
 
List of Figures……………………………………………………………………………….……………vi  
 
 
List of Tables..……………………………………………...………………………………………..…..vii  
 
 
Acknowledgements…………………………………………………………………..…..………..……viii  
 
 
Vita……………………………………………………………….………………………………………...x 
 
 
Publications………………………………………………………………………………….…………....xi 
 
 
Chapter 1: Introduction…………………………………………………………………………………..1 
            
References……………………………………………………………………………………...14 
 
 
Chapter 2: A Multiplexed Assay for Exon Recognition Reveals that an Unappreciated Fraction of 
Rare Genetic Variants Cause Large-Effect Disruptions to Splicing ……………………….……...17 
 Methods………………………………………………………………………………………….44 
 Supplemental Information……………………………………………………………………..62 
References.…………………………...………………………….……………………………..83 
 
 
Chapter 3: Comprehensive Functional Characterization of Escherichia coli  Promoters Reveals 
Key Components of Transcriptional Regulation ………………………..…………………..……….89 
 Methods………………………………………………………………………………………..119 
 Supplemental Information……………………………………………………………………137 
References…………………………………………………………….….…………………...144 
 
 
Chapter 4: Conclusion and Future Directions……………………….……………………………...150 
 
References………………………………………………………..………………………...…142 
  
 vii 
LIST OF FIGURES 
Figure 2.1 Multiplexed Functional Assay of Splicing by Sort-seq (MFASS) 
Figure 2.2 Effects on exon recognition are not easily predicted across 6,713 designed 
mutations in splicing regulatory elements 
Figure 2.3 MFASS enables functional characterization of variant effect on splicing at scale 
across libraries of human variants 
Figure 2.4 Global analysis of splice-disrupting variants across 27,733 ExAC SNVs in or near 
2,198 human exons 
Figure 2.5 Population genetics, evolutionary and functional analyses of splice-disrupting 
variants (SDVs) across 27,733 ExAC SNVs 
Figure 2.6 Evaluation of genomic and deep-learning predictors for rare variation on splicing 
Figure 2.S1 MFASS reporter design, workflow optimization and testing. Related to Figure 2.1. 
Figure 2.S2 Exon inclusion rates and alternative hexamer score metrics related to SRE 
library. Related to Figure 2.2. 
Figure 2.S3 Flow cytometry and MFASS in four different cell lines. Related to Figure 2.S3 
Figure 2.S4 Related to Figure 2.4. 
Figure 2.S5 Evaluation of the effects of splice-disrupting variants assayed by MFASS. Related 
to Figure 2.5. 
Figure 2.S6 Evaluation of algorithms and metrics for large-effect disruptions to splicing. Related 
to Figure 2.6. 
Figure 3.1 Functional characterization of 17,635 previously reported E. coli promoters 
Figure 3.2 Genome-wide survey of the E. coli promoter landscape 
Figure 3.3 High-resolution tiling of promoter regions identifies sequences encoding 
promoter activity 
Figure 3.4 Scanning mutagenesis of 2,057 TSS-associated promoters identifies known and 
novel regulatory motifs 
Figure 3.5 Global identification of E. coli regulatory motifs by scanning mutagenesis 
 viii 
Figure 3.6 Various machine learning models for promoter activity classification and 
Regression 
Figure 3.S1 TSS-associated promoters are represented by multiple barcodes and provide 
replicable measurements between genomic positions. Related to Figure 3.1. 
Figure 3.S2 TSS-associated promoters are represented by multiple barcodes and provide 
replicable measurements between genomic positions. Related to Figure 3.2. 
Figure 3.S3 Quality control for peak tiling and scrambled TSS libraries. Related to Figures 3.3 
and 3.4. 
Figure 3.S4, related to Figure 3.3. 
Figure 3.S5 Global identification of E. coli regulatory motifs by scanning mutagenesis. Related 
to Figure 3.5. 
Figure 3.S6 An appreciable number of random 150mer oligos encode promoter activity  
 ix 
 
LIST OF TABLES 
 
Table 2.S1 Description of Motif Types used in Splicing Regulatory Element (SRE) Library 
Design. Related to Figure 2.2. 
Table 2.S2 Description of Functional Classes in Splicing Regulatory Element (SRE) 
Library. Related to Figure 2.2. 
Table 2.S3 Gene Ontology (GO) Enrichment for ExAC Splice-Disrupting Variants (SDVs, n 
= 1,050). Related to Figure 2.5. 
Table 2.S4 Primers used in this study. Related to Figures 2.3, 2.S1, and 2.S5. 
Table 2.S1 Primers used in this study.  
 x 
ACKNOWLEDGEMENTS 
 
 
First and foremost, I would like to thank my advisor, Professor Sriram Kosuri, for his excellent 
mentorship throughout my graduate career. None of the work presented here would be possible 
without his invaluable support and guidance. I could not have asked for a better mentor and feel 
very lucky that he accepted me as a student. He taught me how to become a true scientist by 
setting a constant example for critical thinking and tireless pursuit of the truth. He pushed me 
when I most needed it because he always believed in me and gave me confidence when I 
needed him most, especially when transitioning out of academia into the field of data science. 
He has shaped me into the person I am today and I am forever grateful. 
 
Furthermore, I would like to thank Professors Jason Ernst, Leonid Kruglyak, and Xinshu Grace 
Xiao for serving as my committee members. Their continual guidance, suggestion, and 
comments are greatly appreciated. 
 
Other current and past members of the Kosuri lab have played a pivotal role during my PhD 
career. I would like to thank Rocky Cheung, a postdoc, for his mentorship during both my 
rotation and as co-first author on one of my main projects in the lab. The project would have 
been impossible without his experimental expertise, bioinformatics skills, and Adobe Illustrator 
mastery. Also, David Yao made significant experimental contributions to the splicing work, and 
Christina Burghard on the computational side. Next, I would like to thank Guillaume Urtecho, a 
graduate student in the lab, and co-first author on the E. coli work. He was one of my first 
friends in graduate school and we have worked on this project together since we first joined the 
lab. It has been such a pleasure to work with him and we have become close friends in the 
process. This would not be possible without his synthetic biology expertise, his willingness to 
whip up an analysis in search of a biological hunch, and excellent writing skills. Two 
undergraduates, Arielle Tripp and Marcia Brinck, made substantial experimental contributions to 
 xi 
this work. I would also like to thank the current and former postdocs, students, and members of 
the Kosuri Lab for the countless hours of scientific insight and socializing, which kept me sane: 
Dr. Hwangbeom Kim, Dr. Calin Plesa, Jessica Davis, Clifford Boldridge, Angus Sidore, Jeff 
Wang, Joyce Samson, and Johnny Lee.  
 
I would like to thank Professor Mete Civelek at the University of Virginia, a former postdoc in the 
Lusis Lab at UCLA, who served as my mentor during a summer of research after my junior year 
of undergraduate. He was my first truly great mentor and he helped me develop the first 
research project I felt I could call my own. Under his guidance, I learned the R programming 
language and executed a project from start to finish that I felt proud of. At his encouragement, I 
applied for graduate school that coming fall. Without his constant support and inspiration, I may 
never have pursued a PhD in bioinformatics. I cannot say thank you enough for giving me that 
crucial initial push.  
 
I would like to thank my parents and my sister for their support. Thank you for thinking I was 
smart enough when I did not always believe it. None of this would be possible without you. 
 
I would like to thank the friends and colleagues I met here at UCLA. I am lucky to be surrounded 
by such intelligent people, and every person has impacted my life positively. In particular, I 
would like to thank my good friends, R.W., C.L., J.S., A.C, T.G.  
 
Finally, I would like to thank my partner C.B. for his endless support. You have been there from 
the first months when all I did was read papers, to years later when I was interviewing for my 
first job. Thank you for always listening to my frustrations, feelings of imposter syndrome, and 
existential crises. Thank you for all the times you took out the dog, prepared food, and helped 
me de-stress. Thank you for standing by my side at the frontlines of this journey.  
 xii 
VITA 
Education 
 
B.S. Bioengineering: Bioinformatics (cum laude), University of California San Diego 
June 2014 
 
Research Experience 
 
Graduate Student Researcher, Kosuri Lab, UCLA 
June 2015 – August 2019 
Undergraduate Research Assistant, Lusis Lab, UCLA 
June 2013 – March 2014 
Undergraduate Research Assistant, McCammon Lab, UCSD 
October 2012 – June 2013 
Undergraduate Research Assistant, Abagyan Lab, UCSD 
June 2012 – August 2012 
Memberships 
University of California Leadership Excellence Through Advanced Degrees (UC LEADS) 
April 2011 – June 2014 
 
 
  
 xiii 
PUBLICATIONS 
 
 
Comprehensive functional characterization of Escherichia coli promoters reveals key 
components of transcriptional regulation. Guillaume Urtecho*, Kimberly D. Insigne*, Arielle D. 
Tripp, Marcia Brinck, Nathan B. Lubock, Hwangbeom Kim, Tracey Chan, Sriram Kosuri. In 
preparation. 
 
A multiplexed assay for exon recognition reveals that an unappreciated fraction of rare genetic 
variants cause large-effect splicing disruptions. Rocky Cheung*, Kimberly D. Insigne*, David 
Yao, Christina P. Burghard, Jeff Wang, Yun-Hua E. Hsiao, Eric M. Jones, Daniel B. Goodman, 
Xinshu Xiao, Sriram Kosuri. January 3 2019 Molecular Cell (2018) doi : 
https://doi.org/10.1016/j.molcel.2018.10.037 
 
Systematic dissection of sequence elements controlling σ70 promoters using a genomically-
encoded multiplexed reporter assay in E. coli. Guillaume Urtecho, Arielle D. Tripp, Kimberly D. 
Insigne, Hwangbeom Kim, Sriram Kosuri. February 1 2018 Biochemistry, 2019, 58 (11), pp 
1539–1551 doi: 10.1021/acs.biochem.7b01069 
 
 
 
 
 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER ONE 
Introduction 
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Sequence-function relationships are key to understanding many diverse biological 
problems 
An organism’s genome encodes all the necessary functions of life within its sequence, including 
the ability to regulate the expression of tens of thousands of genes in a finely-tuned and complex 
manner. One of the major goals in biology is to precisely understand  how these sequences 
encode function. Sequence-function relationships arise in many different contexts – single 
nucleotide variants identified from genome-wide association studies and their influence on a 
phenotype of interest, variants in non-coding regions and splice sites and their effect on splicing, 
and more broadly sequence variants in cis-regulatory elements (CREs) and their impact on gene 
regulation. A deeper and more quantitative understanding of sequence-function relationships 
would not only advance genomics in general, but potentially lead to algorithms that more 
accurately predict effects of sequence variants on gene expression, new mechanisms and targets 
for therapeutics, improved variant interpretation in a clinical setting, and a more precise and finely-
tuned way to engineer biology. 
 
Learning sequence-function relationships from high-throughput genomics datasets 
remains challenging 
Prior to the advent of high-throughput techniques, sequence-function relationships were 
commonly probed by testing a limited number of sequence variants1,2 or by “knocking out” 
sequences of interest and studying their effect on a biological function of interest. Indeed, many 
consensus CREs (TFs, splice sites, promoter motifs, etc.) and fundamental principles of gene 
expression and regulation were discovered in this manner. The decreasing cost of high-
throughput sequencing technologies has made it routine to study many different facets of gene 
expression and regulation at a genome-wide scale and across many conditions. Armed with this 
massive amount of information, it is relatively simple to discover genetic variants associated with 
perturbed function, yet we are limited by the ability to interpret these variants. There is a 
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proliferation of computational approaches that attempt to learn genotype-phenotype relationships 
from these datasets, but accurate and quantitative predictions remain elusive. In addition, 
conventional attempts to biologically validate predictions requires laborious, low-throughput 
assays, limiting our ability to effectively improve prediction algorithms.  
 
Generally speaking, genomics attempts to solve the inverse problem of understanding biological 
mechanism from observations, a type of problem that is very difficult if not impossible to solve3. 
Genomics relies on a wealth of information to draw biological inferences, but using inference to 
establish causality can be challenging as many genetic factors correlate with one another. To add 
another layer of complexity, learning on natural sequence space may confound prediction since 
it is typically evolutionarily constrained and very sparse compared to the vast potential sequence 
space. Finally, learning sequence-function relationships may be limited by the nature of the data 
- it remains unclear how well indirect measures of cis-regulatory function predict actual function.  
 
Massively parallel reporter assays enable functional testing of a large library of sequences 
in a single experiment 
Due to the declining cost of both reading and writing DNA, a recently developed class of 
techniques known as massively parallel reporter assays (MPRAs) has emerged, enabling 
functional testing of tens to hundreds of thousands of sequences simultaneously in a single 
experiment. Prior to MPRAs, there existed effective methods for studying cis-regulatory function 
such as classic saturation mutagenesis4 and combinatorial promoter shuffling5, but they had only 
been applied at low-throughput. MPRAs are superior to traditional gene reporter assays because 
they utilize programmable microarrays6 and next-generation sequencing to synthesize and 
quantify large libraries of sequences of interest, respectively. Each MPRA is tailored to the 
question of interest and comes in many varieties, but each follows the same basic framework: 
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creation of a large variant library of interest, delivery into an organism of interest, a functional 
assay, sequencing to quantify variant levels, and calculation of functional scores for each variant.   
There are two different approaches commonly used to quantify reporter gene activity. In 
the first approach, each variant is identified by a short barcode sequence which is placed in the 
3’ UTR and is co-transcribed with the reporter gene. RNA-seq is used to quantify the levels of the 
co-transcribed barcodes, measuring the activity of thousands of variants simultaneously. An 
important advantage to this approach is that each variant has multiple barcodes and therefore 
multiple replicate measurements are taken. The second approach requires a fluorescent reporter 
gene and sorts a population of cells using flow cytometry, avoiding the need for a co-transcribed 
barcode. DNA sequencing is performed on each bin and variant expression is calculated based 
on its distribution across bins. This method is a discrete measurement of expression compared 
to the continuous RNA-seq readout, but there is typically a sufficient number of sequences to train 
quantitative sequence-function models. 
The MPRA approach was first demonstrated by Patwardhan et al.7, who used 
programmable microarrays to synthesize barcoded oligonucleotides containing all possible 
single-nucleotide mutations in three bacteriophage promoters and three mammalian core 
promoters in a single experiment per promoter. The library was transcribed in vitro to measure 
activity, although the technique was subsequently adapted for living cells by cloning the library 
into a plasmid backbone8. Many subsequent MPRA approaches choose to focus heavily on only 
a few sequences of interest, but with great statistical power, measuring the effects of all possible 
single nucleotide substitutions in a regulatory element (high-throughput saturation 
mutagenesis)7,9. These types of synthetic saturation mutagenesis approaches have proven 
powerful in developing sequence-function relationships for a sequence of interest, recapitulating 
known motifs and enabling de novo motif discovery. 
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Massively parallel reporter assays utilizing designed sequence libraries enables testing of 
thousands of hypotheses simultaneously 
In contrast to approaches that leverage the high-throughput nature of MPRAs to deeply dissect a 
few sequences of interest, others use this capability to test many thousands of regulatory 
elements at once. A recent study tested over 2,000 candidate enhancers in two human cell lines 
and synthesized not only the wild-type sequences but also engineered variants that removed, 
disrupted, or improved predicted causal regulatory motifs of five activators and two repressors10.  
While the first type of MPRA approach discussed is a powerful exploratory tool that can lead to 
quantitative sequence-function relationships for a few sequences of interest, approaches that 
utilize designed sequence libraries have the distinct advantage of directly testing thousands of 
hypotheses simultaneously. A multitude of mechanistic hypotheses can be directly tested and can 
focus more broadly on how this mechanism operates on a global scale. Furthermore, one can 
incorporate existing knowledge and design libraries of sequences to differentiate between 
competing models. MPRAs offer models of sequence-function relationships a unique ability to not 
only learn on large biological datasets, but to quickly iterate and improve with each successive 
library design. Each experiment can further refine existing predictive models, act as test sets for 
previous models, and guide model selection and inform the next iteration of experiments. Here, I 
propose an outline to leverage these techniques to test existing hypotheses, design the next set 
of optimal experiments based on previous iterations, and learn better quantitative models of 
sequence-function relationships in two model systems in gene expression. 
 
Human splicing is an ideal system to study complex and clinically relevant sequence-
function relationships  
My first project detailed in Chapter 2 is focused on quantifying the effects of sequence variants 
on exon skipping in the human genome. Towards a deeper understanding of the splicing code, 
we designed an initial library containing all human exons < 100 bp, as well as designed 
sequence variants predicted to impact exon skipping.  
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An increasing proportion of human diseases are associated with aberrant splicing, underscoring 
the clinical importance of interpreting sequence variants and their potential impact on splicing. 
Many of the core consensus sequences of splicing are known, but there are many other 
regulatory elements and trans-acting factors that can modulate splicing, making quantitative and 
predictive models of splicing difficult to achieve. 
 
The splicing code is complex and degenerate 
Human protein diversity is primarily due to alternative splicing, a common mechanism that occurs 
in more than 90% of protein-coding genes to give rise to multiple mRNA isoforms11.  There are 
several common types of alternative splicing including cassette exon skipping (the most prevalent 
type11), mutually exclusive exons, alternative 5’ splice site, alternative 3’ splice site, and intron 
retention12. The most prevalent types of mutations that affect splicing occur in core consensus 
sequences – the 5’ splice site, branch-point adenosine, and the 3’ splice site – or cis-acting 
regulatory sequences that occur in exons or introns to enhance (ESEs/ISEs, exonic/intronic 
splicing enhancers) or suppress (ESSs/ISSs, exonic/intronic splicing silencers) splicing13. The 
sequences that demarcate exon-intron boundaries are short, degenerate signals of varying 
strength that are necessary but not sufficient for splicing and occur with high frequency in the 
genome14. Additionally, the same splicing regulatory element can have varying and even 
opposing effects depending on sequence context or cell-type identity, allowing finely-tuned tissue-
dependent regulation of splicing.  
 
Splicing is difficult to quantitatively predict 
High-throughput RNA sequencing has enabled transcriptomic profiling in many tissues and 
disease states, providing a basis to deciphering the splicing code. Previous work developed a 
splicing code, known as SPANR (Splicing-based Analysis of Variants), based on combinations of 
hundreds of  hand-crafted RNA features trained on thousands of exon-skipping events in the 
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human genome, that predicted tissue-dependent splicing changes from sequence alone for the 
first time15. This work was subsequently expanded to incorporate hundreds of new features and 
implemented a deep neural network to effectively learn a comprehensive splicing code16. 
Although the code predicts quantitative and tissue-dependent splicing changes, it performs best 
at predicting only the direction of change and can quantify effects for single nucleotide variants 
only. Recent work based only on conservation sequence scores and locations of splice sites 
outperformed state-of-the-art models using hand-crafted biological features, demonstrating that 
conservation is an unexpectedly powerful indicator of alternative splicing patterns17.  However, 
this model cannot predict tissue-differential levels of splicing or the effects of mutations on splicing 
as the model inherently does not have access to the sequence information. Circumventing a 
genomic approach, Rosenberg et al18 learned a splicing model based entirely on millions of 
synthetic mini-genes containing degenerate regions representing alternative 5’ and 3’ splicing 
events. Their model converts input sequences into hexamer features and learns individual effect 
scores (hexamer additive linear model, HAL), which are used to predict splice site usage between 
two different sites. Although their model was empirically trained on synthetic libraries from an 
MPRA, it can predict the quantitative effect of variants on exon skipping in Mendelian diseases. 
Their model can generate predictions for any combination of exonic variants and is not limited to 
single nucleotide changes, but it cannot interpret intronic variants, and performs best when only 
considering direction of change instead of absolute values. This study demonstrates the power of 
using MPRAs to explore vastly more splicing events than those that naturally occur in the human 
genome, and further insights are possible with a more designed and focused approach.  
 
Initial library design 
Our initial splicing library includes all human exons < 100bp (8.5% of all human exons) flanked 
with 50bp of surrounding intronic sequence on each side (current OLS technologies are limited to 
< 200bp). Each natural sequence has 60-80 mutated versions which test different combinations 
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of splice site strengths, exonic/intronic enhancers/suppressors (ESEs/ISEs/ESSs/ISSs), SNPs, 
and synonymous codons. Additionally, we included 96 previously characterized splicing efficiency 
constructs that span a range of splicing efficiencies to give a final library size of 17,290 oligos. 
There is evidence that alternative exons are associated with longer introns and that intron length 
may influence exon skipping levels39. In order to test our design in a more natural context without 
artificially short introns, we cloned our exon library into two different constant intron backgrounds, 
DHFR, (300bp of 5’ intron and 700bp of 3’ intron) and SMNI (400bp of 5’ intron and 500bp of 3’ 
intron), which more closely resemble the average human intron length (~2000bp). However, the 
original library with short flanking native sequence is still biologically relevant as recent work 
suggests much of the regulatory information is captured within the first 100bp of flanking intronic 
sequence38. 
  
Massively parallel reporter assay to quantify exon skipping in human cells 
The library is cloned into a split GFP reporter with a downstream constitutive RFP reporter gene 
in HEK-2943 cells (Figure 2.1A). We use flow cytometry to measure the GFP/RFP ratio to 
quantify the level of exon skipping (Figure 2.1B). If exon skipping occurs, the GFP will be 
reconstituted, resulting in a high GFP/RFP ratio. If exon inclusion occurs, the GFP will remain split 
and only the constitutive RFP will be expressed, leading to a low GFP/RFP ratio. Intermediate 
levels of exon skipping are easily quantified with the continuous readout of GFP/RFP ratio. The 
population of cells is sorted using fluorescence activated cell sorting (FACS) and each bin is 
sequenced, giving the quantitative variant levels in bins of different GFP/RFP intensity. 
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Studying global promoter architecture in E. coli is an ideal system to quickly iterate  
through experimental designs 
My second project detailed in Chapter 3 is focused on global gene regulation in E. coli. This long-
studied model organism is an ideal system to test and develop models of sequence-function 
relationships because it is relatively fast to test designed libraries, enabling relatively rapid 
improvements and refinements to models. Prokaryotic gene regulation is a model system that has 
been extensively studied for decades, and many of the basic mechanistic details are well 
understood. Promoters are the principal drivers in gene regulatory networks and although much 
is known about prokaryotic transcription, we are still unable to accurately predict the level of gene 
expression from promoter sequence alone.   
 
E. coli promoters are degenerate, modular, and difficult to predict 
 
Initiation of RNA-transcript formation is a key regulation point in transcriptional control. Transcript 
initiation requires the interaction of the RNA polymerase (RNAP) with the promoter DNA, which 
is mediated by a s factor to form an active holoenzyme. The s factor ensures promoter specificity, 
correct positioning of the polymerase at target promoters, and facilitates unwinding of the DNA 
near the TSS19. Most bacteria contain multiple s factors, all of which share common features, that 
allow regulation of basal gene expression as well as regulation in response to altered 
environmental conditions20.  The main step in initiation is promoter recognition, which is facilitated 
by four different sequence elements, each of which bind to different subunits of the s factor. The 
two primary elements are the -35 and -10 elements, two hexamer elements with known 
consensus sequences which are located 35 and 10 bp upstream of the TSS, respectively21. The 
two other important elements are the extended -10 element, a 3-4bp motif immediately upstream 
of the -10 element22, and the UP element, a ~20bp sequence located upstream of the -35 
element23. These four elements together specify the initial binding of RNAP to the promoter, but 
the relative contribution of each element differs from promoter to promoter. The primarily role of 
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these elements seems to be docking the polymerase to the promoter DNA for subsequent open 
complex formation, therefore deficiencies in one element can be compensated for by another. 
Indeed, there is no naturally occurring promoter which has all four consensus elements present, 
as this promoter would bind the polymerase too strongly and inhibit transcription. The degeneracy 
and modularity of these core promoter elements complicate efforts to develop universal rules 
governing promoter activity.  
Previous work predicted the strength of full-length E. coli  promoters, a set of 60 promoters 
dependent on the alternative  factor, using an UP-element contribution score in combination with 
a PWM-based core promoter model24,25. The model was able to distinguish between active and 
weak promoters, but is not applicable to the majority of promoters under control of the 
housekeeping  factor. A recent study by Cox et al.26 created a library of more than 200,000 
variants of the E. coli  lacI promoter fused upstream of a GFP reporter and used flow cytometry 
to characterize function. They learned a sequence-function map of the lacI promoter which 
recapitulated the known binding sites of the CAP responsive protein (CRP) and RNAP. They used 
this sequence-function map to explicitly model each protein’s sequence-dependent binding 
energy and how their interaction affects transcription. They subsequently used this model to 
design promoters with a range of expression by tuning the strength of the RNAP binding site27. 
This approach is generally applicable to biophysically characterize transcriptional regulation by a 
specific sequence of interest, but is inherently limited in scope to only a few regulatory sequences 
at one time. 
 
Thousands of putative transcription start sites have been identified in genome-wide 
studies 
Recent efforts have been made to comprehensively characterize the E. coli genome using RNA-
seq for global transcription start site mapping. A study by Conway et al.28 analyzed the 
transcriptome of E. coli K-12 using strand-specific RNA-seq at single nucleotide resolution during 
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log-phase and stationary growth in glucose minimal medium and initially identified ~11,000 
putative TSSs. Upon further curation, they report ~2,000 precisely annotated promoters. Another 
study by Thomason et al.29 also analyzed the transcriptome of E. coli K-12 in three different growth 
conditions using differential RNA-seq, which can distinguish between primary and processed 
transcripts, and predicted ~14,000 TSS candidates. Both studies noted several novel antisense 
transcripts and functions. The TSS numbers reported in both of these studies far exceed the 
number of annotated genes in E. coli (~4,000) and the inflated numbers and reports of prevalent 
anti-sense transcription could be partially due to the imprecision of the computational predictions 
or artifacts of deep RNA-seq coverage30. This discrepancy between recent findings and known 
gene annotations highlights the complexity and remaining uncertainty still present in one of our 
most basic and longest studied model organisms. In order to provide a strong foundation for future 
study of promoter sequence-function relationships, we must begin with a confident set of TSSs 
and promoter sequences. 
 
Initial library design 
In a first step to understanding promoter sequence-function relationships in E. coli, our initial 
library design tests every reported putative TSS in its local sequence context and will determine 
which are functionally active in vivo.  This initial design will provide a firm foundation that will 
enable us to build more quantitative and accurate sequence-function relationships. Our initial 
library design incorporates all TSSs from the RegulonDB database31 and those identified in two 
recent genome-wide TSS mapping studies28,29 described above.  We synthesize each TSS 
embedded in its local sequence context -120 to +30 relative the TSS, capturing most of the cis--
regulatory elements - most regulatory motifs fall within 100bp upstream of the TSS26 and it has 
been shown that the initial transcribed region (+1 to +20) can also influence gene expression. 
Additionally, we included 500 negative controls from the E. coli genome that are not expected to 
have regulatory activity. These 150bp sequences are more than 200bp from a TSS (on either 
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strand) and fall mostly within coding sequences. Incorporating all three sources, there were 
23,798 unique TSSs - for simplicity we reduced this set so that each TSS is at least 20bp apart, 
yielding a final library size of 17,836.  
 
Massively parallel reporter assay to quantify promoter strength in E. coli 
In order to efficiently test our large synthesized library, we designed a massively parallel reporter 
assay in E. coli (Figure 3.1B). Due to the current nature of oligonucleotide (oligo) synthesis (OLS) 
chemistry, only 30-40% of synthesized sequences are error-free and chip-synthesized barcodes 
would be attached to perfect as well as imperfect sequences.  If barcode readout is the primary 
measurement (as is the case in our assay), there is no way to remove the potential effects of 
imperfect sequences – to do so you must sequence the entire construct. To avoid this issue, each 
variant is tagged with a unique random 20bp barcode added using polymerase chain reaction 
(PCR) during library amplification instead of using designed barcodes synthesized on the chip.  
 
Next, a self-cleaving ribozyme (RiboJ), constant ribosome binding site, and GFP reporter are 
cloned immediately downstream – each variant drives the same construct with a constant 5’ 
initially transcribed region to reduce any variable effects not due to promoter sequence. The GFP 
reporter stabilizes expression of the short barcode and provides an alternate method of functional 
characterization using flow cytometry. Prior to this cloning step, we perform an initial mapping 
step using DNA sequencing to identify barcodes for each variant, which allows us to efficiently 
sequence only the short barcode in downstream quantification. The library is integrated into a 
genomic “landing pad”, an intergenic locus whose expression is not influenced by nearby genetic 
factors, using a Cre-Lox recombination system to induce a cassette exchange. Landing pads 
enable singly integrated, stable, and consistent expression across variants so that variations in 
expression are mainly due to variations in promoter sequence only. Genomic integration more 
faithfully represents an in vivo context compared to libraries expressed on plasmids, the dominant 
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method for library delivery in MPRAs27. Plasmids can have variable copy number between cells, 
necessitating the need for DNA sequencing for normalization in each tested condition. More 
importantly, variable plasmid copy number can artificially increase the presence of competing 
binding sites and change the effective amount of TFs, which can produce sharp changes in the 
input-output relationship between TFs and gene expression, an observation known as the 
transcription factor titration effect32.  Following library integration, we perform a one-time barcode 
DNA sequencing to quantify construct levels post-integration. The initial stage of the workflow 
only has to be performed once per library, enabling us to quantify promoter strength in various 
conditions using only RNA-sequencing of the barcode. Our assay provides a quantitative level of 
promoter strength that is distinct from transcriptomic measurements – our readout depends only 
on the cis-sequence information and is not influenced by post-transcriptional mechanisms that 
affect expression. While these are important, training models based on a quantitative readout that 
is more representative of cis-sequence function will provide a solid foundation upon which to build 
more complicated models that incorporate additional layers of regulation. 
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CHAPTER TWO 
A Multiplexed Assay for Exon Recognition Reveals that an Unappreciated Fraction of Rare 
Genetic Variants Cause Large-Effect Disruptions to Splicing 
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SUMMARY 
Mutations that cause exon skipping can have severe consequences on gene function and cause 
disease. Here we explore how human genetic variation affects exon recognition by developing a 
Multiplexed Functional Assay of Splicing using Sort-seq (MFASS). We assayed 27,733 variants 
in the Exome Aggregation Consortium (ExAC) within or adjacent to 2,198 human exons in the 
MFASS minigene reporter, and found that 3.8% (1,050) of variants, most of which are extremely 
rare, led to large-effect splice-disrupting variants (SDVs). Importantly, we find that 83% of SDVs 
are located outside of canonical splice sites, are distributed evenly across distinct exonic and 
intronic regions, and are difficult to predict a priori. Our results indicate extant, rare genetic 
variants, can have large functional effects at appreciable rates even outside the context of 
disease, and MFASS enables their empirical assessment for large-effect splicing defects at scale.  
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INTRODUCTION 
Any individual’s genome contains ~4-5 million genetic variants that differ from reference, and 
understanding how these variants give rise to trait diversity and disease susceptibility is a central 
goal of human genetics (Auton et al., 2015). A vast majority (96-99%) of an individual’s variants 
are common, though at the population level the overwhelming majority of variants are rare 
(Montgomery et al., 2011; Nelson et al., 2012; Tennessen et al., 2012; UK10K Consortium et al., 
2015). Common variants in the human population usually contribute small, additive effects 
towards complex traits, as negative selection has removed large-effect deleterious alleles 
(Altshuler et al., 2008). However, population expansion ~10,000 years ago left humans with an 
abundance of rare variation, and most Mendelian disease traits are caused by rare alleles with 
large effect sizes (Keinan and Clark, 2012). Because of their scarcity in an individual’s genome, 
rare variants that play important roles in complex traits are likely to have large functional effects 
(Bomba et al., 2017; Gibson, 2012), and traditional population or computational genomic methods 
cannot reliably estimate their contribution (Uricchio et al., 2016).  
 
Recent whole genome and transcriptome sequencing studies of large cohorts indicate that rare 
variation is playing an important role in shaping global gene expression (GTEx Consortium et al., 
2017; Hernandez et al., 2017; Li et al., 2017). However, new comprehensive reverse-genetic 
studies indicate that individual mutations in promoter and enhancer regions rarely have large 
effects (Canver et al., 2015; Diao et al., 2016; Gasperini et al., 2017; Rajagopal et al., 2016; 
Sanjana et al., 2016), which could be the result of functional redundancy between transcription 
control elements (Frankel et al., 2010; Hong et al., 2008; Osterwalder et al., 2018). How can 
individual rare variants be broadly shaping gene expression, but at the same time rarely having 
large effects on transcriptional control? We can expect the mutational profiles of large-effect rare 
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variants to mirror those that cause Mendelian traits, which are dominated by non-synonymous 
exonic mutations, structural and copy number variants, or mutations that affect splicing (Bamshad 
et al., 2011; Chong et al., 2015). While copy number changes and non-synonymous mutations 
are easy to detect, splicing changes are more difficult to diagnose, as only mutations at canonical 
splice sites are easy to predict and interpret (Jian et al., 2014).  
 
Recent evidence indicates that splicing is a major mechanism by which genetic variation 
influences traits. For common variants, large-cohort RNA-Seq studies that examine splicing are 
finding many splicing quantitative trait loci (sQTL), especially when considering exon-level 
expression differences (GTEx Consortium, 2015; Ongen and Dermitzakis, 2015; Zhang et al., 
2015). Moreover, a majority of eQTLs tend to act on an individual exon level rather than the gene 
level, indicating that cis-eQTLs might be broadly affecting exon recognition (Ramasamy et al., 
2014). In addition, functional genomic measurements of GEUVADIS individuals indicate that 
common genetic variation influencing splicing is a primary mechanism that confers susceptibility 
to common diseases (Li et al., 2016). For rare variation, analysis of bottlenecked populations find 
that many rare variants which segregate with large-effect expression changes are enriched at 
splice sites (Pala et al., 2017). In addition, prospective transcriptional profiling studies for 
Mendelian diseases are increasingly finding many rare variants that affect splicing are difficult to 
predict a priori (Cummings et al., 2017; Kremer et al., 2017). More broadly, computational splicing 
predictors trained on RNA-Seq data and sequence features seem to indicate that many rare and 
disease variants are predicted to influence splicing levels (Xiong et al., 2015). Finally, mutations 
that cause an exon to be skipped can have severe functional consequences on gene function, 
and many known disease-causing mutations reduce or eliminate exon recognition (Baralle and 
Buratti, 2017). A large-scale functional assay examining ~5,000 exonic disease mutations 
indicates that ~10% of them have some effect on splicing (Soemedi et al., 2017). Many of these 
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variants that alter splicing are not located close to the splice sites, suggesting that many splicing 
defects are likely yet to be discovered.  
 
We developed MFASS as a multiplexed, scalable platform to test the extent to which mutations, 
both within exons and introns, can lead to large-effect defects in exon recognition. MFASS uses 
a set of three-exon, two-intron minigene reporters in which skipping of the middle exon leads to 
reconstitution of fluorescence (Figures 2.1A and 2.S1A-S1D). We cloned libraries of microarray-
derived oligonucleotides that encoded human exons and surrounding intronic sequences into 
these reporters en masse to construct reporter libraries (LeProust et al., 2010). These libraries 
are then integrated into HEK293T human cell lines using high-efficiency, serine-integrase based, 
site-specific integration (Figure 2.1A), ensuring one copy of library sequence per cell (Duportet 
et al., 2014; Matreyek et al., 2017). The pooled sequence library is then separated into bins using 
fluorescence-activated cell sorting (FACS), and we use DNA-Seq of the constructs to quantify 
which variants are sorted into which bins. We used MFASS to functionally classify 27,733 exonic 
and intronic natural genetic variants from ExAC for exon recognition across 1,626 genes in 2,198 
exon backgrounds, most of which are extremely rare variation in the human population. Here we 
show that more than a thousand (3.8%) of these rare genetic variants leads to near complete loss 
of exon recognition, on par with the prevalence of protein-truncating variants within genomes. 
Most of the effects of rare variants on splicing are challenging to predict. 
 
RESULTS 
Optimization of MFASS 
We tested human exons in several reporter designs. Our initial designs relied on the reconstitution 
of fluorescence using a pair of constant short DHFR introns (~100bp) flanking the exon library 
(Figure 2.S1D). However, we found that much of the library had little to no fluorescence, and 
even when signal was present, the expression levels were low compared to the longer intron 
 
 
 
 22 
contexts (Figures 2.S1E and 2.S1F). These results were suggestive of intron retention, which is 
a process that dominates in lower eukaryotic organisms. In humans, due to long intron lengths, 
exons are first recognized by the splicing machinery in a process called exon definition (Berget, 
1995, Black, 2003; De Conti et al., 2012; Keren et al., 2010) and thus mutations that affect exon 
recognition often result in exon skipping rather than intron retention (Baralle and Buratti, 2017). 
Due to these concerns, we optimized our reporter designs with longer constant intron backbones. 
With these backbones, we observed ~20 to 100-fold higher level of fluorescence overall. 
 
In order for MFASS to work in a multiplexed, scalable format, the assay relies on a single copy of 
the reporter construct per cell before FACS sorting, thereby ensuring that our splicing 
fluorescence readout corresponds to a single sequence. Each library sequence is integrated once 
per cell using high efficiency site-specific genome integration (Figures 2.1A and 2.S1G-S1I), and 
expressed at a defined AAVS1 locus to minimize any pleiotropic effects. However, we noticed 
upon transient transfection of the splicing reporter libraries that each cell contains hundreds of 
reporter copies on average (Figure 2.S1J, top left). We characterized the copy number of the 
reporter library in human cells across culture passages by flow cytometry and RT-PCR and found 
~100,000-fold cell dilution to be sufficient (Figure 2.S1K). Therefore, we obtained MFASS data 
only at passage number beyond 1:100,000 from initial transfection, to ensure single copy 
integration without contaminating plasmids (Figure 2.S1M). 
 
While transient assays with splicing minigene reporters are commonly used due to their relative 
simplicity, it has been reported that splicing outcomes can be more reproducible when sequences 
are genomically integrated in many cell types (Smith and Lynch, 2014). To compare the effect of 
genome-integration as opposed to transient expression for our splicing reporters, we constructed 
reporters corresponding to individual library sequences, and evaluated both fluorescence and 
RNA splicing under transient expression and site-specific genome integration (Figures 2.S1N-
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2.S1Q). We selected nine sequence variants that match our reference library for further analysis 
by flow cytometry (Figures 2.S1N and 2.S1O; STAR Methods) and RT-PCR (Figures 2.S1P 
and 2.S1Q) and to validate results from MFASS. Individual controls sorted from the library 
showed consistent behavior between inclusion rates estimated by RT-PCR and fluorescence 
output (Figures 2.S1N-2.S1Q). While the level of exon inclusion as measured by RT-PCR is 
consistent between transient and stable expression, reporter fluorescence in stably integrated 
constructs is more consistent with RT-PCR results because the transient transfections included 
signals at very high gene dosage (Figure 2.S1N, note behaviors of individual constructs that show 
saturation of fluorescence only at high expression) that is only alleviated when single-copy 
integration is achieved (Figure 2.S1O).  
 
Evaluating MFASS Based on Known Splicing Regulatory Elements 
To test and validate MFASS, we first designed, built and assayed a test library of 6,713 mutations 
aimed at perturbing regulatory elements across a randomly chosen library of 205 natural in-frame 
human exons and surrounding intronic sequences (Splicing Regulatory Element library). We first 
developed this test library in order to evaluate the MFASS assay and test the effects of designed 
mutations in a large set of natural sequence contexts. To mutate sequences iteratively while 
accounting for the creation of unintentional motifs, we developed a custom software toolkit for the 
design of in silico splicing mutations. In particular, this toolkit incorporates information about 
splicing regulatory elements from the literature to calculate a composite score for each sequence 
across different functional classes. We chose natural human exons that are less than 100 bp and 
begin and end on frame 0, and designed a 170-bp exon library with its surrounding intronic 
contexts, that includes at least 40 bp of upstream intron and at least 30 bp of downstream intron. 
Overall, we randomly chose a subset of ~200 human exons and iteratively designed 60-80 
perturbations per sequence that weaken, strengthen or destroy splicing motifs focused on three 
major motif types (Tables 2.S1 and 2.S2; STAR Methods).  
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We used MFASS to assay the SRE library with biological replicates across two different intronic 
backbones (Figure 2.1A). We expanded these sorted bins over several passages and observed 
that the sorted populations remained stable (Figure 2.1B). We also performed bulk RT-PCR for 
each bin, and found that the observed RNA splicing efficiencies corresponded with observed 
fluorescence of the bins (Figure 2.1C). To obtain an exon inclusion index for each sequence, we 
first considered reads which perfectly matched the SRE library, and normalized based on read 
depth and weighted by the corresponding bin population percentage from FACS. Finally, we 
computed a weighted average of normalized read counts across all bins using the average exon 
inclusion level in each bin as measured by the GFP:RFP ratio and confirmed by bulk RT-PCR 
(STAR Methods). Overall, the inclusion indices for our library are bimodal, with most library 
sequences represented predominantly in one bin, showing either complete exon inclusion or 
skipping (Figures 2.1D).  
 
We measured the replicability of inclusion indices across biological replicates using the tetrachoric 
correlation (rt) due to the bimodality in our results (Pearson correlation provided as a comparison). 
We tested these libraries across two constant intron backbones (SMN1 and DHFR), and found 
that exon inclusion metrics are highly reproducible within the backbone across biological 
replicates (Figures 2.1E and 2.1F) (rt = 1.00, p < 10-16, tetrachoric; r = 0.94, p < 10-16, Pearson, 
DHFR intron backbone; rt = 0.97, P < 10-16, tetrachoric, r = 0.89, p < 10-16, Pearson, SMN1 intron 
backbone), and between backbones (Figure 2.1G) (rt = 0.96, p < 10-16, tetrachoric; r = 0.85, p < 
10-16, Pearson). We consider 6,713 designed mutations present across both backbones in 
subsequent analysis and highlight data for the SMN1 intron backbone (Figure 2.2). 
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Figure 2.1. Multiplexed Functional Assay of Splicing by Sort-seq (MFASS).  
(A) We cloned synthetic human exons (black) and surrounding intronic sequences (dark grey) 
into our reporter plasmid containing a split-GFP reporter with flanking constant intron backbones 
(light grey), followed by site-specific integration into HEK293T cells using Bxb1 integrase. Cells 
are sorted into bins based on fluorescence, followed by amplicon sequencing of DNA from cells 
in each sorted bin. We calculated exon inclusion index for each sequence using a weighted 
average of normalized read counts based on exon inclusion level from bins (STAR Methods). 
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(B) We used FACS to sort the genomically-integrated SRE library into three separate populations 
(left). After expansion, the sorted populations remained stable (right). GFP-int, GFP-intermediate. 
For this library (SMN1 intron backbone), we obtained ~4 million cells for GFP+ and GFPneg bins, 
and 4.2 x 105 cells for GFPint bin. The percentage of cells sorted is as follows: GFP+ (33.3%), 
GFPneg (44.5%), GFP-int (5.6%). 
(C) The observed RNA splicing efficiencies of the sorted bins as measured by RT-PCR 
correspond almost directly with observed fluorescence of the bins.  
(D) We plotted the percentage of reads for each construct in the SRE library containing both 
natural and mutant exons (n = 10,477). We showed that most sequences fall predominantly into 
one bin, exhibiting either complete exon skipping or inclusion, allowing for facile classification of 
exon skipping variants of large effects (Δinclusion index ≤ -0.5). Corresponding exon inclusion 
indices for each bin are indicated at top panel. The data shown in (D) corresponds to the SMN1 
backbone. 
(E, F and G). SRE library splicing behavior replicates between individual biological replicates and 
across two constant intron backbones. Tetrachoric correlation indicates whether two distinct 
measurements are concordant in one of the four quadrants, and is more suited to assess large-
effect variants. (E) Exon inclusion indices show strong correlation between two independent 
biological replicates for C. griseus DHFR intron backbone (rt = 1.00, p < 10-16, tetrachoric; r = 0.94, 
p < 10-16, Pearson). (F) Exon inclusion indices show strong correlation between two independent 
biological replicates for human SMN1 intron backbone (rt = 0.97, p < 10-16, tetrachoric, r = 0.89, p 
< 10-16, Pearson). For (E) and (F), after calculation of correlation coefficients, sequences for which 
inclusion indices do not agree within 0.30 (outside the dashed lines) are excluded from 
subsequent analysis. (G) Results are robust across different intron backbones (rt = 0.96, p < 10-
16, tetrachoric; r = 0.85, p < 10-16, Pearson).  
See also Figure S1. 
 
Overall, we showed that while the loss of exon recognition is consistent with known splicing motifs, 
the effects of these perturbations are not easily predicted for 6,713 designed mutations across 
205 human exons (Figure 2.2). To focus on the mechanisms by which large-effect splicing 
changes can occur, we defined large-effect variants as Δinclusion index ≤ -0.5 (i.e., mutations to 
a wild-type exon with an inclusion index of ≥ 0.5, that is reduced by an absolute value of at least 
0.5), which we term “splice-disrupting variants” (SDVs). We quantified the percentage of SDVs 
for designed mutations in each category (Figure 2.2A). As expected, we found that splice-site 
mutations to the nearly invariant dinucleotides cause SDVs at the highest rates (Figure 2.2A). 
Mutations to the splice site (splice acceptor, positions -20 to +3; splice donor, positions -3 to +6) 
individually result in SDVs 48-73% of the time (Figure 2.2A, “acceptor site” and “donor site”), and 
96% of the time when mutating simultaneously both splice donor and acceptor (Figure 2.2A, 
“acceptor + donor site”). This is likely an underestimate as mutations eliminating splice site 
recognition may be utilizing alternative splice acceptors or donors, which cannot be distinguished 
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from exon inclusion by MFASS. Within exons, mutations can still have strong effects. Encoded 
synonymous mutations to all putative exonic splicing enhancers (ESEs) lead to SDVs ~72% of 
the time (Figure 2.2A, “all exonic splicing enhancers”). While removing clusters of putative exonic 
splicing silencers (ESSs) result in increased exon inclusion (Figure 2.S2A, “all exonic splicing 
silencers”), removing the strongest identified ESE alone results in 30% SDVs (Figure 2.2C, 
“strongest exonic splicing enhancer”). More generally, splicing metrics such as MaxEnt for splice 
site strength (Figure 2.2B) or exon hexamer metrics (Figures 2.2C and 2.S2B) are consistent 
with predicted effects on splicing behavior.  
 
Effects of Rare Human Variation on Exon Recognition 
While these results indicate that mutations intended to alter previously recognized motifs can 
commonly lead to loss of exon recognition, we wanted to explore the extent to which natural 
genetic variation in the human population results in SDVs. We generated the Single Nucleotide 
Variant library (SNV library) for which we designed and synthesized all cataloged exonic and 
intronic single nucleotide variants (SNVs) from the Exome Aggregation Consortium (ExAC), for 
all 2,902 wild-type human exons that demonstrated exon inclusion (inclusion index ≥ 0.8) in the 
SRE library (STAR Methods). From this SNV library, we first tested two reporter constructs that 
split at distinct positions of GFP to assess how the reading frame affects exon inclusion for either 
exons that start and end at phase 1, or exons that start and end at phase 0. To evaluate the 
splicing reporter output across two versions of the SNV dataset from the MFASS assay, we 
monitored GFP and mCherry fluorescence from the initial library and sorted cells using flow 
cytometry (Figures 2.S3A and 2.S3B). We observe that the fluorescent output from all sorted  
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Figure 2.2. Effects on exon recognition are not easily predicted across 6,713 designed 
mutations in splicing regulatory elements.  
(A) We quantitatively measured exon inclusion for iteratively-designed mutations (n = 6,713) 
across categories of splicing regulatory elements from 205 human exons (see Tables 2.S1 and 
2.S2 for complete categorical explanations and definitions). For each designed category we show 
the distribution of inclusion indices, the proportion of splice-disrupting variants (SDVs), and the 
average number of mutations within one standard deviation. We defined SDVs as variants that 
result in a Δinclusion index ≤ -0.5 (relative to the wild-type sequence; STAR Methods). We only 
consider SNVs when the corresponding wild-type sequence is also detected, requiring that the 
wild-type exons demonstrate inclusion in our assay (inclusion index of ≥ 0.5) for variants to be 
considered an SDV. Dashed lines mark the thresholds for no change in exon inclusion (Δinclusion 
index = 0) and for SDVs (Δinclusion index = -0.5). Here we highlight the data for the SMN1 intron 
backbone and detected 21.3% (1,428/6,713) of variants as SDVs across all categories. See also 
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Figure 2.S2A for mutations to exons that are skipped in MFASS  (inclusion index of < 0.5) across 
designed categories. Splice acceptor, positions -20 to +3; splice donor, positions -3 to +6. 
(B) Mutating the splice acceptor and splice donor sites adversely affects exon inclusion based on 
MaxEnt prediction for included exons (inclusion index of ≥ 0.5) (Yeo and Burge, 2004).  
(C) There is a significant difference in average Δinclusion index between sequences which 
increase (up) or decrease (down) overall exon hexamer score (Mann-Whitney U test, p < 10-16) 
for included exons. Decreasing overall exon hexamer score leads to more exon skipping. 
Hexamer scores are based on the HAL model (Rosenberg et al., 2015). An alternative score 
metric is evaluated in Figure 2.S2B (Ke et al., 2011). 
See also Figure 2.S2, Tables 2.S1 and 2.S2. 
 
populations is stable upon passaging. Overall, the two different contexts displayed high 
correlations for detecting splice-disrupting variants. (Figure 2.S3C, n = 5,740, rt = 1.00, p < 10-16, 
tetrachoric; r = 0.94, p < 10-16, Pearson). Since the SNV library was examined in independent 
reporter constructs testing different frames, this indicates we will be able to use MFASS to screen 
for exons across in-frame and frameshifting exons for future studies. These results suggest that 
the exons examined across diverse reporter contexts are functionally consistent and relevant in 
the context of exon recognition in human cells.  
 
Overall, we quantified the effects of more than half (52.4%, 27,733 of 52,965) of the ExAC SNVs 
found across 2,198 exons and found that 1,050 of 27,733 (3.8%) ExAC variants assayed led to 
almost complete loss of exon recognition, are broadly spread across 543 human exon 
backgrounds from 473 genes (Figure 2.3A), correspond to 1,038 distinct genomic positions, and 
show increased sensitivity at the splice regions (Figure 2.3B). Correlations between biological 
replicates were high (n = 31,583, rt = 0.94, p < 10-16, tetrachoric; r = 0.80, p < 10-16, Pearson) 
(Figure 2.S3D). To minimize false positives, we require replicate agreement within 0.20 instead 
of 0.30 used for the SRE library (STAR Methods). To ensure that MFASS-identified SDVs are 
robust to experimental artifacts, we additionally analyzed a number of controls. First, we tested 
the SNV library using three control sets (Figure 2.3C): (1) scrambled nucleotides, (2) a previously 
tested set of skipped exons in our SRE library, and (3) systematic mutations of both splice sites 
from the wild-type sequences. As expected, 24 of 24 (100.0%) scrambled nucleotides, 70 of 71 
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(98.6%) skipped exons, and 945 of 977 (97.3%) broken splice-signal sequences result in loss of 
exon recognition (inclusion index < 0.5) (Figure 2.3C), noting that alternative 5’ and 3’ splice site 
usage result in false negatives for MFASS. In addition, we also analyzed sequences containing 
synthetic errors resulting in single nucleotide deletions (n = 9,801) from our designed sequence 
library (STAR Methods). SDVs are enriched across the exon-intron junction at the splice acceptor 
and donor for these deletions derived from synthetic errors (Figure 2.3D). 
 
Finally, we further validated MFASS results individually for 34 SDVs across multiple functional 
classes of splicing variation across the original tested context as well as longer intronic contexts 
in HEK293T cells (Figure 2.3E; STAR Methods). Our results suggest that MFASS is robust 
across a majority of rare genetic variants tested for splicing defects. We individually verified SDVs 
using transient expression assays and found that nine of 11 (81.8%) showed large-effect splicing 
defects, with all 11 (100.0%) showing reduced exon inclusion relative to their respective wild-type 
sequences (Figure 2.3E). Furthermore, we tested the effect of longer intronic context on 
individual SDVs, and found that 17 of 23 (73.9%) showed large defects in splicing, with only one 
of 23 (4.3%) mutations showing no appreciable exon recognition defect (Figure 2.3E). Finally, to 
examine the cell-type specificity of SDVs, we further picked a subset of 15 SDVs with the 
strongest changes in exon inclusion, and tested wild-type or matched SDV reporter constructs 
across three additional cell types in the ENCODE consortium (n = 14,15 for HEK293T; n = 14,15 
for HeLa S3; n = 14,15 for HepG2; n = 14,15 for K562; n = WT, SDV respectively). We found that 
large-effect splicing disruptions are consistent across four cell types in all 15 of the splice-
disrupting variants assayed (15/15, 100.0%) (Figure 2.3F). Individually, exon inclusion levels also 
largely transfer across these cell types for all 29 sequences examined (Figure 2.S3E). 
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Figure 2.3. MFASS enables functional characterization of variant effect on splicing at scale 
across libraries of human variants. 
(A) The number of SNVs per exon sequence (top) and the Δinclusion index (bottom) of the 27,733 
ExAC SNVs are plotted against the wild-type exon backgrounds (n = 2,198), and colored by the 
inclusion index of the corresponding WT sequence. Both the top and bottom panels are ordered 
in decreasing number of variants tested from 44 to 1 per human exon background, with an 
average of 12.6 human variants and 3.8 SDVs per assayed wild-type exon sequence background. 
We find 1,050 of 27,733 SNVs tested (3.8%) are SDVs (Δinclusion index ≤ -0.5) and are broadly 
spread across the 543 human exon backgrounds in 473 genes. Dashed line indicates the 
threshold (Δinclusion index = -0.5) below which we call SDVs. 
(B) The change in inclusion index as a function of relative position for our SNV library across 
2,198 human exon sequences shows that the splice donor and acceptor sites are most sensitive 
to mutations. Intron-exon boundary on the left corresponds to the splice acceptor, while the intron-
exon boundary on the right corresponds to the splice donor. The splice donor is more sensitive to 
mutation because its consensus site is longer and more conserved. The bottom panel displays 
the relative sensitivity of each position. Each bin corresponds to 1-2 nucleotides per position, and 
locations are relative as we test a range of exon lengths.  
(C) Three control sets for validating the SNV library (n = 1,072). Most control sequences that were 
designed to cause exon skipping led to almost complete loss of exon recognition. The three 
control sets were (i) scrambled sequences (n = 24), (ii) a previously tested subset of exons that 
were skipped in the SRE library (n = 71), and (iii) breakage of the splice sites (n = 977). The 
broken splice-signal control library mutates 5’ splice sites (SD) at the downstream intron from GT 
to CC, and 3’ splice sites (SA) at the upstream intron from AG to TT. SD, splice donor, SA, splice 
acceptor. We include the distribution of wild-type sequences (i.e., natural exons) (n = 2,339, of 
which 2,198 sequences have relevant SNV data, STAR Methods).These exons initially 
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demonstrated exon inclusion in the SRE library (inclusion index ≥ 0.8), and we subsequently retest 
them and their associated SNVs in the SNV library. 
(D) We analyzed the effects of deletions derived from synthetic errors on exon inclusion. We 
showed the effect of exon inclusion for synthetic deletions (n = 9,801) across replicates, with an 
SDV rate of 3.59%. We observed an enrichment of SDVs at or near the splice sites. 
(E) We validated large-effect rare variants detected by MFASS (n = 34) and their corresponding 
wild-type sequences. We measured exon inclusion in either the original sequence context 
examined in MFASS (n = 11), or as a more stringent test with an additional 130bp of longer 
intronic contexts (n = 23) in HEK293T cells. For the longer set, we tested SDVs that represent 
variant classes in Figure 4B: missense variants (n = 3), synonymous variants (n = 3), intron 
variants (n = 4), splice donor (n = 4), splice acceptor (n = 5), and splice region variants (n = 4). 
The levels of exon inclusion were calculated for both the individual SDV and its respective wild-
type sequence. The change in % exon inclusion is calculated as an absolute difference for that of 
the mutant and the respective wild-type sequence, with a negative value indicating exon skipping 
for a variant relative to the wild-type. All mutants were normalized to a no-insert control as a 
baseline of complete exon skipping for the assessment of change in exon inclusion. Dashed line 
indicates the threshold (Δ % inclusion = 50%) below which we call splicing-disrupting variants 
(SDVs).  
(F) To examine the cell-type specificity of SDVs, we further picked a subset of 15 SDVs from the 
long intronic context with the strongest change in inclusion levels for testing their effects across 4 
cell types, and validated reporter constructs for wild-types (WT) or the corresponding SDVs. n = 
WT, SDV: 14,15 (HEK293T), 14,15 (HeLa S3), 14,15 (HepG2), 14,15 (K562). We found that 
large-effect splicing disruptions are consistent across 4 cell types in all 15 of the splice-disrupting 
variants assayed (15 of 15, 100%). The generalizability of per variant exon inclusion 
measurements across cell types is included in Figure 2.S3E. 
See also Figure 2.S3. 
 
Of the 1,050 SDVs detected, we observe almost equal contributions from introns (561, 54%) and 
exons (489, 46%) among the variants we tested (Figure 2.4A). We found that 76% of splice site 
variants are SDVs (Figure 2.4B, left). Compared to the splice site variants, variants in the broader 
splice region, synonymous exonic variants, non-synonymous exonic variants, and deeper intronic 
variants disrupt splicing more rarely at 8.5%, 3.0%, 3.1%, and 1.5% respectively (Figure 2.4B, 
left, Figures 2.S4A and 2.S4B). Interestingly, because SNVs are not equally distributed among 
these categories, splice site SDVs only constitute 17% of all SDVs, whereas intron variants, which 
are the least sensitive to splicing disruption, comprised 16% of SDVs (Figure 2.4B, right). The 
splice donor and acceptor regions show different patterns of sensitivity to splicing disruptions 
(Figure 2.4C), with splice donor regions being more sensitive than splice acceptor regions. SNVs 
at the  splice sites are rare in our library (Figure 2.4C, bottom, SNV density), and also for all ~7.4 
million  
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Figure 2.4. Global analysis of splice-disrupting variants across 27,733 ExAC SNVs in or 
near 2,198 human exons.  
(A) We functionally classified our variants by variant class from the Ensembl variant effect 
predictor (STAR Methods). SDVs (n = 1,050) from natural genetic variation are split almost 
equally between exonic and intronic regions (blue and red respectively). Dashed line separates 
the exonic regions (4%) and intronic regions (17%) of the splice region variants. Splice site 
variants are defined as those within 2 bp of intron adjacent to exon, whereas splice region variants 
are located 3 bp into the exon and 8 bp into the intron, excluding splice sites. 
(B) Splice site mutations are by far the most likely region to result in an SDV (left). However, 
because SNVs at splice sites are relatively rare, SDVs in regions other than the splice site 
constitute 83% of all SDVs (right). The distributions for non-SDVs across variant classes and the 
distribution of SDV effect sizes are shown in Figure 2.S4A. 
(C) The percentage of SDVs as a function of position along the exon and surrounding intron 
sequence shows that splice donor regions are more sensitive than splice acceptor regions (top 
panel). Plotted below is the average change in mammalian evolutionary conservation (phyloP 
score averages) and ExAC SNV density as a function of location. Each bin corresponds to 1 to 2 
nucleotides per position, and locations are relative to account for variable exon length. 
See also Figure 2.S4. 
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ExAC variants (Figure 2.S4C). The larger number of variants in regions away from the splice 
sites outweighs their reduced sensitivity (Figure 2.4C, bottom, SNV density), and contribute 83% 
of the 1,050 SDVs reported here.  
 
Population Genetic, Evolutionary and Functional Analyses of Splice-Disrupting Variants  
A number of population genetic, evolutionary, and functional characterizations indicate that our 
measured SDVs are relevant. First, the proportion of SNVs that are SDVs shows significant 
reductions as a function of allele frequency (chi-squared test, p = 1.03 x 10-4). Consistent with 
population genetic theory, a vast majority (98.8%) of our SDVs are extremely rare (allele 
frequency from the Genome Aggregation Database (gnomAD) < 0.5%) (Figure 2.5A). Second, 
we find a significantly lower SDV rate (~2x) within genes that rarely have protein-truncating 
variants (PTVs) within ExAC indicating strong functional constraint (pLI ≥ 0.9) (Lek et al., 2016) 
(Figure 2.5B) (two-tailed Fisher’s exact test, p = 3.0 x 10-11). Considering the rates of SDV and 
PTV overall, we conclude our SDV rate is at least on par to that of protein-truncating variants from 
ExAC. Third, SNVs that are SDVs show significantly stronger evolutionary conservation, 
suggesting purifying selection at these sites (Mann-Whitney U test, p < 10-16) (Figure 2.5C). 
Missense variants alone do not seem to drive the conservation signature, as the difference in 
mean phyloP conservation score is greater without missense variants (phyloPnon-SDV  = 0.04 vs 
phyloPSDV = 2.7) than with missense variants (phyloPnon-SDV = 1.4 vs phyloPnon-SDV = 3.1) (Student’s 
two-sample t-test, p < 10-16, two-sided), suggesting that SDVs are under stronger evolutionary 
conservation independent of missense variation. Fourth, nucleotide positions under strong 
evolutionary conservation have higher rates of SDVs, and this is especially apparent within introns 
(two-tailed Fisher’s exact test, p < 10-16) (Figure 2.5D). However, this conservation has limited 
predictive power, because within introns there are many more SNVs at neutral sites than sites 
under strong conservation, and within exons most sites are highly conserved (Figure 2.5E). Fifth, 
for exonic SNVs, we observed that SDVs significantly reduce exon hexamer scores when 
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compared with non-SDVs, suggesting that SDVs are disrupting important functional sites for exon 
recognition (Student’s t test, p < 10-16) (Figure 2.5F). Sixth, motif enrichments at the splice 
acceptor suggests that SDVs enriched for T to A mutations disrupt the area near the 
mechanistically important polypyrimidine tract, while for splice donors we find that guanine-rich 
motifs are less tolerated (Figure 2.S5A). Seventh, we found several enriched gene ontology (GO) 
terms for SDVs (compared to the tested SNV library) comprising of four enriched categories  
(Table 2.S3; STAR Methods). Three of the GO categories contain mostly collagen genes, many 
of which have large repeated protein domains. In addition, the last category, post-Golgi vesicle-
mediated transport, also contained a number of SDVs in genes with other repeat domains such 
as ankyrin and spectrin repeat domains. Such repeat-expansion genes can often be variable 
between populations, and in-frame exon skipping events are likely to have fewer severe 
consequences (Chan et al., 2008).  
 
Cross-validation of Individual SDVs 
It is likely that some fraction of SDVs detected by MFASS do not reflect actual changes in humans 
because minigene reporters are widely used but imperfect models of endogenous exon 
recognition (Cooper, 2005; Gaildrat et al., 2010). For example, we detect 11 SDVs with a minor 
allele frequency of greater than 0.5% that correspond to a set of common variants. Since common 
variants will likely overlap with other datasets, we first cross-referenced our ExAC library with the 
ClinVar database (Landrum et al., 2013). Only 0.5% (141/27,733) of the ExAC library is present 
in ClinVar, with eight SDVs and two annotated pathogenic variants in MTMR2 and PARN genes. 
To look more broadly in the datasets of healthy cohorts other than ExAC, we cross-referenced 
our assayed SNVs with the Genotype Tissue-Expression (GTEx) project (GTEx Consortium, 
2015). Overall, 9 of these 11 common variants have exon inclusion levels from GTEx (∆percent 
spliced in, ∆PSI, Figure 2.S5B), and three had globally significant differences (Figure 2.S5B, i, 
ii, and v). If we extend this analysis to rare variants as well, we were able to determine PSI values 
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for 1,471 assayed exons (STAR Methods), but only 28 are SDVs (including the common SDVs 
described above). Of these 28, seven (25%) show globally significant difference in exon inclusion 
levels from RNA-Seq, and five (20%) of which are larger effects. In addition, two additional SNVs 
have large-effect splicing disruptions in the single tissue they were expressed in (Figure 2.S5B, 
viii and vi). Overall, we consider magnitude instead of sign-concordance, which allows more 
stringent comparison of splicing changes for specific variants, and that there are some important 
caveats with this analysis. First, we only use pre-computed PSI values (STAR Methods), which 
cannot account for more complex splicing defects like alternative splice donors or acceptors. 
Second, the intersection of the two sets of variants are enriched for the most common variants 
that we call as SDVs, and are likely to be false positives because of the propensity of smaller 
effect changes in common variants.  
 
To better understand how rare SDVs in ExAC replicate in their full gene context, we assembled 
19 SDVs and associated wild-type controls for 12 full-length genes (4 to 13kb in length) using 
isothermal gene assembly, and examined splicing disruptions using RT-PCR after transient 
expression of the full gene (STAR Methods). We validated that 13 variants in nine genes cause 
splicing disruptions (Figures 2.S5C and 2.S5D) (68.4%, 13/19 variants; or 75.0%, 9/12 genes), 
with nine of 19 variants (42.1%) having appreciable effects on exon recognition. Interestingly, five 
of the detected changes involved alternative 5’ and 3’ splice site usage in the broader full gene 
context, indicating that many of the identified exon skipping events in MFASS might have different 
consequences in vivo. 
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Figure 2.5. Population genetics, evolutionary and functional analyses of splice-disrupting 
variants (SDVs) across 27,733 ExAC SNVs.  
(A) The percentage of SDVs as a function of allele frequency shows significant reductions across 
allele frequencies from the Genome Aggregation Database (gnomAD) (chi-squared test, p = 1.03 
x 10-4). A vast majority (97.9%) of the ExAC variants assayed were rare (gnomAD global minor 
allele frequencies (MAF) ≤ 0.5%). Allele frequencies are not available for 2,460 variants because 
of insufficient coverage in gnomAD.  
(B) We analyzed the proportion of SDVs and PTVs in genes predicted to be intolerant to loss-of-
function alleles (pLI ≥ 0.9) and tolerant genes. We observe both significantly fewer SDVs (two-
tailed Fisher’s exact test, p = 3.03 x 10-11) and significant fewer PTVs (two-tailed Fisher’s exact 
test, p < 10-16) for exons within intolerant genes. Dashed lines mark the overall percentage of 
SDVs (3.8%) and PTVs (1.2%) in our dataset without considering the pLI metric. 
(C) SDVs are under stronger evolutionary conservation as evidenced by higher overall phyloP 
scores (Mann-Whitney U test, p < 10-16). 
(D) Within introns, we find that positions that are evolutionarily conserved (deleterious, phyloP > 
2.0, purple) have a higher SDV rate than those under neutral (-1.2 ≤ phyloP ≤ 1.2, blue) or 
accelerating selection (phyloP < -2.0, green) (two-tailed Fisher’s exact test, p < 10-16).  
(E) There are more SNVs outside of regions of high intron conservation, which leads to many 
SDVs located within nucleotides that display neutral selection.  
(F) We observed a significantly higher negative maximum change in predicted exonic hexamer 
scores within exonic SDVs than non-SDVs (Student’s t test, p < 10-16).  
See also Figure 2.S5 
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Large-Effect Rare Variants on Splicing are Challenging to Predict 
 
Our results indicate that traditional metrics for assessing how mutations affect splicing are likely 
to fail, because while it is known that splice site variants are likely deleterious, it has been unclear 
to what extent rare genetic variation affects splicing outside of these sites. For example, the 
existing variant effect predictors for missense mutations, such as Polyphen and SIFT, either 
largely provide no annotation for SDVs or call them benign (Figures 2.6A and 2.S6A). 
Meanwhile, the SDV rate in synonymous mutations, which are usually assumed to be benign, is 
nearly equivalent to missense variants (3.0% vs 3.1%, Figure 2.3A).  
 
We used a number of contemporary variant effect predictors that are capable of predicting the 
effects of non-coding variation based on both functional genomic and/or evolutionary information 
(CADD, Kircher et al., 2014), DANN (Quang et al., 2015), FATHMM-MKL (Shihab et al., 2015), 
fitCons (Huang et al., 2017), LINSIGHT (Gulko et al., 2015), phastCons (Siepel et al., 2005) and 
phyloP (Pollard et al., 2010), as well as two specifically designed for splicing (SPANR, Xiong et 
al., 2015) and HAL (Rosenberg et al., 2015) (Figure 2.6B). Most predictors have low precision, 
with several providing no better prediction than random guessing. FATHMM-MKL, CADD, and 
DANN perform best among those not trained specifically for splicing, but only achieve ~7-8% 
precision at any appreciable recall. Much of their power is the result of the ability to call intronic 
SDVs (Figures 2.6C and 2.S6B), likely due to increased conservation or molecular function near 
or at those nucleotides. Not surprisingly, those predictors trained specifically for calling splice 
defects perform best. At equivalent effect size compared to our assay (>50% splicing disruption), 
SPANR achieves 44.5% precision, though only a minority of the SDVs are called (11.8%) (Figure 
2.6B). As we lower the threshold for calling an SDV (i.e., the predicted effect size of an SNV), 
SPANR can achieve 14.9% precision at 50% recall level, though the predicted effect size is ~2% 
loss of inclusion. More generally, the SPANR effect sizes poorly predict our observed inclusion
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Figure 2.6. Evaluation of genomic and deep-learning predictors for rare variation on 
splicing.  (A) Functional prediction from SIFT and Polyphen for missense SDVs (n = 250) show 
few are predicted to be loss-of-function variants. The distributions for missense non-SDVs for 
SIFT and Polyphen are shown in Figure 2.S6A. (B) Precision-recall curves for algorithms that 
can predict splicing or non-coding genetic variants. Dashed line represents the overall percentage 
of SDVs (3.8%) from MFASS. Corresponding receiver operating characteristic (ROC) curves are 
shown in Figure 2.S6B. (C) Precision-recall curves for algorithms that can predict splicing or non-
coding genetic variants, focusing on either intronic or exonic variants only.  
See also Figure 2.S6. 
 
rates (R2 = 0.11, Figure 2.S6C). The increased power of SPANR over other predictions is largely 
due to its ability to predict exonic SDVs. HAL provides even better precision in these exonic 
regions (Figure 2.6C), but only calls SNVs within exons. 
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DISCUSSION 
In this work, we tested over half of the variants found in 2,198 human exons across ~60,000 
individuals and observed that 3.8% of these variants (1,050 of 27,733) can cause loss of exon 
recognition. The rate of SDVs we find here is surprisingly high. Our SDV rate (3.8%) is ~73% of 
the rate of probably damaging variants predicted by PolyPhen for the same set of SNVs (5.2%, 
1,437 of 27,733), and ~3-fold higher than the observed rate of protein truncating variants found 
in ExAC as a whole (1.3%, 121,309 of 7,404,909) (Lek et al., 2016). We would expect such exon 
skipping events to be detrimental not only to protein function but, if our results generalize to exons 
that do not preserve frame, also cause large changes to mRNA stability through nonsense-
mediated mRNA decay (Lewis et al., 2003). This may help explain why extremely rare variation 
seems to have large predicted effects on gene expression even though we rarely observe 
individual mutations with large effects on transcription control elements (Hernandez et al. 2017, 
Li et al., 2017).  
 
In MFASS, most of the assayed SNVs result in either no effect or near complete exon skipping. 
These large effect sizes are in contrast with typical effect sizes of sQTLs (GTEx Consortium, 
2015, Pala et al., 2017, Takata et al., 2017). We speculate this apparent discrepancy is for several 
reasons. First, MFASS is not well suited to detect small-effect variations due to the limitations of 
flow cytometry; detecting 10% changes is difficult, unlike in RNA-sequencing. Second, we do 
reproducibly observe smaller differences for some SNVs, but the unnatural context and cell type 
in MFASS makes it unlikely that small-effect changes we observe actually reflect genuine 
changes in vivo. Third, most sQTL studies are done in tissue or blood RNA-seq from 
heterogeneous cell types. In contrast, in a homogeneous cell type we might expect more bimodal 
splicing events, such as those revealed in single-cell sequencing studies (Shalek et al., 2013, 
Faigenbloom et al., 2015). Fourth, sQTL studies are usually limited by small sample sizes and 
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thus are only powered to study common variation, where we would expect few large-effect 
disruptions to splicing (which we also observe in MFASS). As a vast majority of the variants we 
assay in MFASS are rare (91% of SNV library, gnomAD MAF <0.5%), we would expect a much 
larger percentage of large-effect changes. Indeed, many studies of rare variants find large-effect 
mutations that affect splicing, most notably in GTEx (Li et al., 2017) and in Mendelian diseases 
(Kremer et al., 2017).  
 
There are a number of technical and biological reasons we may be over- or under-estimating the 
number of SDVs using MFASS, including the choice of exon set and cell line, ascertainment bias 
in the experimental workflow, as well as limitations in the reporter assay. First, while minigene 
reporters represent an important standard for the evaluation of clinically relevant splicing 
mutations, false positives from individual validations of SDVs in their full gene context suggests 
that minigene reporters do not always capture the necessary context for splicing. Second, we only 
chose exons that are less than 100 bp in length, and start and end at phase 0, due to initial 
concerns we would only be able to screen in-frame exons using MFASS. We see no appreciable 
difference in average phastCons conservation in SNVs for in-frame and out-of-frame exons found 
in ExAC (Figure 2.S4C). However, we do find that these constraints do enrich for genes with 
large repeat expansions such as collagen, where an individual skipped exon is likely to have fewer 
functional consequences. Third, we may not be including enough intronic context to correctly 
diagnose mutations that will result in SDVs, even though most of the intronic conservation signal 
was contained within the intron sizes we chose (Figure 2.S6D). Because the intronic variation in 
our genome is on average ~3-fold greater than exonic variation from ExAC, we might be missing 
a substantial number of SDVs contained within intron regions we do not assay. In addition, 
because the ExAC consortium is an aggregation of exome sequencing data, surrounding introns 
have lower coverage and thus fewer covered SNVs. Further development in gene library 
synthesis may alleviate some, but not all of these issues (Kosuri and Church, 2014; Plesa et al., 
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2018). Fourth, because the expected number of constructs in each sorted bin is not equal, we 
may have more power to observe variants for skipped exons. To get an approximate upper-bound 
on this effect, we found an additional 15,665 SNVs that appear with at least one read in either 
replicate from our MFASS assay. If we assume these additional SNVs have no effect, we would 
have an SDV rate of 2.4% (1,050 of 43,398) instead of 3.8% (1,050 of 27,733). Fifth, because our 
reporter can only faithfully report exon skipping when fluorescence is reconstituted, any 
alternative 5’ and 3’ splice site usage are false negatives from MFASS, which could still lead to 
large loss-of-function effects by disrupting protein domains or frame-shifting. Alternatively, SDVs 
detected by MFASS as exon skipping events might also manifest as alternative splice donors or 
acceptors in vivo, as seen in many of the variants also found in GTEx. Finally, we only tested a 
subset of SDVs for potential cell-type specific splicing regulation. While the SDVs appear to 
transfer between cell types (Figure 2.3F), there may be certain variants that have cell-type 
specific effects and thus will require MFASS to be conducted in relevant cell types to be detected. 
 
Our results suggest loss of exon recognition by rare human variants may be a major source of 
functional and expression variation, and their effects are particularly difficult to predict a priori 
using computational prediction. We show most of the large-effect rare variation on splicing 
would not be easily recognized, as only ~17% of such functional rare variation we found are in 
canonical splice sites. Compared to other multiplexed splicing reporters, MFASS is unique in 
that it screens both exonic and intronic variants, uses long constant intron backbones, site-
specifically integrates reporters into the same safe-harbor loci at single copy, is applicable to a 
broad spectrum of human exons, and provides increased power for detecting large-effect loss-
of-function variants (Julien et al., 2016; Ke et al., 2011; Rosenberg et al., 2015; Soemedi et al., 
2017; Adamson et al., 2018). MFASS is best suited for screening large numbers of large-effect 
rare variants, which is especially useful for the analysis of mutations in Mendelian diseases, 
cancer, and population genetics. MFASS is the largest study of splicing defects in SNVs of 
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natural human exons to date by ~10-fold, and can likely be scaled substantially. More broadly, 
MFASS, combined with multiplexed assays for variant effects (Gasperini et al., 2016), can help 
interpret variants found in large exome datasets to obtain a broader understanding for how rare, 
de novo, and somatic variants are shaping complex traits and diseases (MacArthur et al., 2014). 
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STAR METHODS 
 
CONTACT FOR REAGENT AND RESOURCE SHARING 
 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Sriram Kosuri (sri@ucla.edu). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Human cell lines 
All cell culture reagents were obtained from Thermo Fisher Scientific. HEK293T chromosomal 
landing pad cells and derivatives, HepG2 cells, and HeLa S3 cells were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/mL 
penicillin, and 0.1 mg/mL streptomycin. K562 cells were cultured and maintained in RPMI 
supplemented with 10% FBS, 100 U/mL penicillin, and 0.1 mg/mL streptomycin. All cells except 
K562 cells were passaged using 1x TrypLE Express. All restriction enzymes were obtained from 
New England Biolabs. Plasmid modifications were performed either by restriction cloning or 
Gibson assembly (SGI-DNA). Synthesized genes were obtained as sequence fragments from 
either Gen9 or Twist Biosciences. All oligonucleotides indicated below were obtained from IDT 
Technologies or Eurofins. 
 
METHOD DETAILS 
Splicing reporter design 
The organization and key features of our MFASS splicing reporter constructs are as follows: 
emerald GFP (emGFP) coding sequence is split into two exons that flank a constant intron 
backbone sequence (Figures 2.S1A-S1D). emGFP is split at two different locations for various 
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reporter designs without disrupting the downstream reading frame. For the SRE library and 
version 1 of the SNV library, the reporter library contains exons that start and end on phase 1. 
For version 2 of the SNV library, the reporter library contains exons that start and end on phase 
0. The synthetic sequence library is cloned into a pair of restriction sites, AgeI and NheI, or AscI 
and PacI, in the middle of the backbone. The expression of the splicing reporter module is 
driven by the CAG-GS promoter. For selection of genomic integrants, we included a Bxb1 attB 
site and promoterless puromycin such that drug resistance is conferred in the HEK293T cell 
library following site-specific recombination, due to a CAGGS promoter adjacent to the Bxb1 
attP site in the landing pad cell line. We tested two sets of longer constant intron backbones 
with >250bp of sequence for each intron, which have both been previously characterized as 
more faithful intron backbones in the context of such three-exon, two-intron reporters (Figures 
2.S1A-S1D). These two backbones were the C. griseus long DHFR intron backbone (Arias et 
al., 2015) and human SMN1 intron backbone (Cho et al., 2015) (Figures 2.S1A-S1D). In 
particular, the long DHFR introns were the same introns used in previous characterizations of 
exon definition (Arias et al., 2015). 
 
Microarray-derived oligonucleotide library design 
We obtained microarray-derived oligonucleotides of 200 to 212 bp from Agilent Technologies to 
generate synthetic DNA libraries. We selected human exons that are less than 100 bp and begin 
and end on frame 0 from the Ensembl mySQL server (Aken et al., 2016). We designed a 170-bp 
intron-exon-intron sequence library in silico containing all 9,634 human exons fulfilling above 
criteria (Ensembl release 73, hg19 assembly), which includes at least 40 bp of upstream intron 
and at least 30 bp of downstream intron, with the exon in the middle. We added extra native 
intronic sequences as length limitations allowed (i.e., if exons were shorter), split between the 
upstream and downstream equally with an extra base added to the donor side for odd number of 
bases added. Finally, a pair of 15-mer amplification primer sequences, containing either AscI and 
 
 
 
 46 
PacI or AgeI and NheI restriction sites, were added to yield 200-mer or 212-mer sequences for 
DNA synthesis respectively for the SRE or SNV libraries. 
 
Design of SRE library 
For the SRE library, we obtained 9,634 human exons that are less than 100 bp and begin and 
end on frame 0, and designed a 170-bp exon library with its surrounding intronic contexts, that 
includes at least 40 bp of upstream intron and at least 30 bp of downstream intron. Overall, we 
randomly chose 230 exons from this set and designed 60-80 synonymous mutations per 
sequence that correspond to specific functional classes of regulatory elements governing splicing 
using a toolkit of custom Python scripts we developed for scoring these mutations using defined 
scoring criteria as detailed below. We focused on three major motif types related to splicing in our 
custom scoring algorithm (Table 2.S1). The first major motif type is the splice acceptors and 
donors. These sequences are scored with MaxEntScan (Yeo and Burge, 2004), an algorithm 
based on the maximum entropy principle that learns splice site motif strength. The second major 
motif type is the exonic splicing enhancers/silencers (ESEs/ESSs) based on the results from Ke 
et al. (Ke et al., 2011). The third major motif type is the conserved intronic sequences that affect 
splicing in either the acceptor or donor side of the intron (Voelker and Berglund, 2007). Next, we 
iteratively designed synonymous mutations in exons and/or introns that affect splicing (Table 
2.S2). Mutations made to sequences were scored in the same fashion as wild-type sequences, 
with a higher score as a proxy for increased exon inclusion. Mutations were scored and generated 
to weaken, strengthen or destroy splicing motifs. We define functional classes of mutants that 
differ in score requirements, minimum base separation between mutants and the number of 
mutants per class. Mutations were made iteratively until we generate the desired number of 
mutants or reach the maximum number of iterations. For splice sites or splice regions, the 
invariant positions of the splice donor or acceptor are not mutated, with the exception for the 
“weaken splice site” category. In addition, we tested 53 RNA-binding protein motifs obtained from 
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the RNA-binding protein database (RBPDB) (Cook et al., 2011) as position frequency matrices 
and thresholded at 1% false positive rate, and 109 human single-nucleotide polymorphisms 
(SNPs) obtained from dbSNP (build 133) (Smigielski, 2000). 
Design of SNV library 
For the SNV library, we started with a library of 2,920 natural exons that exhibited exon inclusion 
using MFASS (inclusion index ≥ 0.8; SRE library, DHFR intron backbone). We designed single 
nucleotide variants (SNVs) from the Exome Aggregation Consortium (Lek et al., 2016) (ExAC, 
version 0.3.1). We stored hg19 genomic coordinates of each sequence in BED file format, and 
used bcftools to intersect the ExAC variants with our library of wild-type human exons to subset 
all relevant SNVs. We only synthesized variants with a filter status of “PASS”, and generated all 
alternate alleles (up to 3) if more than one alternate allele was indicated. These sequences were 
filtered to (i) exclude sequences containing unique NheI or AgeI restriction sites used for library 
cloning and (ii) include SNVs only within nucleotides 11 through 160 of each 170 bp library 
sequence to avoid possible spurious interactions with restriction sites, resulting in 2,902 exons as 
template with their associated variants that fit above criteria. 
 
We designed two library subpools with redundancy for wild type that enables separate retrieval 
of sublibraries from the microarray. We transfected these pools at the stage of plasmid reporters 
at the ratio of 1:3 that enables increased representation of natural sequences. From the initial 
design carried through to the completion of MFASS, 80.5% of the designed natural sequences 
(2,339 of 2,902) were represented in the final cell reporter library. 2,198 out of 2,339 natural 
sequences have at least one corresponding SNV, while an additional 30 sequences 
represented in the control library. Ultimately, we only report and include SNV data for which 
data for natural sequences are available, have replicable data across two biological replicates, 
and have an inclusion index of greater than or equal to 0.5 for wild-type. For these 2,198 exon 
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backgrounds, we obtained the corresponding paired variant data for 27,733 SNVs, from which 
1,050 SDVs are observed (Figures 2.3A and 2.4A). 
 
Library amplification and cloning 
The splicing regulatory element (SRE) library was amplified with KAPA HiFi HotStart (KK2701) 
in eight 50 μL reactions, each with 500 pg of oligonucleotide library, and 0.4μM of ORC405 and 
ORC406 primers. The reaction and cycling conditions are: 95°C for 3 minutes, 5 cycles of 95°C 
for 3 seconds, 50°C for 20 seconds, 60°C for 10 seconds, 15 cycles of 95°C for 3 seconds, 
60°C for 30 seconds, followed by an extension of 60°C for 5 minutes. The SRE library was 
amplified similarly as above with ORC403 and ORC404 primers, as well as the following cycling 
conditions: 95°C for 3 minutes, 5 cycles of 95°C for 3 seconds, 50°C for 20 seconds, 60°C for 
10 seconds, 11 cycles of 95°C for 3 seconds, 60°C for 30 seconds, followed by an extension of 
60°C for 5 minutes. Splicing reporter plasmids and SRE library were digested with AscI and 
PacI. Reporter plasmid and library were ligated with T4 DNA ligase (New England Biolabs).  
For the SNV library, we performed similar procedures as above with the following alterations: 
we performed emulsion PCR for the two subpools (35 cycles) containing both natural exons and 
SNVs with biotinylated primers. The second subpool was amplified similarly (40 cycles), with 
biotinylated ORC513 and ORC514 primers, and both pools were processed with AgeI and NheI 
at 37°C before ligation-based cloning in E. coli.  
 
Generation of landing pad cell lines and integration 
For site-specific integration of exon libraries in HEK293T cells, we engineered a chromosomal 
landing pad cell line which allows stable expression of splicing reporter library at the AAVS1 
locus, which is modified from Duportet et al. by CRISPR-Cas9 in order to remove expression of 
the endogenous YFP gene (Duportet et al., 2014). We characterized 25 clones expanded from 
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single cells by flow cytometry, microscopy and genomic PCR, and selected a clone (which we 
termed RCA7) that does not express any YFP or mCherry fluorescence for our current study.  
 
We site-specifically integrated the splicing reporter using Bxb1 integrase into cells containing 
the chromosomal landing pad (Figures 2.1 and 2.S1), first without any exon library sequences 
between the intron backbones, and later with individual exons and/or synthetic sequence 
libraries cloned in between. For the SRE library, we transfected HEK293T chromosomal landing 
pad cells, grown in six T-225 flasks (BD) per biological replicate that were processed in tandem. 
Each T-225 flask was transfected at 80% confluency with 50 μg of plasmids containing exon 
library and Bxb1 integrase, and 150 μL Polyethylenimine (Polysciences Inc.) or 75 μL 
Lipofectamine 3000 (Thermo Fisher Scientific). Cells were transfected for 72 hours, and then 
selected with 5 μg/mL puromycin (Thermo Fisher Scientific). Cells were subsequently passaged 
serially for at least 18 days before cell sorting. For the SNV library, we transfected HEK293T 
chromosomal landing pad cells, grown in sixteen 150 cm2 plates (45 μg plasmids per plate) for 
three days, pooled and transferred to two 4500 cm2 roller bottles (BD Biosciences) or equivalent 
volume for 150 cm2 plates per biological replicate, selected for integrants as above, and 
maintained in eight 150 cm2 plates per biological replicate for 20 days before cell sorting. 
 
Fluorescence-activated cell sorting 
We measured cell samples for GFP and mCherry fluorescence intensities by flow cytometry (BD 
LSRFortessa or LSRII) across passages. Cells harboring variant libraries were sorted using a 
FACSAria III (BD Biosciences) into bins based on GFP fluorescence, given a minimal amount of 
mCherry fluorescence (threshold set using a genome-integrated mCherry driven by the 
pCAGGS promoter as a positive expression control, Figure 2.1A). For the SRE library (DHFR 
intron backbone), we sorted ~7.5 million cells for GFP+ and GFPneg bins, and 7.5 x 105 cells for 
GFPint bin. For the SRE library (SMN1 intron backbone), we obtained ~4 million cells for GFP+ 
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and GFPneg bins, and 4.2 x 105 cells for GFPint bin. Sorted sub-libraries for each replicate were 
grown separately and passaged. We eliminated dead cells, debris, and doublets based on 
forward and side scatter, and single-color and double-negative controls were used for gating 
and calibration. For the SNV library (v1), we performed two sorts to ensure purity of the final 
populations of GFP+, GFPint and GFPneg cells (Figure 2.S3A). For the first sort, we obtained 16 
million cells for GFPneg library, 2.6 million cells for GFP+ library and 2.7 million cells for GFPint 
library (biological replicate 1), 15 million cells for GFPneg library, 2 million cells for GFP+ library 
and 2.8 million cells for GFPint library (biological replicate 2). For the purifying sort, we further 
sub-sorted the libraries from the first sort, and obtained ~2 million cells for GFPneg library, 1 
million cells for GFP+ library and 2.5 million cells for GFPint library (biological replicate 1), and 1 
million cells for GFPneg library, 1 million cells for GFP+ library and 2.5 million cells for GFPint 
library (biological replicate 2).  
 
For the SNV library (v2), we sorted cells based on GFP fluorescence into four bins: GFP+, 
GFPint-hi, GFPint-lo, and GFPneg bins (Figure 2.S3B). For both biological replicates, we obtained 
16 million cells for GFPneg library, 2 million cells for GFP+ library, 2 million cells for GFPint-hi and 
GFPint-lo library.  
 
DNA-Seq of FACS-sorted libraries 
To obtain cells containing a single individual reporter construct, we first sorted single cells by 
FACS from individual bins, with GFP fluorescence gates defined from library sort, and expanded 
homogeneous clones from single cell sort. For the SRE library, we extracted genomic DNA from 
10 million cells for the sorted populations using blood and cell culture DNA midi kit (Qiagen). We 
amplified each sublibrary for ~300-fold amplicon coverage, and reactions were performed in 96-
well format in three to nine 50 μL reactions for each sublibrary proportional to bin size. Per 
biological replicate, we amplified library variants from genomic DNA with KAPA HiFi HotStart, 
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using 5 μg of template for GFP+ and GFPneg sub-libraries, and 2 μg of template for the GFPint 
sublibrary, with 500 nM of the primers ODY093 and ODY028 for the DHFR intron backbone, or 
the primers ODY088 and ODY089 for the SMN1 intron backbone. The following cycling 
conditions were used: for the DHFR intron backbone, 98°C for 45 seconds, 23 cycles for GFPint, 
or 22 cycles for GFP+ and GFPneg using: 98°C for 15 seconds, 68°C for 30 seconds, 72°C for 30 
seconds, followed by an extension of 72°C for 1 minute; for the SMN1 intron backbone: 98°C for 
45 seconds, 24 cycles for GFPint, or 29 cycles for GFP+ and GFPneg of: 98°C for 15 seconds, 
68°C for 30 seconds, 72°C for 30 seconds, followed by an extension of 72°C for 1 minute. The 
reactions for each population were pooled separately, purified and gel-extracted on 1% agarose 
gel and quantified using Tapestation 2200 (Agilent).  
 
For the SNV library, procedures were performed similarly to the SRE library in the DHFR intron 
backbone, with the following optimizations. Library variants was amplified from genomic DNA 
(ORC515 and ODY028), and genomic DNA was extracted similar to procedures for the SRE 
library. Sorted libraries were indexed by PCR amplification, in twenty-four 50 μL reactions for 
GFPneg and eight 50 μL reactions for all other sublibraries, using the forward primer ORC522, 
and the reverse primers ODY32 through ODY41, and ORC531 through ORC534.  
 
Validation of MFASS using individual exon controls 
We performed individual controls to assess the correspondence to sequences in our library and 
to observe consistent splicing behavior across RNA and fluorescence output. For the data from 
Figures S1N through S1Q, we characterized more than 20 cell clones expanded from single 
cells, and only 9 individual sequences that perfectly match the reference SRE library were used 
for RT-PCR and flow cytometry analysis. 
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RNA from sorted sub-libraries as well as individual control exons were extracted using RNEasy 
MiniKit (Qiagen). Reverse transcription-PCR was performed using Superscript III or Superscript 
IV (Thermo Fisher Scientific) according to manufacturer’s protocol using reverse transcription 
primer (Table 2.S4), which binds to a region in exon 2 of emGFP, and PCR was performed with 
extracted cDNA. The reaction and cycling conditions are optimized as follows: 95°C for 2 
minutes, 18 cycles of 98°C for 3 seconds, 62°C for 15 seconds, 72°C for 10 seconds, followed 
by an extension of 72°C for 2 minutes.  
 
34 SDVs were tested for exon inclusion by transient transfection using Lipofectamine 3000 (Life 
Technologies) in HEK293T cells for 24 hours. A ratio of GFP:mCherry fluorescence was obtained 
in linear mode (BD LSRII or BD LSRFortessa) for the comparison of exon inclusion rates across 
samples. We subtracted background fluorescence based on a transfected empty vector control, 
and only consider GFP:mCherry fluorescence above the threshold. We tested sequences either 
exactly in the original sequence context in the reporter construct examined in MFASS, or with an 
additional 130 bp of endogenous intronic contexts (65 bp upstream and 65 bp downstream). 
Percent inclusion is calculated for both the individual SDV and its respective wild-type sequence, 
with the change in percent inclusion calculated as the absolute difference between the mutant 
and the wild-type sequence. All mutants were normalized to a no-insert control as a baseline for 
complete exon skipping for assessment of change in exon inclusion. 
 
Cell-type specificity of SDVs across four cell types 
We tested 29 human exons with its surrounding intronic contexts (15 SDVs with the 14 
corresponding wild-type sequences) across 4 human cell types. The four human cell lines 
tested are HEK293T (RCA7 cell line established in this study), HeLa S3 (ATCC CCL-2.2), 
HepG2 (ATCC HB-8065) and K562 (ATCC CCL-243). We validated these constructs across cell 
types in the same manner that we validated individual exon controls in above section. 
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Validation of rare SDVs in full genes 
We considered rare 61 SNVs in 34 genes that have a change in inclusion index of ≤ -0.50 
across both replicates from MFASS (i.e. SDVs) under 15kb. From these, we were able to 
assemble complete 12 wild-type full genes (up to ~13kb) with at least one corresponding SDV 
(19 SDVs total, Figures 2.S5C and 2.S5D). Using isothermal gene assembly, mutations were 
introduced in the middle of the oligonucleotide with ~40bp overlap on each overlapping 
fragment, and assembled without the mutations for the wild-type gene sequences. Genomic 
sequences with wild-type and matched SNVs were amplified from the same human genomic 
DNA template (NIST, SRM 2372, or Promega, G1521) using PrimeSTAR GXL polymerase 
(R050, Takara). Each partial gene fragment was amplified using 25ng of genomic DNA in a 
single 50μL PCR reaction, and purified with either the DNA Clean and Concentrator Kit (Zymo 
Research) or Agencourt AmPURE XP beads (Beckman Coulter). The reaction and cycling 
conditions are optimized as follows: 94°C for 1 minute, 28 to 30 cycles of 98°C for 10 seconds, 
68°C for 5 minutes, followed by an extension of 72°C for 5 minutes. A linear plasmid backbone 
fragment (~5.2kb) was prepared for isothermal assembly using BamHI and SacI, purified and 
concentrated using DNA Clean and Concentrator Kit (Zymo Research), and further gel purified 
using Zymoclean Gel Recovery Kit (Zymo Research). We expressed a subset of these fully 
assembled genes between the BamHI and SacI sites of the splicing reporter plasmid backbone 
in this study, in place of the MFASS splicing reporter (see Splicing Reporter Design section). 
We performed isothermal assembly of 3 to 4 gene fragments of interest and the plasmid 
backbone using the Gibson Assembly Ultra Kit (SGI-DNA), and transformed into 
electrocompetent DH10B E. coli cells (New England Biolabs, or Life Technologies) to select for 
correct gene assembly. We confirmed the sequence for each gene with or without splice-
disrupting variants using Sanger sequencing, before transfection into HEK293T cells for testing 
of mutation effects. We extracted and performed reverse transcription from RNA using the Cells 
to cDNA II kit (Thermo Fisher Scientific) and corresponding gene-specific primer for each exon 
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(Table 2.S4) according to manufacturer’s protocol. For each tested exon, qPCR was performed 
with SYBR FAST qPCR Mastermix (Kapa Biosystems), using 1μL of reverse-transcribed cDNA 
in a 20μL PCR reaction, as well as primers flanking the upstream and downstream exons, and 
compared RT-PCR gene 
products of wild-type and mutant sequences for each gene of interest. Fragments of interest 
were further PCR purified and verified using Sanger sequencing. 
QUANTIFICATION AND STATISTICAL ANALYSIS 
DNA-Seq read processing and filtering 
SRE library datasets were generated from two Illumina MiSeq 300-bp paired-end sequencing 
runs and a Illumina HiSeq 2500 150-bp paired-end sequencing run. SNV library version 1 dataset 
was generated from Illumina MiSeq 300-bp paired-end sequencing. SNV library version 2 dataset 
was generated from Illumina NextSeq 2500 150-bp paired-end sequencing. We removed read 
pairs with any ambiguous “N” base calls, followed by read pair merging with bbmerge from the 
BBMap suite (BBtools package version 37). We developed custom Python and bash scripts to 
filter for perfect reads aligned to our reference, from which we can aggregate read counts for 
sequences from each sorted bin. We then further process these read counts to calculate inclusion 
index (see below section on the quantification of inclusion index).  
 
To allow for stringent analysis of replicable data for SNVs, we require a coverage of at least 5 
reads for the SRE library and at least 10 reads across all bins for the SNV library for the two 
biological replicates. Our SRE library size was 16,717 (5,975 wild-type sequences, 10,683 
mutants, 59 controls) for the SMN1 intron backbone, and 13,922 (4,920 wild-type sequences, 
8,942 mutants, 60 controls) for the DHFR intron backbone. We additionally require that inclusion 
indices agree between biological replicates within 0.30 (SRE library) and 0.20 (SNV library). For 
the SNV library, we only analyzed a mutant sequence if its corresponding wild-type sequence 
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has an inclusion index of ≥ 0.5. The final library size after all filtering steps for the SRE library is 
10,482 (3,714 wild-type sequences, 6,713 mutants, 55 controls). The final library size after all 
filtering steps for the SNV library size (version 1) is 6,768 (1,981 wild-type sequences, 3,853 
mutants, 934 controls). The SNV library size (version 2) is 31,144 (2,339 wild-type sequences, 
27,733 mutants that correspond to 2,198 wild-type sequences, 1,072 controls). 
Exon inclusion quantification 
We normalized bin counts based on read depth (reads per million, RPM) and corresponding bin 
population percentage after FACS using the following formula:  
 
We calculated exon inclusion index for each sequence based on a weighted average of 
normalized counts across all bins. Bin weights are assigned based on GFP fluorescence 
measurements of individual bins that correspond to the extent of exon inclusion or skipping. For 
the splicing regulatory element (SRE) library and single nucleotide variant (SNV) library, version 
1: 
 
 
For the SNV library, version 2: 
 
The change in inclusion index for an individual library sequence between wild-type (WT) and 
mutant is computed as follows: 
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A positive Δinclusion index denotes increased exon inclusion for the mutant relative to WT, while 
a negative Δinclusion index denotes increased exon skipping for the mutant relative to WT. 
 
ExAC and gnomAD data analysis 
Annotation of variants for individual human samples in VCF format were obtained from the Exome 
Aggregation Consortium (Lek et al., 2016) (ExAC, version 0.3.1), including global allele 
frequencies. We further obtained global allele frequencies of individual variants from the Genome 
Aggregation Database (gnomAD). We binned gnomAD global allele frequency similar to the ExAC 
study (Lek et al., 2016), and tested for significant difference between allele frequency bins using 
chi-squared test of independence. We obtained the rate of protein-truncating variants from ExAC. 
We also obtained gene level evolutionary constraint estimates from ExAC based on probability of 
loss-of-function intolerance (pLI), and defined genes that are extremely intolerant of loss-of-
function as those with a pLI score ≥ 0.9. We then tested for genes with enrichment in splice-
disrupting variants (SDVs) using Fisher’s exact test.  
Functional genomic analysis of SNVs 
We functionally classified our variants using the Ensembl variant effect predictor (McLaren et al., 
2016) (VEP v80), and filtered the most severe sequence ontology (SO) term for a given variant. 
We obtained phyloP 100-way (v1.4) nucleotide conservation for the hg38 genome for the SNV 
library, and classified quickly evolving regions of the genome (accelerating, phyloP < -2.0), neutral 
selection (-1.2 ≤ phyloP ≤ 1.2) and highly conserved region of the genome (deleterious, phyloP > 
2.0). To compute genome-wide locations of ExAC SNVs by gene regions, we used GENCODE 
(Harrow et al., 2012) (release 27, GRCh38 reference assembly) for exon annotation, and bedtools 
(Quinlan, 2014) to annotate intronic regions by subtracting exon coordinates from gene 
coordinates. To determine the density of SNVs for each genomic position, we determined the 
number of SNVs averaged at each relative position for the SNV library across exons and 
upstream/downstream introns, and relative position is set such that the boundary of upstream 
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intron/5’ exon = 0, and the boundary of 3’ exon/downstream intron boundary = 1. In addition, we 
incorporated scaled positions to normalize for variable intron and exon lengths. We performed 
similar positional SNV density analysis for genome-wide SNVs from the ExAC consortium across 
gene regions.  
Motif analysis 
To define potential disruption of k-mer motifs by ExAC SNVs, we performed k-mer based motif 
enrichment analysis using kpLogo (git/e2fac18) for both splice acceptor (positions -20 to +3, 
upstream intron-exon junction) and splice donor (positions -3 to +6, downstream exon-intron 
junction). Based on our SNV dataset, SDVs are background-corrected against non-SDVs to 
obtain motif logos that are enriched or depleted at each nucleotide. We used a p-value cutoff of 
p < 0.01, gapped k-mer length of k = 1,2,3,4 and fixation frequency of 0.75 (Wu and Bartel, 2017).  
 
We scored splice acceptors and donors at the consensus positions, same as above, using 
MaxEntScan (Yeo and Burge, 2004), an algorithm based on the maximum entropy principle than 
learns splice site motif strength (Table 2.S1). We scored exonic splicing enhancers/silencers 
(ESEs/ESSs) based on work from Ke et al. 2011 and scored conserved acceptor and donor 
intronic sequences based on work from Voelker and Berglund, 2007. 
 
In addition, we implemented the hexamer additive linear (HAL) model, which estimates a splicing 
strength score for every possible exon hexamer (Rosenberg et al., 2015). A positive score 
indicates the hexamer is more likely to activate nearby splice sites, and a negative score indicates 
the hexamer is more likely to silence nearby splice sites. For each variant, we calculated the 
change in score at each position relative to the wild-type sequence, and identified the maximum 
change in score. We compared the distribution of maximum score change between SDVs and 
non-SDVs using the Mann-Whitney U test, which does not assume normality. 
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Assessment of variant prediction algorithms 
To computationally predict the effects of rare genetic variants on splicing, we used various 
prediction algorithms that are able to assess coding and/or non-coding SNVs in our assay. For 
the purpose of method comparison, we selected Δinclusion index ≤ -0.5 as the threshold for 
splice-disrupting variant (SDV) and designate our calls as true positives. We assessed 
performance by varying the score threshold at which a variant is called splice-disrupting 
(considering whether the score is positively or negatively correlated to Δinclusion index). We 
assessed various genomic predictors that use a variety of machine learning methods, 
annotations, and training sets to predict the functional impact of coding and non-coding variants. 
These methods incorporate a variety of functional data, including conservation, histone 
modifications, DNase hypersensitivity, transcription factor binding, transcript abundance, and 
protein-level scores.  
 
We obtained functional scores of single nucleotide variants from four genomic predictors based 
on the hg19 assembly: raw CADD scores from CADD v1.3 (r0.3 Exome Aggregation 
Consortium dataset), DANN whole-genome SNV scores (Nov. 2014), FATHMM-MKL 
(git/908d865), fitCons multi-cell (i6 dataset, git/20f336d) highly significant scores (p < ~0.003), 
and LINSIGHT (git/58fe558). For SPANR (splicing-based analysis of variants) (Xiong et al., 
2015), we obtained the predicted change in percent spliced in (Δψ, or ΔPSI) for single 
nucleotide variants in our SNV library across the genome. The hexamer additive linear model 
(HAL) (Rosenberg et al., 2015) can only assess exonic variants. 
 
To consider the predictive power of conservation alone, we obtained phyloP 100-way (v1.4) 
nucleotide conservation for the hg19 genome for the SNV library. In addition, we obtained 
phastCons (v1.4) scores for 100-way eutherian mammalian nucleotide conservation for our SNV 
library and genome-wide SNVs from the ExAC consortium (Siepel et al., 2005). To assess the 
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functional effects of missense, exonic single nucleotide variants from the SNV library, we used 
variant annotations from PolyPhen (v2.2.2) and SIFT (v5.2.2).  
 
We assessed above predictors using receiver operating characteristic and precision-recall 
analysis. We used the pROC package version 1.10.0 to compute and plot the ROC curves, 
calculate the 95% confidence interval, and calculate the area under the curve. The precision recall 
curves were plotted with a custom function which evaluates each method by varying the score 
threshold at which a sequence is classified as an SDV, and calculating the corresponding 
precision and recall. The area under the precision recall curve is calculated with the trapz function 
in R.  
 
Analysis of SDVs from GTEx RNA-Seq 
Genotype data (from Illumina SNP arrays, whole exome sequencing, or whole genome 
sequencing) and RNA-Seq data were obtained from the GTEx database (v6p release, GTEx 
Consortium, 2015). To get a list of high-quality SNVs for further analyses, we used a quality 
filter of GQ ≥ 20 for whole-genome sequencing and whole-exome sequencing and a quality filter 
of IGC ≥ 0.2 for Illumina SNP arrays, all of which were provided by GTEx. These cutoffs are 
similar as recommended by the GATK package (DePristo et al., 2011; Van der Auwera et al., 
2013). In addition to the genotyped SNPs, we also identified dbSNPs (version 146) that are 
expressed in the RNA-Seq data by requiring a minimum total read coverage of 10 and a 
minimum read coverage of 3 for the alternative allele (Zhang and Xiao, 2015). 
 
The RNA-Seq data in FASTQ format were first adaptor-trimmed using Cutadapt (Martin, 2011). 
Subsequently, the reads were aligned to the hg19 genome and transcriptome (Ensembl 
Release 75) using HISAT2 (Kim et al., 2015) with parameters --mp 6,4 --no-softclip --no-mixed -
-no-discordant. Only uniquely mapped read pairs were retained for further analyses. Samples 
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with fewer than 25 million uniquely aligned read pairs were excluded due to low depth for 
splicing analysis. In total, 7822 RNA-Seq datasets from 47 tissues and 515 donors were 
retained.  
 
Percent-spliced-in (PSI) values were calculated using the method described in Schafer et al. 
(Schafer et al., 2015). This analysis was carried out for all internal exons from the GENCODE 
comprehensive annotation (v24lift37). To ensure the accuracy of PSI estimation, we required 
the exons to be covered by ≥ 15 total reads (inclusion reads + exclusion reads) or ≥ 2 exclusion 
reads per sample (Barbosa-Morais et al., 2012; Hsiao et al., 2018). 
 
We compared PSI values from tissues expressing the gene containing an SDV with a cutoff of 
transcript per million (TPM) ≥ 1 based on median gene TPM values. After filtering on 
expression, exon PSI for 28 SDVs (out of 1,050 ExAC SDVs in this study) were available in at 
least one tissue sample. The distribution of PSI values across tissues was compared for 
individuals with the alternative SDV alleles versus those with the corresponding reference 
alleles. Comparisons were made with the Mann-Whitney U test, and adjusted p-values were 
calculated using the Benjamini-Hochberg procedure at an FDR of 5%. 
 
Gene ontology enrichment analysis 
We performed Gene Ontology (GO) enrichment analysis using the topGO package in 
Bioconductor (Alexa, A. and Rahnenfuhrer, J. 2016) between SDV-containing genes (n = 473, 
for 1,050 SDVs) and all genes in the ExAC SNV library (n = 1,616, for 27,733 SNVs). We 
determined over-representation of GO terms for SDV genes based on gene counts using 
Fisher’s exact test. Each GO term is tested independently and only terms with p < 0.01 are 
shown (see Table 2.S3). 
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Software 
bbmerge from the BBMap suite (v37) was used to merge raw paired-end sequencing files. 
Custom python and bash scripts used for read processing, and mapping reference and 
synthetic error read counts. Further analysis was performed with Python 2.7, using Pandas 
v0.21.0 and Numpy v1.13.3, and R v3.4.2, using tidyverse including dplyr v0.7.4 and ggplot2 
v2.2.1. Variant analyses were performed using Ensembl variant effect predictor (v80), CADD 
(v1.3), MaxEntScan (Yeo and Burge, 2004), DANN (https://cbcl.ics.uci.edu/public_data/DANN/), 
FATHMM-MKL (git/908d865), fitCons (i6 dataset, git/20f336d), HAL (git/ca54d11), kpLogo 
(git/e2fac18), LINSIGHT (git/58fe558), phastCons (v1.4), phyloP (v1.4), PolyPhen (v2.2.2), SIFT 
(v5.2.2), and SPANR/SPIDEX (v1.0) (http://annovar.openbioinformatics.org/). 
 
DATA AND SOFTWARE AVAILABILITY 
Sequencing data were deposited into the Gene Expression Omnibus (GEO) under the 
accession number GEO: GSE120695. Pre-processed data sets are available upon request. All 
code needed to reproduce the analyses is included in the following repository: 
https://github.com/KosuriLab/MFASS 
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SUPPLEMENTAL INFORMATION 
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Figure 2.S1. MFASS reporter design, workflow optimization and testing. Related to Figure 
2.1. 
(A) The Split-GFP construct with the DHFR constant intron backbone (289 bp upstream, 622 bp 
downstream) is used for both the SRE and SNV libraries.  
(B) The Split-GFP construct with the SMN1 constant intron backbone (543 bp upstream, 414 bp 
downstream) is used for the SRE library.   
(C) The Split-GFP construct with DHFR constant intron backbone (289 bp upstream, 622 bp 
downstream), located in a different position along the split-GFP, is used for the SNV library.  
(D) The split-mCherry construct with constant DHFR short-intron backbone (101 bp upstream, 
101 bp downstream) was a prior iteration of the reporter that displayed significant intron 
retention (Figure 2.S2B). The synthetic library (black) contains human exons with surrounding 
native intron contexts (dark gray). The constant intron backbones are colored in light gray.  
(E and F) Flow cytometry of splicing regulatory element (SRE) library expressed in two splicing 
reporter constructs with different lengths of constant intron backbones. (E) Flow cytometry 
results for the standard DHFR backbone (Figure 2.S1D) used in the SRE and SNV datasets of 
the landing pad cell line before (left) and after (right) to integration of the SRE library. (F) Flow 
cytometry results of the same library as in a, but integrated into the short-intron DHFR backbone 
(as in Figure 2.S1D). We see far less expression, and much larger double-fluorescence 
negative population possibly indicating increased intron retention. 
(G, H and I) High-efficiency integration of large splicing reporter libraries in human cells. We 
monitored integration efficiency by comparing genome integration of genetic packages 
transfected (H) without and (I) with Bxb1 serine integrase, compared to (G) Untransfected 
control cell line. ~6.7% of mCherry plasmids are site-specifically integrated into the genome. 
The middle panel includes a promoter-less mCherry plasmid without the Bxb1 integrase, serving 
as a control for non-specific integration across tissue culture passages.  
(J and K) Evaluation of genome-integrated library across cell culture passages. (J) Flow 
cytometry analysis of the SRE library at various cell culture passages. We characterized 
reporter copy number per cell in detail, after library transfection, across cell culture passages. 
Only at 1:100,000 passage do we lose detectable levels of plasmid remaining within the cells. 
(K) We performed quantitative PCR to determine normalized copy number of reporter 
constructs per cell across cell culture passages. Copy number for each sample is normalized to 
that of the genome-integrated cell line containing a single construct. Landing pad HEK293T cell 
line that does not contain any reporter construct serves as negative control. Error bar indicates 
standard error of the mean. We see that at the 1:100,000 passage, we fail to detect plasmid 
remaining over background singly-integrated population. Based on this and the flow cytometry 
results, we only use the 1:100,000 for Flow-Seq experiments.  
(M) Verification of library integration by flow cytometry. In particular, flow cytometry analysis for 
the SRE library in the DHFR intron backbone with MFASS reporter is shown here in biological 
replicates. The percentage and number of cells sorted (in millions, M) per bin are shown. 
(N-Q) We measured exon inclusion by using RT-PCR for measurement of splicing at the RNA 
level, and using flow cytometry for the MFASS splicing readout, from which we calculate an 
inclusion index for each exon measured. Nine individual single cells from the SRE library were 
sorted from the library based on fluorescence behavior, expanded to establish individual cell 
lines, from which we performed individual validation. In addition, we performed transient 
transfection for the same sequences that we integrated genomically. (N and O) Flow cytometry 
analysis of single exons under (N) transient expression, and (O) site-specific genome-
integrated. (P and Q) RT-PCR analysis of the same individual control exons under (P) transient 
expression, and (Q) genome integration. Inclusion indices from MFASS assay are indicated on 
the upper left hand corner of flow cytometry plots (N and O) and under each exon (P and Q). 
We found the indices correlate strongly with observed splicing levels for individual exons.  
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Figure 2.S2. Exon inclusion rates and alternative hexamer score metrics related to SRE 
library. Related to Figure 2.2. 
 
(A) Exon inclusion rates of designed mutants for skipped natural exons in SRE library. We 
quantify Δinclusion index for a mutant sequence relative to wild-type (WT) for all skipped exons 
(inclusion index < 0.50) from the SRE library.  
(B) Evaluation of an alternative exon hexamer score metric. Average exonic scores defined in 
Ke et al. for 6,713 designed sequences in (i) included wild-type exons and (ii) skipped wild-type 
exons (Ke et al., 2011). Consistent with observations from the HAL model (Figure 2.2C), there 
is a significant difference in average Δinclusion index between sequences that increase (up) or 
decrease (down) overall exon hexamer score, for both included exons (Mann-Whitney U test, p 
< 10-16) and skipped exons (Mann-Whitney U test, p < 10-16). We quantify Δinclusion index for a 
mutant sequence relative to wild-type (WT), and colored each point by the inclusion index of the 
corresponding WT sequence. Included wild-type exons are defined as exons with inclusion 
index ≥ 0.50, while skipped wild-type exons are defined as exons with inclusion index < 0.50. 
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Figure 2.S3. Related to Figure 2.3. 
 
(A) Flow cytometry analysis of ExAC SNV library (version 1) integrated in human cells. For this 
SNV dataset, the library was sorted and expanded two times to ensure purity of the final 
population. Three populations, GFP+, GFPint, and GFPneg, were sorted according to GFP 
fluorescence given a minimal threshold of mCherry expression. The sorted populations were 
expanded in cell culture and subjected to flow cytometry analysis. Populations remained stable 
in fluorescence after sort and expansion in culture.Single fluorescence controls (GFP only and 
mCherry only) and negative control (landing pad cell line only) are shown on the top row. SNV 
library was evaluated in the reporter constructs from Figure 2.S1A. For the first sort, we 
obtained 16 million cells for GFPneg library, 2.6 million cells for GFP+ library and 2.7 million cells 
for GFPint library (biological replicate 1), 15 million cells for GFPneg library, 2 million cells for 
GFP+ library and 2.8 million cells for GFPint library (biological replicate 2). For the purifying sort, 
we further sub-sorted the libraries from the first sort, and obtained ~2 million cells for GFPneg 
library, 1 million cells for GFP+ library and 2.5 million cells for GFPint library (biological replicate 
1), and 1 million cells for GFPneg library, 1 million cells for GFP+ library and 2.5 million cells for 
GFPint library (biological replicate 2). The percentage and number of cells sorted (in millions, M) 
per bin are shown. 
(B) Flow cytometry analysis of ExAC SNV library (version 2) integrated in human cells. For this 
SNV dataset, four populations, GFP+, GFPint-hi, GFPint-lo, and GFPneg, were FACS-sorted 
according to GFP fluorescence given a minimal threshold of mCherry expression. In particular, 
for both biological replicates, we obtained 16 million cells for GFPneg library, 2 million cells for 
GFP+ library, 2 million cells for GFPint-hi and GFPint-lo library. These sorted populations were 
expanded in cell culture and subjected to flow cytometry analysis. Populations remain stable in 
fluorescence after sort and expansion in culture. Single fluorescence controls (GFP only and 
mCherry only) and negative control (landing pad cell line only) are shown on the top row. SNV 
library was evaluated in the reporter construct from Figure 2.S1C. The percentage and number 
of cells sorted (in millions, M) per bin are shown. 
(C) Exon inclusion metrics across two independent biological replicates for version 2 of the SNV 
library (n = 31,144, rt = 0.94, p < 10-16, tetrachoric; r = 0.80, p < 10-16, Pearson). Dashed line 
demarcate inclusion indices that agree within 0.20 across biological replicates for the SNV 
library that we used for subsequent analysis. SNV library were evaluated in the reporter 
constructs from Figure 2.S1C. 
(D) Exon inclusion metrics across two separate reporter constructs located in different parts of 
GFP and in different frames. Data shown are sequences appearing both in versions 1 and 2 for 
the SNV library (n = 5,740, rt = 1.00, p < 10-16, tetrachoric; r = 0.94, p < 10-16, Pearson). SNV 
library was evaluated in the reporter constructs from Figures 2.S1A and 2.S1C. 
(E) Exon inclusion rates of SDVs and corresponding wild-type sequences across four human 
cell types. We tested 15 of the individual control reporter constructs from longer intronic 
contexts (Figure 2.3E) across 4 human cell types: HEK293T, HeLa S3, HepG2 and K562 cells. 
A lower GFP-mCherry ratio indicates increased exon inclusion from MFASS. We found that 
large-effect splicing disruptions are consistent across 4 cell types in all 15 of the splice-
disrupting variants assayed (see also Figure 2.3F). This is indicated by the increased GFP-
mCherry ratio in SDVs (labelled in red as “mut” on the x-axis), as compared to their 
corresponding wild-type controls (labelled in black as “WT” on the x-axis). Note that the effects 
of 15 SDVs tested here are highly transferable across the 4 cell types examined (15/15, 100%). 
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Figure 2.S4. Related to Figure 2.4. 
 
Variants were functionally classified using the Ensembl variant effect predictor (VEP v80) across 
SDVs (n = 1,050) and non-SDVs (n = 26,683).  
(A) (i) Proportions of SDVs and non-SDVs within each functional annotation. The proportions of 
SDV in each category directly correspond to the left panel of Figure 4B, which details SDVs 
only. (ii) Overall percentages of SDVs and non-SDVs by functional annotation.  
(B) Distributions of change in inclusion index for SDVs by functional annotation. Among these 
functional classes, splice site variants have the largest mean effect size, followed by splice 
region variants. Intron variants have roughly the same mean effect size as missense and 
synonymous variants. 
(C) Comparison of genome-wide ExAC SNV conservation profiles and SNV density across gene 
regions. Average phastCons scores for genome-wide ExAC SNVs starting and ending on phase 
0 compared to other phases (Siepel et al., 2005), with SNV density illustrated across gene 
regions (bottom). Because exon sizes are variable, graph shows relative positions for all SNVs 
within 100 bp of the exon-intron boundary for both phastCons and SNV density.  
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Figure 2.S5. Evaluation of the effects of splice-disrupting variants assayed by MFASS. 
Related to Figure 2.5. 
 
(A) Distinct signatures of large-effect rare variants for splicing in splice donor and acceptor 
regions. We used kpLogo (Wu and Bartel, 2017) to generate a motif-based k-mer logo that 
visualizes enriched residues or motifs for SDVs (top) and non-SDVs (bottom). Stacked residues 
at a position represent a single most significant motif, starting or ending at a particular position. 
The total height is scaled relative to the significance of the motif. Motifs are read such that the 
top position correspond to the stacked position, with the rest of the residues read 
correspondingly to the right of the stacked position. N indicates positions with no residue 
preference. For the splice acceptor region (upstream intron-exon boundary), we see that 
adenine-rich motifs are less tolerated for across positions of around the polypyrimidine tract (-14 
to -6), along with an enrichment for thymine-rich motifs for non-SDVs (left bottom), consistent 
with conserved signatures of polypyrimidine tract in our genomes. In contrast, for the splice 
donor region (downstream exon-intron boundary), we see that guanine-rich motifs are less 
tolerated (right top). 
(B) Exon percent-spliced-in (PSI) values for splice-disrupting variants (SDVs) with globally 
significant splicing changes in the Genotype-Tissue Expression (GTEx) project (Quantification 
and Data Analysis, STAR Method). (i - vii) First, we assayed 523 SNVs with MAF >0.5% and 
found 2% (11/523) are SDVs in our assay. 96% of our SNVs with minor allele frequency (MAF) 
> 0.5% (505/523) overlapped with GTEx across 47 human tissues. Of these 505 with MAF > 
0.5% that overlapped with GTEx, 9 were SDVs. Of 1,050 SDVs detected by MFASS, 28 SDVs 
overlapped with GTEx, from which 9 has MAF > 0.5%, 8 with 0.05% < MAF < 0.5%, 10 with 
0.0025% < MAF < 0.5%, 1 with 0.001 < MAF < 0.025% and 1 with MAF < 0.001. 7 of these 
showed globally significant differences in the distribution of tissue PSI values for alternative 
alleles as compared to that of reference alleles (Mann-Whitney U test). Adjusted p-values were 
calculated using the Benjamini-Hochberg procedure at an FDR of 5% [p < 0.05 (*), p < 0.01 (**), 
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p < 0.001 (***)]. n indicates the number of individuals with the genotype indicated, and each 
point in the boxplot represents PSI measurement from a single tissue. (viii, iv) Exon PSI values 
for two variants with tissue-specific behavior. While these two variants do not reach global 
significance, they show reduced exon inclusion in relevant tissue types. (viii) A variant in NEBL, 
a gene that is abundantly expressed in cardiac muscle tissue and potentially involved in cardiac 
myofibril assembly. (iv) A variant in TSPAN16, a member of the tetraspanin protein family, 
whose members mediate signal transduction events in cell development, activation, growth and 
motility. This gene is highly expressed only in testis. 
(C and D) Validation of individual SDVs detected by MFASS within the full gene context.  
(C) SDVs individually validated for exon recognition in their full gene context. We validated 19 
individual SDVs detected by MFASS within their broader gene context by assembling 19 SDV-
containing full genes and 12 corresponding wild-types (up to ~13kb) using isothermal assembly, 
and examined splicing disruptions caused by SDVs using RT-PCR (STAR Method). Missing 
allele frequency indicates insufficient gnomAD coverage for a particular variant. 
(D) RT-PCR data for 19 SDVs across 12 full genes. The sample number on top of lanes in gel 
images corresponds to SDV annotations detailed in (i). Lanes with the same sample ID 
represent biological replicates. For the PCR, we used primers that flank the upstream and 
downstream exons from the exon or intron of interest that contains the SDVs (Table S4, under 
‘RT-PCR primers’ section), thus allowing us to detect exon recognition defects across the exon 
of interest. We observed 13 of 19 variants (68.4%) cause splicing disruptions in 9 of 12 genes 
(75%), with 9 of 19 variants (42.1%) having appreciable effects on exon recognition. These 
disruptions include exon skipping and alternative 5’ and 3’ splice site usage (see inset, B) in the 
broader full gene context. Minigene illustrations for each exon (next to each respective gel 
image) indicate the sizes of genome-annotated major isoforms that correspond to exon 
inclusion, exon skipping or intron retention events. Asterisk(*) alone indicates minor isoforms. 
While we do not notice significant changes in intron retention across all 19 SDVs examined, the 
usage of alternative 5’ splice sites (sample IDs 15 & 17) or 3’ splice site (sample ID 19) were 
confirmed (STAR Method). 
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Figure 2.S6. Evaluation of algorithms and metrics for large-effect disruptions to splicing. 
Related to Figure 2.6. 
 
(A) SIFT and PolyPhen predictions of SDVs and non-SDVs for missense variants from ExAC. 
Distributions of missense SDVs (n = 250) and missense non-SDVs (n = 8,966) across (i) SIFT 
and (ii) PolyPhen predictions. Proportions are shown instead of counts here to allow facile 
comparison between SDVs and non-SDVs. The proportions of SDV in both (i) and (ii) directly 
correspond to Figure 2.6A. These functional predictions show that few SDVs are predicted to 
have functional effect (i.e., benign), and SDVs that do not have any annotations are at a higher 
proportion than that of non-SDVs. 
(B) Prediction algorithms which predict splicing and non-coding genetic variation for ExAC SNV 
library. Receiver operating characteristic (ROC) curves that can predict splicing or non-coding 
genetic variants. The area under the ROC curve for all SNVs of CADD, DANN, FATHMM-MKL, 
fitCons, LINSIGHT and SPANR were 0.629 (95%CI: 0.615-0.647), 0.620 (95%CI: 0.604-0.635), 
0.670 (95%CI: 0.654-0.685), 0.517 (95%CI: 0.500-0.535), 0.604 (95%CI: 0.583-0.624) and 
0.774 (95%CI: 0.752-0.787) respectively. CI, confidence interval. For (B), colors for each 
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algorithm match those in Figure 2.6, with the addition of the HAL predictor for (B) that evaluates 
exonic changes only.  
(C) Predicted percent-spliced-in (PSI) from SPANR plotted against the Δinclusion index 
(inclusion indexmutant - inclusion indexWT) from MFASS (R2 = 0.11). The dashed lines indicate 
threshold (Δinclusion index = -0.50) below which we call splice-disrupting variants (SDVs). 
Contour lines show a density estimation of the points.  
(D) Comparison of length-dependent conservation profiles for human introns in ExAC SNV 
library. Distributions of average phastCons conservation scores for shorter native intron 
contexts across MFASS library sequences, as compared to intron contexts that are not 
included, up to 100bp, on either the acceptor or donor side. For the ExAC SNV library, (i) for the 
splice acceptor side, native intron lengths range from 40 to 81 bp, (ii) for the splice donor side, 
native intron lengths range from 30 to 71 bp. Average conservation across sequences is higher 
for short intron contexts in our library compared to that of the excluded intronic contexts, 
indicating we are likely capturing a large fraction of the relevant conserved intronic elements. 
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Table 2.S1. Description of Motif Types used in Splicing Regulatory Element (SRE) Library 
Design. Related to Figure 2.2. 
 
Motif type Description 
Splice donor (Portales-
Casamar et al., 2010; Yeo and 
Burge, 2004)  
5’ splice site (downstream intron), 9 bp, -3 to +6 
Splice acceptor (Yeo and 
Burge, 2004)  
3’ splice site (upstream intron), 23 bp, -20 to +3 
Exonic splicing enhancer 
(ESE) (Ke et al., 2011)  
Hexamer that is more likely to activate nearby splice sites, 
leading to enhanced exon inclusion 
Exonic splicing silencer (ESS) 
(Ke et al., 2011)   
Hexamer that is more likely to silence nearby splice sites, 
leading to enhanced exon skipping 
Donor intronic conserved 
sequence (Voelker and 
Berglund, 2007) 
Conserved sequence (CS) defined as a contiguous run of at 
least 7 nt of identity in a multiple sequence alignment between 
humans and six eutherian mammals occurring in the donor 
(downstream intron) or acceptor (upstream intron) region 
Acceptor intronic conserved 
sequence (Voelker and 
Berglund, 2007) 
RNA-binding protein (RBP) 
motifs (Cook et al., 2011) 
Position frequency matrix representing binding preferences of 
RBPs which allow for additive probabilistic descriptions 
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Table 2.S2. Description of Functional Classes in Splicing Regulatory Element (SRE) 
Library. Related to Figure 2.2. 
 
Category  Description Criteria to keep 
mutant 
Mutant score 
dbSNP variants Substitute reference allele 
with alternative allele 
Keep all NA 
acceptor site, 
donor site 
Mutate splice acceptor (-20 
to +3) / splice donor (-3 to 
+6) to sequence with lower 
score, but do not mutate 
2bp invariant position 
0 < new score < 3, 
|(original score – 
new score)| > 0.50 
Absolute distance 
of new score from 
the midpoint of (0, 
3) 
acceptor + donor site Weaken both the splice 
acceptor and donor as 
described above 
Refer to weaken splice donor/acceptor 
acceptor invariant 
AG, 
acceptor invariant 
GU 
Mutate splice 
donor/acceptor at invariant 
positions only (last 2 bp of 
upstream intron, first 2 bp of 
downstream intron)  
Keep all New score 
acceptor same 
strength, 
donor same strength 
Mutate splice 
donor/acceptor to sequence 
with comparable MaxEnt 
score, except invariant 2 bp 
|(original score – 
new score)| < 0.50 
|(original score – 
new score)| 
spurious acceptor 
site, 
spurious donor site 
Mutate spurious splice 
donor/acceptor to sequence 
with lower score, except 
invariant 2 bp 
0 < new score < 3, 
|(original score – 
new score)| > 0.50 
Absolute distance 
of new score from 
the midpoint of (0, 
3) 
spurious acceptor 
invariant AG, 
spurious donor 
invariant GU 
Mutate all sequences called 
by MaxEntScan as splice 
sites (but occurring at non-
canonical positions)  
0 > new score New score 
all  
exonic splicing 
enhancers/ 
exonic splicing 
silencers/ 
conserved motifs 
acceptor side/ 
conserved motifs 
donor side 
Mutate all occurrences of 
motif to lower score 
|original score| * 
0.1 >.new score| 
Sum of all mutated 
motif scores 
strongest  
exonic splicing 
enhancer/ 
exonic splicing 
silencer/ 
conserved motif 
acceptor side/ 
conserved motif 
donor side 
Mutate strongest motif to 
lower score than original 
|original score| * 
0.1 >.new score| 
New score 
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RNA-binding protein 
site 
Destroy RBP motifs New score == 0 PFM score 
conserved 1nt, 
conserved 3nt 
Mutate (1,3) random bp of 
conserved features based 
on total conservation 
Keep all NA 
random exon 1nt, 
random exon 2nt, 
random exon 3nt, 
random exon 5 nt 
Randomly mutate 1, 2, 3, or 
5 nt of exonic sequence 
NA NA 
random intron 1nt, 
random intron 2nt, 
random intron 3nt, 
random intron 5nt 
Randomly mutate 1, 2, 3, or 
5 nt of intronic sequence 
NA NA 
all synonymous exon 
mutations 
Synthesize every 
synonymous mutation at 
each position in the exon 
NA NA 
all intronic mutations Synthesize every intronic 
mutation, except at invariant 
2 bp of splice sites 
NA NA 
all synonymous exon 
+ all intronic 
mutations 
Combine both all 
synonymous exon 
mutations and all intronic 
mutations, described above 
NA NA 
all intronic mutations 
+ all random 
1/2/3/5nt mutations 
Combines both of the above 
intronic randomizations 
(random and aggressive) 
Keep all NA 
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Table 2.S3: Gene Ontology (GO) Enrichment for ExAC Splice-Disrupting Variants (SDVs, 
n = 1,050). Related to Figure 2.5. 
 
GO ID Term Annotate
d 
Significan
t 
Expecte
d 
p-
value 
(Fisher’
s test) 
Mean number 
of exons per 
gene 
GO:0030574 collagen catabolic 
process 
26 19 
  
11.16 0.0018 48.8 
GO:0044243 multicellular 
organismal 
catabolic process 
27 19 11.58 0.0036 47.5 
GO:0006892 post-Golgi vesicle-
mediated transport 
14 11 6.01 0.0074 34.4 
GO:0032963 collagen metabolic 
process 
32 21 13.73 0.0080 42.7 
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Table 2.S4. Primers used in this study. Related to Figures 2.3, 2.S1, and 2.S5. 
SRE Library  
ODY093 GCAGTGTTTCTCTAACTTTCGGCG 
ODY028 GGCATGTACTTGTAATCCTATCAGTGG 
ODY088 ACCCGTCCTATATATAGCTATCTATGTCTGGCGCGC 
ODY089 GCGACCGTGTACAAAAGTAAATAGCCCGGCTGG 
ODY031 AATGATACGGCGACCACCGAGATCTACACGCAGTGTTTCTCTAACTTTCGGCGCGCC  
ODY19 GCAGTGTTTCTCTAACTTTCGGCGCGCC  
ODY042 AGTTCCAGCCGGGCTATGGCCAGTGAGATCCAAG  
ODY106 GCAAGAGTTCCAGCCGGGCTATTTACTTTTGTACACGGTCGC 
ODY047 CTTGGATCTCACTGGCCATAGCCCGGCTGGAACTCTTGCTTAATTAA 
ODY95 AATGATACGGCGACCACCGAGATCTACACACCCGTCCTATATATAGCTATCTATGTCTGG 
ODY96 CAAGCAGAAGACGGCATACGAGATTCGCCTTAGCGACCGTGTACAAAAGTAAATAGCC 
ODY097  CAAGCAGAAGACGGCATACGAGATCTAGTACGGCGACCGTGTACAAAAGTAAATAGCC 
ODY098 CAAGCAGAAGACGGCATACGAGATTTCTGCCTGCGACCGTGTACAAAAGTAAATAGCC 
ODY099  CAAGCAGAAGACGGCATACGAGATGCTCAGGAGCGACCGTGTACAAAAGTAAATAGCC 
ODY100  CAAGCAGAAGACGGCATACGAGATAGGAGTCCGCGACCGTGTACAAAAGTAAATAGCC 
ODY101  CAAGCAGAAGACGGCATACGAGATCATGCCTAGCGACCGTGTACAAAAGTAAATAGCC 
ODY102  CAAGCAGAAGACGGCATACGAGATGTAGAGAGGCGACCGTGTACAAAAGTAAATAGCC 
ODY103  CAAGCAGAAGACGGCATACGAGATCAGCCTCGGCGACCGTGTACAAAAGTAAATAGCC 
ODY104  CAAGCAGAAGACGGCATACGAGATTGCCTCTTGCGACCGTGTACAAAAGTAAATAGCC 
ODY105  CAAGCAGAAGACGGCATACGAGATTCCTCTACGCGACCGTGTACAAAAGTAAATAGCC 
ORC403 /5Biosq/CCCTTTAATCAGATGCGTCGTATTATTGGCG 
ORC404 /5Biosq/TGGTAGTAATAAGGGCGACCGGGCGGGTTAA 
ORC405 /5Biosq/ATATAGATGCCGTCCTAGCGTTTATTTGGCG 
ORC406 /5Biosq/AAGTATCTTTCCTGTGCCCACGCGCGCTTAA 
SNV Library  
ORC515 GCAGTGTTTCTCTAACTTTCACCG 
ODY028 GGCATGTACTTGTAATCCTATCAGTGG 
ORC522 AATGATACGGCGACCACCGAGATCTACACAGCACACTGTTAACGCAGTGTTTCTCTAACTTTCACCGGT 
ODY032  CAAGCAGAAGACGGCATACGAGATTCGCCTTACTTGGATCTCACTGGCCATAGCC 
ODY033 CAAGCAGAAGACGGCATACGAGATCTAGTACGCTTGGATCTCACTGGCCATAGCC 
ODY034  CAAGCAGAAGACGGCATACGAGATTTCTGCCTCTTGGATCTCACTGGCCATAGCC 
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ODY035  CAAGCAGAAGACGGCATACGAGATGCTCAGGACTTGGATCTCACTGGCCATAGCC 
ODY036 CAAGCAGAAGACGGCATACGAGATAGGAGTCCCTTGGATCTCACTGGCCATAGCC 
ODY037  CAAGCAGAAGACGGCATACGAGATCATGCCTACTTGGATCTCACTGGCCATAGCC 
ODY038 CAAGCAGAAGACGGCATACGAGATGTAGAGAGCTTGGATCTCACTGGCCATAGCC 
ODY039  CAAGCAGAAGACGGCATACGAGATCAGCCTCGCTTGGATCTCACTGGCCATAGCC 
ODY040  CAAGCAGAAGACGGCATACGAGATTGCCTCTTCTTGGATCTCACTGGCCATAGCC 
ODY041  CAAGCAGAAGACGGCATACGAGATTCCTCTACCTTGGATCTCACTGGCCATAGCC 
ORC517 AGCACACTGTTAACGCAGTGTTTCTCTAACTTTCACCGGT 
ODY042 AGTTCCAGCCGGGCTATGGCCAGTGAGATCCAAG  
ORC518 CTTGGATCTCACTGGCCATAGCCCGGCTGGAACTCTTGCGCTAGC 
RT-PCR (SRE 
Library)  
ORC505 AATGATACGGCGACCACCGAGATCTACACTATGTAAATGTTGTCACCAGTGTGGGC 
ORC527 ATGGTGTCTAAGGGCGAAGAGC 
ORC506 AATGATACGGCGACCACCGA 
Isothermal 
assembly of 
full genes 
 
 
A) Gibson 
assembly 
primers  
ATP5PD_F1 CGCTCCCAGCGCGGCAGACTTCAATAGTTTGG 
ATP5PD_F_ex
t CCCCAGAACCAAAAGGCCATTGCTAGTTCCCTGAAATCCTGG 
ATP5PD_F2 GAATTTCTCTTTCTTCTTAAAAGTGAAATCTTGTGCTGAGTGGGTGTCTCTCTCAAAGGC 
ATP5PD_F2_
WT 
GAATTTCTCTTTCTTCTTAAAGGTGAAATCTTGTGCTGAGTGGGTGTCT
CTCTCAAAGGC 
ATP5PD_F3 TCCCGTGCCAGAGGATAAATATACTGC 
ATP5PD_R1 ACAGATGGCTGGCAACTAGAAGGCAC 
EIF2B2_F1 GGAAGTGCAAACTGTGTGGTCTGGCAGGTGTGG 
EIF2B2_F2 GCCATTTTTGCCGTTATGTCAAGAGTCAACAAGGTGGTTATATCTGGAG 
EIF2B2_F2_W
T 
GCCATTTTTGCCGTTATGTCAAGAGTCAACAAGGTGGGTATATCTGGA
G 
EIF2B2_R1 TGGGCACCCCTGATACCAAGGCTGACAGGTAG 
EIF2B2_R2 CTCCAGATATAACCACCTTGTTGACTCTTGACATAACGGCAAAAATGGC 
EIF2B2_R2_W
T 
CTCCAGATATACCCACCTTGTTGACTCTTGACATAACGGCAAAAATGG
C 
GMPPA_F1 GAGGCCAGGGTTTATTGGACAGAGTCAGTTGTGGGG 
GMPPA_F2 CTGTCTCGGGTGTGTCTGTCTGTCAGGCTAACAGGACG 
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GMPPA_F2_W
T CTGTCTCGGGTGTGTCTGTCTTTCAGGCTAACAGGACG 
GMPPA_R1 CAAGGTTCACGGGGTTTATTAGGGAGTCGGGAGGG 
GMPPA_R2 CGTCCTGTTAGCCTGACAGACAGACACACCCGAGACAG 
GMPPA_R2_
WT CGTCCTGTTAGCCTGAAAGACAGACACACCCGAGACAG 
HYAL2_F1 AAACAGGGTCAAGGCGATCTCCTCCCCCACG 
HYAL2_F2 GTCTCAGTCTTCCCCAGTGAGCATCCCTTTTCCTGC 
HYAL2_F3 GGACCTCATCTCTACCATTGGTGAGAGTGCGGC 
HYAL2_F2_W
T GTCTCAGTCTTCCCCAGTGACCATCCCTTTTCCTGC 
HYAL_F3_WT GGACCTCATCTCTACCATTGGCGAGAGTGCGGC 
HYAL2_R1 ACTATCTAGGGCAAGGGAGTAGGGTCAGGTCCTCCC 
HYAL2_R2 GCAGGAAAAGGGATGCTCACTGGGGAAGACTGAGAC 
HYAL2_R3 GCCGCACTCTCACCAATGGTAGAGATGAGGTCC 
HYAL2_R2_W
T GCAGGAAAAGGGATGGTCACTGGGGAAGACTGAGAC 
HYAL2_R3_W
T GCCGCACTCTCGCCAATGGTAGAGATGAGGTCC 
KRT2_F1 GTGTCTGGTGGAAGCCGGAGATCAACTTCCAGC 
KRT2_F2 GGCCTCAACCTTTCTTGTAGGACGTGGACAATGC 
KRT2_F3 CTCTATGATGCGGTAAAGAGGCTGCTCCGGGACAGTCC 
KRT2_F4 CTCTATGATGCGGTAAGGAGGCTGCTCCAGGACAGTCC 
KRT2_F2_WT GGCCTCAACCTTTCTTGCAGGACGTGGACAATGC 
KRT2_F3_WT CTCTATGATGCGGTAAGGAGGCTGCTCCGGGACAGTCC 
KRT2_R1 CCCAGCACTGCCAGGCTTAGAGATGAAATCCCTGG 
KRT2_R2 GCATTGTCCACGTCCTACAAGAAAGGTTGAGGCC 
KRT2_R3 GGACTGTCCCGGAGCAGCCTCTTTACCGCATCATAGAG 
KRT2_R4 GGACTGTCCTGGAGCAGCCTCCTTACCGCATCATAGAG 
KRT2_R2_WT GCATTGTCCACGTCCTGCAAGAAAGGTTGAGGCC 
KRT2_R3_WT GGACTGTCCCGGAGCAGCCTCCTTACCGCATCATAGAG 
MRPS11_F1 ACTGCTAGAACGAACCATTCGCATATGGAGGGGGTG 
MRPS11_F_ex
t AACACGGGTATACCTGCAGGGACAAGGAAGATGGGG 
MRPS11_F2 CTCCAGAGAGCTAAACAAAAGGGTGTGATCCACATCCG 
MRPS11_F5 GCCAGGACGCTTGGTAAGTTACAGTGACTTCCATAGTGTACTTGCC 
MRPS11_F2_
WT CTCCAGAGAGCTAAACAAAAGGGCGTGATCCACATCCG 
MRPS11_F3_
WT GCCAGGACGCTTGGTAAGTTACAGTGATTTCCATAGTGTACTTGCC 
MRPS11_R1 CAGCACCAGCTTTATTGGCCACTCAGAGCCTGG 
MRPS11_R_ex
t CCCCATCTTCCTTGTCCCTGCAGGTATACCCGTGTT 
MRPS11_R2 CGGATGTGGATCACACCCTTTTGTTTAGCTCTCTGGAG 
MRPS11_R5 GGCAAGTACACTATGGAAGTCACTGTAACTTACCAAGCGTCCTGGC 
MRPS11_R2_
WT CGGATGTGGATCACGCCCTTTTGTTTAGCTCTCTGGAG 
MRPS11_R3_
WT GGCAAGTACACTATGGAAATCACTGTAACTTACCAAGCGTCCTGGC 
OCEL1_F1 CCGCCAGTCGGGTCCATCCTGCAGTAAATGC 
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OCEL1_F2 CCTTTCTACTCCTCCCCTTGCCGAAGGAGGCCC 
OCEL1_F2_W
T CCTTTCTACTCCTCCCCTTGCAGAAGGAGGCCC 
OCEL1_R1 CCCTACTTCCAGGGAACAGGTTGAGATCTGGAGTCCC 
OCEL1_R2 GGGCCTCCTTCGGCAAGGGGAGGAGTAGAAAGG 
OCEL1_R2_W
T GGGCCTCCTTCTGCAAGGGGAGGAGTAGAAAGG 
ROGDI_F1 ACGACGAGGTGCACGCTGTGTTGAAGCAGC 
ROGDI_F2 CATGGAAGCTGGCGTCACCCCTCTGGATGACC 
ROGDI_F3 GACCCCTGCTTCCAGATCCAGGGTGCCAGAAACC 
ROGDI_F4 CCTGCTTACCAGCCGGGACCAAAGCTACCAG 
ROGDI_F2_W
T CATGGAAGCTGGCGTGACCCCTCTGGATGACC 
ROGDI_F3_W
T GACCCCTGCTTCCAGATCCAGGATGCCAGAAACC 
ROGDI_R1 TGGCTCTGTCTGTGGCGTTCCTCACCATCC 
ROGDI_R2 GGTCATCCAGAGGGGTGACGCCAGCTTCCATG 
ROGDI_R3 GGTTTCTGGCACCCTGGATCTGGAAGCAGGGGTC 
ROGDI_R4 CTGGTAGCTTTGGTCCCGGCTGGTAAGCAGG 
ROGDI_R2_W
T GGTCATCCAGAGGGGTCACGCCAGCTTCCATG 
ROGDI_R3_W
T GGTTTCTGGCATCCTGGATCTGGAAGCAGGGGTC 
SPX_F1 GACTGACAAGATGTCCCTGTGGACTCCCAAACTCTACTCC 
SPX_F2 CTGGTTGATAGCTTCATATAGGGACTCAGAAGTCTGGCAGC 
SPX_F4 CCTTGGCTCTTTTCCTGGTGTTTGTTTTTCTGGGAAACTCC 
SPX_F2_WT CTGGTTGATCGCTTCATATAGGGACTCAGAAGTCTGGCAGC 
SPX_F3_WT CTGGCAGCAACAACCTTGGCTCTTTTCCTGGTGTTTG 
SPX_R1 CCAGGCCTTCCTCAGTACCACCTTCTCCTTCAGGG 
SPX_R2 GCTGCCAGACTTCTGAGTCCCTATATGAAGCTATCAACCAG 
SPX_R4 GGAGTTTCCCAGAAAAACAAACACCAGGAAAAGAGCCAAGG 
SPX_R2_WT GCTGCCAGACTTCTGAGTCCCTATATGAAGCGATCAACCAG 
SPX_R3_WT CAAACACCAGGAAAAGAGCCAAGGTTGTTGCTGCCAG 
TMEM176A_F
1 CCTGTCCCAGAGCCTGCGGACTGTGGAG 
TMEM176A_F
2 CCTGCTCCTGGCTCAGTCTCTCCCCAGGC 
TMEM176A_F
2_WT CCTGCTCCTGGCTCAATCTCTCCCCAGGC 
TMEM176A_R
1 ATCACATGACTACTCAGGAGGGGACATGAAGCGGAGC 
TMEM176A_R
2 GCCTGGGGAGAGACTGAGCCAGGAGCAGG 
TMEM176A_R
2_WT GCCTGGGGAGAGATTGAGCCAGGAGCAGG 
TUBG1_F1 GAAAGGCGAGACATCCCTGACCCAGTGTCCAC 
TUBG1_F2 CCCACTCTGACCCTCCCCTACGTCTGTACAGGGAG 
TUBG1_F2_W
T CCCACTCTGACCCTCCCCTATGTCTGTACAGGGAG 
TUBG1_R1 GAGATGCGTGAGGTCCCTGATCTGTGCTCTGAGG 
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TUBG1_R2 CTCCCTGTACAGACGTAGGGGAGGGTCAGAGTGGG 
TUBG1_R2_W
T CTCCCTGTACAGACATAGGGGAGGGTCAGAGTGGG 
TMEM199_F1 GCAACTTCCGGTGCGCTTAGCGTTACTTCCG 
TMEM199_F2 GCAACGTCACTTGTCAGCTAAGGACATGCTCTTCAGTACG 
TMEM199_F2_
WT GCAACGTCACTTGTCAGGTAAGGACATGCTCTTCAGTACG 
TMEM199_R1 CCTGACAGATCTGGGATGGAGGCAGGTATAGCAGC 
TMEM199_R2 CGTACTGAAGAGCATGTCCTTAGCTGACAAGTGACGTTGC 
TMEM199_R2
_WT CGTACTGAAGAGCATGTCCTTACCTGACAAGTGACGTTGC 
B) Gene-
specific RT 
primers(GSP)  
ATP5PD_GSP
_R1 GAAGCTCTGGCCCTTGTATTACACATTCTGGAC 
EIF2B2_GSP_
R1 TGGAGAAAGTTTGAACATAGGTGCACAGACGATGAGT 
GMPPA_GSP_
R1 CAAGGTTCACGGGGTTTATTAGGGAGTCGGGAGGG 
HYAL2_GSP_
R1 AATATTGGGTGGCCCAGGACACATTGACC 
KRT2_GSP_R
1 CTTGACCTCGGCGATGATGCTATCCAAGTC 
MRPS11_GSP
_R1 AAGTGCAGGCCTCCTTCCCATCAC 
OCEL1_GSP_
R1 CCAGAGGAGGAAGTCCTGGAAGGCCTT 
ROGDI_GSP_
R1 GTGGTGAGCCGGTTTCGGGCTCT 
SPX_GSP_R1 GTGCCCCTTTCAGGTAGAGCATAGCTTGA 
TMEM176A_G
SP_R1 GCATGTCCATGAAGGAGGTACATAGGT 
TUBG1_GSP_
R1 CTGTCATTCAGCCGTTCTAAGAGGTAGGAACCCA 
TMEM199_GS
P_R1 GCTTTCCCAGGTCGCTGAGAGTCCCA 
 
C) RT-PCR primers  
ATP5PD_RT_F1 (sample ID 1) GCCCAGGTGGATGCCGAAG 
ATP5PD_RT_R1 (sample ID 1) TCAAGTCCTCAATGGTCATCTGATCAAATGG 
EIF2B2_RT_F1 (sample ID 2) GCAGAGTGTGCTCCTTTCTGCC 
EIF2B2_RT_R1 (sample ID 2) CAGGATGGTCTTCGTGCCAATGATC 
GMPPA_RT_F1 (sample ID 3) GTCACCCTTTCTTACTCCTTGGCAC 
GMPPA_RT_R1 (sample ID 3) GTGCTGGGTTTCTCCACATAGTGC 
HYAL2_RT_F1 (sample IDs 4 & 
5) CCCAGTCTACGTCTTCACACGACC 
HYAL2_RT_R1 (sample IDs 4 & 
5) TCAGGTAATCTTTGAGGTACTGGCAGG 
KRT2_RT_F1 (sample ID 8) GCTGCTGAGAATGATTTTGTGACGC 
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KRT2_RT_R1 (sample ID 8) TGTCAGTGACACTCTGATGTATCTGGG 
KRT2_RT_F3 (sample IDs 6 & 
7) GCGCACAGCTGCTGAGAATGAT 
KRT2_RT_R3 (sample IDs 6 & 
7) CGTTGGTGTCAGTGACACTCTGATG 
MRPS11_RT_F3 (sample IDs 9 
& 10) AGAAGGGCACAGGCATCGC 
MRPS11_RT_R3 (sample IDs 9 
& 10) GTGTTGTCTGTGATTGAGATCACTTCCAG 
OCEL_RT_F1 (sample ID 11) ACAGGCAAAGCTCAGGCAGC 
OCEL_RT_R1 (sample ID 11) AGTTTACCCTTCAGGTAGTGGCAGC 
ROGDI_RT_F1 (sample IDs 12-
14) TTCGCCTTCCGGGAGGACAAG 
ROGDI_RT_R1 (sample IDs 12-
14) CTCTGGTCAGCTGCAGCATCAC 
SPX_RT_F1 (sample ID 15) ATTTCAGGGTTCTGAAAAGACGCAGAAC 
SPX_RT_R1 (sample ID 15) GGAGTCCAGTTCCTTCTCTCCAACAG 
SPX_RT_F2 (sample ID 16) TTTCAGAGCAAGAGTCGAAAACTCACAG 
SPX_RT_R2 (sample ID 16) GGTAGAGCATAGCTTGAGGAGTCCAG 
TMEM176A_RT_F1 (sample ID 
17) TGCCATCTGGACAGGGGCTG 
TMEM176A_RT_R1 (sample ID 
17) AGCGTTAGCAGAGTCCTCAGC 
TUBG1_RT_F1 (sample ID 18) CAACAACTGGGCCAGCGGATTC 
TUBG1_RT_R1 (sample ID 18) CCCAGCAATGGAGTGACACAGC 
TMEM199_RT_F1 (sample ID 
19) GCTCCTAGAAGGCAGTGAAATCTATCTCC 
TMEM199_RT_R1 (sample ID 
19) TCGCTGAGAGTCCCACCATGTC 
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SUMMARY 
Promoter sequence space in bacteria is vast and difficult to study genome-wide due to 
extraneous factors affecting transcript levels. Here, we use a genomically-encoded massively 
parallel reporter assay (MPRA) to characterize the global E. coli promoter landscape and 
dissect active promoters for motifs encoding promoter regulation. We measure promoter activity 
of over 300,000 sequences spanning the entire genome and identify 3,321 active promoter 
regions in glucose minimal media and 3,477 in rich LB media. We show that antisense 
promoters have a profound effect on global transcript levels and how codon usage has adapted 
to encode intragenic promoters. Furthermore, we perform a scanning mutagenesis of 2,057 E. 
coli promoters to identify regulatory sequences. Lastly, we implement a variety of machine 
learning approaches to classify  promoters and predict activity. In summary, we present a series 
of approaches to rapidly characterize promoter sequences within a bacterial genome. 
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INTRODUCTION 
In 1961, François Jacob and Jacques Monod published a review laying the foundation for what 
would later be known as the Escherichia coli promoter1. This seminal work has sparked countless 
studies delving into the many molecular mechanisms operating at promoters, establishing them 
as one of the most well-characterized systems in biology. Several key promoters have been the 
subject of in-depth biochemical and structural studies describing the mechanisms by which the 
RNA polymerase (RNAP) recognizes promoter sequences, as well as the stepwise process to 
engage transcription2–4. In addition, many transcription factors have been described in similar 
detail, revealing the multiple mechanisms through which these proteins interact with promoters to 
modulate the behavior of RNAP and activity of the promoter5–8. Lastly, the binding motifs for the 
majority of these proteins are known and have been studied at high resolution using next-
generation sequencing methods9–12. In short, the myriad components of this system have been 
extensively cataloged and characterized, giving the appearance that bacterial promoters are a 
‘solved’ biological phenomenon. 
 
Despite extensive research on individual E. coli promoters, when we examine the entire genome 
we cannot address the fundamental questions of where promoters exist or how these sequences 
encode transcription. Although the consensus sequences for RNAP recognition motifs have been 
known for decades, a simple search of the genome based on those motifs yields many false 
positives. In fact, true promoters within a given region often do not exhibit the greatest similarity 
to the consensus13,14. Experimental efforts to identify promoters using 5’ RNA-Seq likely also 
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suffer from false positives, identifying tens of thousands of putative transcription start sites (TSSs) 
with little overlap between studies15,16. Furthermore, although many E. coli promoters have been 
identified with strong supporting evidence17, functional annotation of these promoters remains 
challenging due to the universally degenerate nature of transcription factor binding motifs. As a 
result, roughly two-thirds of the 2,565 reported E. coli operons do not contain any transcription 
factor binding site annotations17,18. Finally, even amongst fully annotated promoter sequences we 
are still unable to quantitatively predict the activity or behavior of these supposedly well-
characterized systems due to a lack of understanding of how the arrangement and sequence 
composition of binding motifs relate to activity. 
 
There are various confounding factors which complicate a systematic understanding of genome-
wide promoter function. Genome-wide characterizations of endogenous promoters in their native 
contexts are influenced by various mechanisms contributing to perceived levels of transcription. 
For instance, recent work has shown that promoter activity varies depending on the location in 
the genome due to factors such as variance in chromosomal copy number19,20, the distribution of 
transcription factors within the cell21, and the accessibility of the chromatin22. In addition, RNAs 
produced by promoters are subject to dynamic degradation processes which alter transcript 
levels23,24. Lastly, mechanisms of transcriptional interference, such as RNAP collisions directed 
by antisense promoters, have the potential to further modulate activity of promoters, although the 
impact of this mechanism across the genome has not been fully investigated25–27. These 
extraneous mechanisms confound a deeper understanding of promoter sequences, which will 
require novel methods to circumvent these factors. 
 
In this work, we dissect promoter regulation in E. coli using a massively-parallel reporter assay 
(MPRA) designed to isolate promoter activity from extraneous mechanisms of genetic regulation. 
This system can characterize the promoter activity of hundreds of thousands of sequences in a 
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common genomic location that is insulated from local transcriptional interference and uses a 
standardized transcript to remove the effects of mRNA degradation on expression levels. We use 
this powerful assay to identify promoters throughout the E. coli genome and systematically dissect 
their regulatory motifs which encode promoter activity. We measure promoter activity of 17,189 
reported transcription start sites (TSSs) and find that a majority of reported TSSs are likely due to 
transcriptional noise, rather than productive transcription. Furthermore, we measure promoter 
activity of 321,123 DNA fragments spanning both strands of the E. coli genome with 8.5x 
coverage, allowing us to identify the breadth of endogenous sequences that coordinate 
expression in rich and minimal media. This genome-wide promoter screen reaffirms the pervasive 
nature of antisense transcription and its global role in transcriptional interference. To characterize 
sequence motifs encoding promoter activity in E. coli, we implement a scanning mutagenesis 
approach to systematically dissect the sequences of 2,057 active promoters. With this approach, 
we characterize the regulatory impact of 568 transcription factor binding sites reported by 
RegulonDB as well as 2,583 novel sites, thereby providing functionally annotated profiles for 
promoters driving expression in rich LB media for 1,158 of the 2,56528 operons in E. coli. Lastly, 
we use this rich dataset to train various machine learning models to identify functional E. coli 
promoter sequences and predict their expression levels. In summary, we present a series of high-
throughput approaches to identify and characterize promoters throughout the entire E. coli 
genome. 
 
RESULTS 
Functional characterization of 17,635 previously reported E. coli promoters 
To experimentally characterize endogenous E. coli promoters, we measured the transcriptional 
output of 17,189 previously reported transcriptional start sites (TSSs) from MG1655 cells grown 
in rich LB media. We assembled these TSSs from three sources: the RegulonDB E. coli 
database17 (8,486 unique TSSs), a directional RNA-Seq study by Wanner et. al (2,123 unique 
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TSSs), and a RNA-Seq study by Storz et. al (14,868 unique TSSs). These three sources contain 
23,798 unique TSSs, many of which are within a few bases of each other. To minimize 
redundancy, we collapsed clusters of TSSs within 20 bp of each other into the most upstream 
TSS, reducing the total number for synthesis to 17,635. Surprisingly, there was little agreement 
regarding the location of TSSs between studies, with only 94 shared between all three when 
considering exact matches (Figure 3.1A). Furthermore, the identification of 17,635 TSSs is 
surprising considering the E. coli genome contains 4,419 known genes. While this could be the 
result of an immensely complex transcriptional system, it begs the question of whether or not 
these transcriptional signals are the result of genuine promoters, transcriptional noise, or 
experimental artifacts.   
 
Therefore, we sought to determine whether these previously identified TSSs were indicators of 
true promoter activity and identify the sequence elements that distinguished transcriptionally 
active from inactive sequences. To this end, we implemented a previously described MPRA29 to 
quantitatively measure the individual promoter activity of 17,635 TSSs  (Figure 3.1B). For each 
TSS we synthesized oligonucleotides spanning 120 bp upstream to 30 bp downstream of the 
TSS, which has been reported to encode the majority of promoter activity driving expression at a 
given TSS30. In addition, we synthesized 96 well-characterized promoters from the BioBricks 
registry that are designed to span a wide range of expression and serve as positive controls. We 
included 500 negative controls, identical in length to the main library and randomly selected 
across the genome, that are more than 200 bp from the nearest TSS and are assumed to be 
transcriptionally inactive. We confidently measured 97.5% (17,767/18,222) of the synthesized 
library including controls, and 97.4% (17,189/17,635) of reported TSSs, with an average of 69.5 
barcodes per library member (Figure 3.S1A). Next, we integrated this pooled library of reporter 
constructs into the nth-ydgR intergenic locus within the E. coli chromosomal terminus using a 
recombination-mediated cassette exchange system31. We determined expression levels by 
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quantifying the transcript abundance of each barcode normalized to the DNA-seq abundances, 
and precisely measured 96.6% of promoters in this library (Figure 3.1C). We compare expression 
of the TSS promoters relative to the negative controls to set a threshold for active and inactive 
promoters, which was two standard deviations greater than the median negative control (Figure 
3.1D). Among the 17,635 original TSSs, we identified 2,670 promoters that greater expression 
than our experimentally determined threshold in rich LB media (Figure 3.1E). Notably, this 
amount is more consistent with the number of operons identified by a recent study using long-
read sequencing to characterize full-length E. coli transcripts32. Amongst these 2,670 confirmed 
promoters, we recovered expression data for many well-known promoters. In particular, three of 
the strongest TSS promoters identified corresponded to the 16S and 23S polycistronic operon, 
the most abundantly expressed operon in the E. coli genome. 
 
Location-dependent promoter activity is mostly constant across promoters 
An early concern arose regarding whether the genomic location where we integrated our promoter 
library had a significant effect on the expression values determined by our MPRA. Indeed, several 
recent studies have shown that promoter expression levels can be highly variable between 
locations of the genome21,22,33. However, these studies have looked at these effects on single 
promoters, so it is unclear whether location-dependent effects are promoter specific or general. 
To determine whether genomic position had an effect on our measurements, we also integrated 
the TSS promoter library in both chromosomal mid-replichores and compared expression 
measurements between these positions and the E. coli chromosomal terminus (Figure 3.S1B). 
We observed that promoter measurements remained highly consistent between integrated 
locations, although the mid-replichore positions exhibited slightly higher concordance than either 
to the terminus. It is worth mentioning that RNA-Seq provides us with relative expression between 
promoters at each location. Therefore, although the relative activity levels between promoters are 
consistent at different locations, it is likely that the absolute transcription levels differ due to 
 
 
 
 96 
previously described chromosomal position effects22. We conclude that relative promoter activity 
levels acquired from our assay are consistent between the three locations tested, which suggests 
that genome-position effects on expression are predominately consistent between promoters. 
 
The promoter architecture of inactive promoters resemble tssRNA-associated promoters 
An overwhelming majority of E. coli promoters are directly regulated by the housekeeping sigma 
factor σ70, thus we expected that active promoters would be enriched for the canonical σ70 
motifs. Promoters of the σ70 family are well known for containing two hexamer motifs, the -10 
and -35 motifs, which recruit RNAP and are named after their position relative to the TSS. We 
used a broadly accepted σ70 PWM13 to analyze whether active TSS promoters were enriched for 
these motifs. Interestingly, although both active and inactive promoters were enriched for the 
canonical -10 motif compared to our negative controls (p < 2.2 x 10-16, p < 3.8 x 10-7) we found 
that the -35 scores of  inactive promoters were generally no greater than negative controls (p = 
0.21) (Figure 3.1E). Recent work has shown that promoters containing a -10 but lacking a 
correctly positioned -35 motif allow for the production of short (approximately 35-50 bp) 
transcripts. These transcripts are known as tssRNAs and do not result in mature, translated 
products34,35. Notably, these short transcripts could be indistinguishable from biologically 
productive transcripts in 5’ RNA-Seq studies, yet would not be detected by our assay, which 
requires transcription of a barcode within the 3’ UTR of the reporter gene. Thus, we find that the 
sequences encoding inactive TSSs bear a greater resemblance to tssRNA-associated promoters 
rather than true promoters.  
 
Genome-wide survey of the E. coli promoter landscape 
Despite functionally screening of 17,635 previously implicated genomic regions for promoter 
activity, we remained unconvinced that we had captured the entire assortment of endogenous 
promoters in E. coli. Indeed, we discovered several cases where our screening active TSSs did  
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Figure 3.1. Functional characterization of 17,635 previously reported E. coli promoters. A) 
We synthesized 17,635 previously identified TSSs and the surrounding -120 to +30 bp context 
and genomically integrated the construct at a fixed landing pad in the E. coli genome (left). 
There is little agreement between the three different sources at the single nucleotide level 
(right). B) Massively parallel reporter assay (MPRA) (previously described in Urtecho et. al 
201829) captures quantitative measurement of transcriptional activity for individual TSSs in 
multiplex. C) MPRA is highly replicable across technical replicates (r = 0.965. D) The TSS 
library spans a wide functional range, over 100-fold, with negative controls exhibiting low levels 
of expression. E) The majority of tested TSSs are inactive in rich LB medium. We report 2,670 
active promoters as having expression two standard deviations greater than the median of the 
negative controls.  F) Active and inactive TSSs have significantly different mean scores for the 
two core promoter motifs (Student’s t-test, two-sided, “***”=<0.001, “**”=<0.01, “*”=<0.05).  
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not identify promoters for several essential operons (data not shown), which implied that our initial 
approach had not completely sampled the entire promoter landscape. 
 
We adapted our MPRA to screen a library of sequences completely spanning the entire E. coli 
genome (Figure 3.2A) and discover the full catalog of endogenous promoters. We created this 
library using sonication to randomly shear the E. coli genome, isolate fragments between 200 and 
300 bp, and barcode each fragment before passaging them through our MPRA. Using this 
pipeline, we measured the transcriptional activity of 321,123 fragments with a median size of 244 
bp spanning the entire double-stranded E. coli genome with an average of 8.5x coverage (Figure 
3.S2A, Figure 3.S2B). We averaged the expression of all fragments overlapping each genomic 
position to achieve highly replicable values of promoter activity at single-nucleotide resolution and 
in a strand-specific manner (Figure 3.S2C). We have created a custom visualization for this data, 
which reveals remarkably defined regions of promoter activity across the entire E. coli genome 
(Figure 3.2B). The detected promoter signals are in strong agreement with our previous 
characterization of TSS-associated promoters, with active TSSs showing greater signals for 
promoter activity compared to inactive TSSs (Figure 3.2C). We identify “promoter regions” 
considering contiguous regions of at least 60 bp with activity measurements higher than an 
empirically-derived threshold determined from previously identified TSS-associated promoters 
(described in methods). Thus, we find that this approach is capable of rapidly screening entire 
bacterial genomes for regions demonstrating promoter activity.   
 
The E. coli promoter landscape is dynamic in response to environmental conditions 
We used this approach to explore the complex landscape of promoters in E. coli and its dynamic 
rearrangement in response to environmental changes. We measured expression of our fragment 
library grown to exponential phase in rich LB media as well as a defined minimal media 
supplemented with glucose. We predicted that under minimal media conditions global promoter 
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activity would increase in order to accommodate an increased dependence on endogenous 
biosynthetic pathways to create necessary resources. Despite our expectations, we identified 
3,321 active promoters in minimal media and a comparable 3,477 in rich media (Figure 3.2D). 
However, although the absolute number of promoters between these conditions is similar, the 
identity of active promoters was variable between conditions, with only 2,466 shared by both 
conditions. 
 
We reasoned that this dynamic promoter response was mediated by condition-dependent 
transcription factors and evaluated the TFBS composition of promoters unique to each condition 
(Figure 3.2E). Examining TFBSs reported by RegulonDB, we found 324 TFBS annotations 
unique to rich media promoters and 370 overlapping promoters unique to glucose minimal media 
conditions. Upon comparing TFBS content of these promoters, we found that binding sites for 
several global transcriptional regulators36, including ArcA, Lrp, and Fis occurred at similar 
frequencies between these conditions. Conversely, binding sites for CRP, an abundant glucose-
inhibited transcription factor, were enriched by roughly three-fold amongst rich media promoters 
when compared to promoters active in glucose minimal media. Interestingly, we found many 
TFBSs that appear to be nearly or entirely condition-dependent and these appeared to generally 
be local regulators. We conclude that the remodeling of the promoter landscape between these 
conditions is primarily determined by global regulation of CRP as well as many condition-
dependent transcription factors with more local effects. 
 
Antisense transcription is a pervasive means of repression 
Having identified the arrangement of promoters throughout the genome, we investigated how their 
positioning influenced local transcription profiles. We first evaluated the position of promoters in 
the  genome and identified 1,465 and 1,623 intergenic promoters in LB and M9, respectively. 
These were predominantly positioned in the sense orientation relative to the nearest downstream 
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gene. Surprisingly, 1,998 and 1,660 intragenic promoters were identified in LB and M9, 
respectively, and nearly half of these promoters were positioned antisense relative to the genes 
they regulate (Figure 3.2F).  
 
The large amount of antisense promoters we discovered encouraged us to explore whether these 
antisense promoters played a significant role in global expression levels. Although promoters are 
primarily thought to be positioned upstream of the genes they regulate, many recent studies have 
focused on their impact when positioned within and downstream of transcriptional units 12,37. In 
particular, these alternative positions have generated significant interest in the cases where 
promoters are poised for cis-antisense transcription, a transcriptional interference mechanism 
where promoters drive transcription against the direction of genes, typically resulting in 
transcriptional repression27,37,38. However, the significance of antisense transcription has recently 
come under question as being predominantly associated with transcriptional noise that is 
biologically irrelevant39.  
 
To explore the impact of antisense transcription, we evaluated whether genes regulated by 
antisense promoters are associated with a significant reduction in expression. We performed 
RNA-Seq on MG1655 grown in minimal glucose media and compared the transcript coverage of 
all genes with sense promoters, antisense promoters, and both sense and antisense promoters. 
We found that overall, genes with both sense and antisense promoters exhibited a two-fold 
decrease in expression compared to strictly sense-regulated genes, and this lower expression 
occurred despite nearly identical levels of sense-promoter activity (Figure 3.2G). To explore the 
quantitative nature of antisense promoter repression, we separated genes by the strength of their 
sense and antisense promoters into quartiles and determined expression levels of these genes 
(Figure 3.2H). This analysis revealed an interplay between the strength of a gene’s sense  
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Figure 3.2. Genome-wide survey of the E. coli promoter landscape. A) We adapted our 
MPRA to screen genome fragments spanning the entire genome. Fragments were derived 
using sonication to generate 321,123 fragments of 200 to 300 bp in size with an average of 10x 
coverage. B) We developed custom visualization using Bokeh that enables users to select any 
genomic position and display multiple layers of information, including our TSS MPRA activity 
(Figure 1), genome fragmentation screen, and existing gene annotations. C) Meta-analysis of 
mean promoter activity at experimentally validated active TSSs, inactive TSSs, and negative 
controls. TSSs previously determined to be active are enriched for promoter activity in our 
genomic fragment screen. D) Overlap of promoters active in M9 Minimal media + .2% glucose 
and rich LB media. E) Frequencies of TFBSs overlapping unique, condition-dependent 
promoters. TFBS locations are reported by RegulonDB and frequencies are normalized to 100 
kb of promoter sequence. Dotted-black lines indicate a two-fold enrichment. F) Orientation and 
positioning of identified promoters separated by condition. G) Left: Meta-gene analysis showing 
median RNA-Seq read coverage across all sense, antisense, and dual regulated genes. Middle: 
Sense promoter activity at sense, antisense, and dual regulated genes. H) Median RNA-Seq 
coverage per kb across genes separated by sense and antisense promoter strength. 
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promoter and antisense promoter, where increasing sense strength was associated with 
increased expression, whereas increased antisense strength resulted in an overall decrease in 
expression. Thus, we conclude that this analysis provides clear evidence in support of the impact 
of antisense-regulation on global transcript levels. 
 
Fine-mapping of E. coli promoters within transcriptionally active regions 
Our assay of genomic fragments identified regions of promoter activity that were fairly broad 
(Figure 3.S2D) and well above the expected size of typical promoters30. Our next goal was to 
explore these regions further and reveal concise boundaries for sequence elements encoding 
promoter activity. To finely map promoter sequence elements, we implemented a synthetic tiling 
approach to study these promoter regions in greater detail. We used our MPRA assay to measure 
expression of 46,713 150 bp oligos tiling the length of each of the 3,477 active promoter regions 
identified in rich media in 10 bp intervals (Figure 3.3A). For active promoter regions under 150 
bp, we measured expression of a single oligo consisting of the entire region. This approach 
allowed us to precisely identify the boundaries of sequence elements encoding promoter activity 
by determining where along the promoter region oligo tiles gained and lost expression.  
 
Interestingly, this analysis showed many of the broad promoter regions we previously identified 
actually contained multiple discrete promoters (Figure 3.3B). As might be expected, the number 
of promoters within a given region corresponded with the size of the region identified by our 
genome fragmentation promoter assay (Figure 3.S4A). However, we could not identify active 
oligo tiles for 1,476 of the promoter regions previously identified as active. Regions without 
promoters were generally less than 150 bp in length, suggesting the entire functional promoter 
sequence was not captured. These regions without promoters were generally under 150 bp in 
length, therefore we may not have tested the entire promoter sequence. Nonetheless, we 
precisely mapped the promoter sequences within 1,599 of the original 3,480 promoter regions 
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identified in rich media as well as 400 containing multiple discrete promoters (Figure 3.3C). 
Furthermore, with this approach we could infer the minimal sequence necessary for promoter 
activity at each sub promoter by determining the overlap of all active tiles composing each sub 
promoter. When comparing the sizes of the minimal sequence necessary for promoter activity, 
we observed an enrichment of approximately 40 bp which is a typical size for σ70 promoters40–42, 
the most abundant class of promoters in E. coli (Figure 3.3D). We also observed an enrichment 
for 150 bp minimal promoter regions, although these were generally weak indicating that our 
resolution had been limited when tiling weaker promoters. Overall, we were able to identify precise 
boundaries for 2,228 promoters active in rich media. 
 
Having identified the minimal sequences necessary for promoter activity, we sought to explore 
how these promoters were encoded within intragenic regions. The sequences of intragenic 
promoters are inherently constrained by the coding regions they overlap and so we were curious 
how the E. coli genome had adapted sequence content to enable promoter activity within these 
restrictions. After comparing the amino acid composition within intragenic promoters, we found 
that these sequences were especially enriched for containing STOP codons, and showed a 
preference for many many other amino acids (Figure 3.3E). This enrichment for STOP codons is 
compelling, as two of the three codons, TGA and TAA match the consensus motifs of sigma70 
promoters (the -35 TTGACA motif as well as the -10 TATAA motif). Next, we explored whether 
codon selection had been influenced to encode intragenic promoters. Indeed, we found that 
codon usage within intragenic promoters is significantly biased towards certain codons (Figure 
3.3F). In particular, we found the strongest bias amongst arginine codons, with a strong 
preference for AGA and AGG. Interestingly, it appears that codons enriched within intragenic 
promoters are typically rare in the genome. This surprising new role for rare codons may partially 
explain recent findings that synonymous codons were unequivolent in genome recoding  
 
 
 
 104 
 
 
 
 
 
 105 
Figure 3.3. High-resolution tiling of promoter regions identifies sequences encoding 
promoter activity. A) We synthesized 150 bp oligos tiling all promoter regions identified in rich 
media at 10 bp intervals. We determine minimal promoter boundaries by identifying overlapping 
segments of transcriptionally active tiles. B) Expression of oligo tiles spanning the mraZ 
promoter. Points are shown at the right-most position of their corresponding oligo. Interval bars 
show two distinct sub promoters within this region. The threshold for active promoters was set to 
two standard deviations greater than the expression of a set of 500 negative controls. C) 
Number of sub promoters may encode multiple sub promoters. Sub promoters were considered 
distinct if they were separated by more than 40 bp from other active oligo tiles. D) Distribution of 
the lengths of the minimal sequence encoding promoter activity for each sub promoter. The 
minimal sequence is acquired from the overlap of all active oligo tiles composing each sub 
promoter. E) Amino acid enrichment within intragenic promoters relative to whole genome 
amino acid frequencies. F) Codon bias within intragenic promoters relative to whole genome. 
Codons are colored by the relative usage compared to other synonymous codons. 
 
projects43. Overall, our findings suggest that the E. coli genome has evolved to encode intragenic 
promoters by manipulating codon usage. 
 
Mutational scanning of 2,057 active promoters in E. coli 
Our next goal of this work was to develop an approach to identify motifs responsible for 
transcriptional regulation within the identified promoters. Recent work by Belliveau et al.18 
demonstrated a high-resolution saturation mutagenesis approach for identifying regulatory motifs 
within entirely uncharacterized promoters on an individual basis. Inspired by this work, we 
implemented a scanning mutagenesis strategy to explore the sequence features that defined 
active promoters. For each of the 2,057 active TSS-associated promoters identified in rich LB 
media, we systematically scrambled 10 bp sequences spanning the -120 to +30 positions at five 
bp intervals (Figure 3.4A). Although single-point mutations can provide detailed information on 
how individual bases encode regulation at promoters9,18, we chose 10 bp scrambling mutations 
to evaluate the contribution of each site as a whole. Furthermore, these scrambled sequences 
were designed to maximize distance from the original sequence, thereby further guaranteeing 
that we could obviate any motifs at each position contributing to transcription regulation. Using 
this approach, we would expect that disrupting a repressor site would increase expression, 
whereas scrambling an RNAP or activator site would decrease expression. In total, we designed 
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a library of 59,653 sequences consisting of nearly all 2,057 active TSS-associated promoters and 
their scrambled variants and measured their expression using our genomically-encoded reporter 
assay. We recovered expression measurements in rich LB media for 89% (52,900/59,653) of this 
library, with an average of 8 barcodes per scrambled variant (Figure 3.S3C, 3.S3D). By 
scrambling sequences across active promoters, we could identify regions within these sequences 
that either increased or reduced expression (Figure 3.4B). As expected, these sequences were 
enriched for regions that increased expression at the -35 and -10 regions in addition to many 
other regions within these promoters that modulated expression. However, we also identified 
many sequences throughout these promoters that also contributed to regulation. 
 
Scanning mutagenesis reconfirms previously validated regulatory sequences 
We explored if our data could reaffirm known regulatory motifs to determine if we could effectively 
identify potentially novel regulatory elements. We first examined our scanning mutagenesis of the 
lacZYA promoter, a classic gene regulation model whose regulatory motifs are well characterized. 
This promoter is an excellent example as it is known to contain a variety of regulatory motifs, 
including twin LacI repressor sites centered at +11 and -8244, a CAP activator site centered at -
6145, and a σ70 RNAP binding site. Our scanning mutagenesis of lacZ promoter revealed distinct 
signals corresponding with each of these sites, as well as quantitative measurements for their 
contribution to expression (Figure 3.4C). Scanning mutagenesis of the relBE promoter achieved 
similar results, identifying a previously reported RelBE repressor site at the +1 position46 as well 
as the -10 and -35 σ70 recognition motifs46. This evidence suggests that our scanning 
mutagenesis approach is amenable to identifying functional regulatory elements within E. coli 
promoters. 
 
Given that our approach could capture the effects of known binding sites, we next explored 
whether we could effectively identify novel regulatory sites within promoters. Although we 
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performed this scanning mutagenesis for 2,057 promoters we choose to highlight a few examples 
to demonstrate the utility of this method. The cyclopropane fatty acyl phospholipid synthase gene, 
cfa, exhibits dynamic expression47 and is responsible for a major component of the cell membrane 
necessary for cell survival in acidic conditions48. While there have been several transcription 
factors implicated in regulation of cfa, the motifs responsible for its direct regulation are still 
unknown. Our scanning mutagenesis approach has identified a candidate σ70 promoter 
regulating this gene with a -10 motif centered 34 nucleotides upstream of the tested TSS as well 
as two novel repressor sites located in the spacer region and upstream of the -35 motif. As another 
example of newly characterized promoter sequences we have also identified novel regulatory 
motifs for rpsL, an essential gene and component of the 30S ribosomal subunit. For this gene, we 
have found a candidate  σ70 RNAP binding site as well as an unknown repressor positioned over 
the transcription start site which, once obviated, results in a 5-fold increase in expression of the 
promoter. Although further experiments18 are necessary to accurately name the transcription 
factors acting at the regulatory sites acting on these promoters, these results provide clear 
insights into the regulation of these genes and implicate strong candidate motifs for further 
dissection. 
 
Global identification of 7,293 E. coli promoter regulatory motifs 
Next, we expanded the scope of our analysis to characterize regulatory sites at the global level. 
We used the individual barcode measurements, across four replicates, to find significant 
differences between the mean expression of the unscrambled sequence and the scrambled 
sequence (Student’s t-test with FDR at 1%). We identified scrambled regions that significantly 
increased or decreased expression and found 1,885 and 5,408 regions, respectively (Figure 
3.5A). These sites were located throughout promoters and scrambling these sites resulted in 
dramatic changes in expression, some over 100-fold (Figure 3.S5A). We observed markedly 
different distributions for the position of regions that either increased or decreased expression  
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Figure 3.4. Scanning mutagenesis of 2,057 TSS-associated promoters identifies known 
and novel regulatory motifs A) Each of the 2,057 active TSS-associated promoters were 
subject to a scanning mutagenesis to identify motifs encoding regulatory activity. We 
synthesized 59,653 promoter variants in which we scrambled 10 bp sequences for each 5 bp 
interval across each promoter. B) Global promoter scanning mutagenesis profiles. Top: 
Averaged relative activity of variants scrambled at each position. Bottom: Heatmap representing 
the impact of mutating each position for 1,826 promoters. Rows are rearranged using 
hierarchical clustering and the intensities are normalized within each row to accommodate 
differences in unscrambled promoter activities. C) Left: Scanning mutagenesis of the well-
characterized lacZYA promoter. Right: Scanning mutagenesis of the well-characterized relBE 
promoter. D) Left: Scanning mutagenesis of the cfa promoter. Right: Scanning mutagenesis of 
the rpsL promoter. 
 
(Figure 3.5B). Increased regions were particularly enriched at the -10, -35, and -70 positions, 
which is consistent with the canonical σ70 RNAP binding motif as well as the typical position of 
transcriptional activators amongst class I bacterial promoters 49–51. On the other hand, reduced 
regions localized to the TSS, spacer, and -35, which is consistent with known mechanisms of 
RNAP occlusion by steric hindrance51,52.   
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Identified motif effects generally agree with reported annotations 
Having identified 7,293 regulatory regions throughout the E. coli genome, we wanted to cross-
reference these with the extensive collection of putative and experimentally determined regulatory 
sites reported by RegulonDB. Of the 2,453 unique transcription factor binding sites (TFBSs) 
reported by RegulonDB, 1156 overlap with regulatory sites whose effects were captured by our 
scanning mutagenesis. We identified at least one scramble that significantly changed expression 
for 49% (5667/1,156) of these previously annotated sites. After merging contiguous significant 
scrambled sites into distinct regulatory regions we identified 1,414 and 1,903 merged sites that 
increase or reduce expression, respectively. Sites were, on average, 20 bp (Figure 3.S5B) with 
effect sizes of these scrambles largely independent of their lengths (Figure 3.S5C). Our 
scrambling results agreed with the reported impact for 65% (185/283) of activators and 43% 
(196/450) of repressors (Figure 3.5B). Our lower concordance for repressors could be due to a 
scramble disrupting both a repressor and -35 or -10 element, resulting in a decrease in expression 
which would appear to contradict a reported repressor site. We looked at the distribution of 
concordance for merged scrambles by position relative to the TSS (Figure 3.5SD, 3.5SE) and 
observed a higher proportion of disagreement near the -35 and -10 elements, suggesting these 
scrambles are disrupting crucial promoter elements. This may be expected considering that many 
repressor operate by binding regions proximal to the RNAP binding site. Regardless, we found 
several examples where the regulatory effects predicted by RegulonDB were contradicted by our 
results with strong evidence (Figure 3.5D). Overall, we were able to generate functional 
regulatory profiles for promoters driving expression of 1,158 of the 2,56528 operons in E. coli as 
well as many other promoters that contribute to global expression levels. Thus, we conclude that 
this approach is an efficient method to rapidly characterize regulatory motifs within thousands of 
experimentally verified promoter regions. 
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Figure 3.5. Global identification of E. coli regulatory motifs by scanning mutagenesis. We 
selected 2,057 active TSS-associated promoters identified in LB-rich media and systematically 
scrambled 10 bp sequences spanning the -120 to +30 positions at five bp intervals. A) We 
identified scrambles that significantly increase (N = 1,885) or decrease (N=5,408) expression 
relative to the unscrambled sequence based on the mean RNA/DNA ratio at the individual 
barcode level across four replicates (Student’s t-test, two-sided, adjusted to 1% FDR). Data are 
colored whether the scrambled regulatory region activated or repressed transcription of the 
promoter. B) Distribution of the location of significant scrambles relative to TSS. C) Comparison 
of scramble effect to RegulonDB annotation. We compared each significant scramble to all 
annotated RegulonDB TFBSs that overlapped the genomic coordinates of the scramble. The 
scrambles are grouped by the effect of the overlapping TFBS as reported by RegulonDB, either 
repressors, activators, or unreported in the database. 77.8%  (2,583/3,317) of significant 
scrambles are not annotated.  D) Scanning mutagenesis of the FadR promoter (bottom) 
compared to reported architecture (top).   
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Promoter activity prediction remains a challenge 
In this study we generated a powerful dataset of three distinct library designs, totaling 117,556 
unique sequences, that provide a quantitative measure of promoter activity in vivo. Using this 
unique dataset, we sought to evaluate our ability to predict promoter activity from sequence alone, 
which would be invaluable for annotating promoter sequence space de novo as well as designing 
promoters with designed activities. We leveraged this information and trained several machine 
learning models of varying complexity, for both classification and regression. Many sequences 
have high overlap with other sequences, due to library design and close proximity of previously 
reported TSSs. We split the data into 75% for training (n = 87,164) and 25% (n = 30,392) for 
testing according to genomic location, ensuring the two sets contain sequences equidistant to the 
origin (see Methods). For classification, we further filtered the data and only considered 
expression < 0.75 as negatives and > 1.25 as positives (all datasets have activity threshold 
normalized to 1). There is some amount of noise in our assay leading us to not evaluate 
sequences close to the threshold, yielding a training set of 53,326 (12,918 positives and 40,408 
negatives) and test set of 18,567 (4,414 positives and 14,153 negatives).  
 
We trained several different classifiers to predict whether a given sequence was active or inactive 
(Figure 3.6A). All classifiers output the predicted probability for each class, rather than directly 
predicting the class, so they can be compared using precision-recall curves. Further details for all 
models are included in the methods. We trained a “baseline” logistic regression based on four 
“mechanistic” features known to be associated with promoter strength: max -10 sigma70 motif 
position weight matrix (PWM) score, max σ70 -35 motif PWM score, paired -10 and -35 PWM 
score (PWMs scanned jointly allowing for, 16, 17, or 18 gap), and percent GC content. We trained 
this model only for the TSS library, split by genome location as described above, because it 
directly represent endogenous genomic sequence. For comparison, we trained a gapped k-mer 
SVM (gkm-SVM) model with word-length 10 and 8 informative columns (L= 10, K = 8) on the  
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Figure 3.6. Various machine learning models for promoter activity classification and 
regression. We trained various models to predict promoter activity across all three library 
designs: endogenous TSS, peak tiling, and scramble. We split the datasets into 75% training (n 
= 87,164) and 25% testing (n = 30,392) based on their genomic position to prevent overfitting, as 
many sequences have overlapping sequence content. Classification and regression models were 
trained independently and details about each model and feature set can be found in Methods. A) 
We trained classification models to predict if a sequence was active or inactive. We considered 
all samples with activity < 0.75 to be inactive and activity > 1.25 to be active. We created this 
buffer around the activity threshold of 1 to shift focus away from potentially noisy observations 
around the threshold. We evaluated classification performance using precision-recall curves 
because our data is imbalanced. Convolutional neural networks performed best in the lower recall 
range, while logistic regression based on simple hand-crafted features performs better in the 
higher recall range. Dashed line represents the expected performance from random prediction. 
B) We trained regression models to predict a quantitative level of promoter activity. We evaluated 
performance using both root mean squared error (RMSE) and coefficient of determination (R2 ) 
on the held-out test set. Similar to classification, convolutional neural networks performed the best 
with the lowest RMSE and highest R2. Simple linear regression based on hand-crafted features 
performed the worst with the highest RMSE and lowest R2. 
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same training set, as this model is best suited for sample sizes under 20,000, and observed 
decreased performance relative to the logistic regression (AUPRC = 0.43, AUPRC = 0.53, 
respectively). Furthermore, we created a feature set of all 3 to 6-mer frequencies and trained a 
logistic regression, partial least squares discriminant analysis (PLS-DA), and multi-layer 
perceptron (MLP). To observe the effects of reducing dimensionality, we additionally trained on 
only 6-mer frequencies for the MLP and random forest. For the simpler logistic regression and 
PLS-DA we performed an additional feature selection step based on the performance of a 
“random” k-mer (Methods). All of these models performed similarly, with AUPRC ranging from 
0.29 to 0.35.  
 
We were interested in a more complex model that could capture more intricate sequence features 
beyond the core promoter motifs without any a priori knowledge, such as RNAP binding motifs or 
TFBSs. There has been recent work which predicts transcriptional regulatory activity from MPRA 
data using convolutional neural networks (CNNs)53. Inspired by this work, we trained a CNN using 
the DragoNN toolkit which is built on top of the keras python package. We performed 
hyperparameter tuning for a three layer CNN and achieved AUPRC = 0.52. Next, we compared 
the CNN to other machine learning models that require less hyperparameter tuning, construct 
more interpretable models, and have a faster runtime. For comparison, we trained a random forest 
on one-hot encoded DNA, although this model is not well suited to categorical input features, and 
achieved AUPRC = 0.31. To overcome this limitation, we trained the random forest using 
frequencies of 6-mers and observed a slight increase in performance (AUPRC = 0.34). Overall, 
the CNN achieved the highest AUPRC, but the logistic regression fit with four features performs 
better at higher recall. The two models are not directly comparable because they are trained on 
different datasets, as the logistic regression fails to converge when run on the combined dataset. 
 
 
 
 
 114 
We separately trained all of the models described above, with the exception of gkm-SVM, for the 
more difficult task of regression. Additionally, we included linear regression fit to the four 
“mechanistic” features, for log-transformed expression. We evaluated each model using root 
mean squared error (RMSE) and R-squared between predicted and observed values for promoter 
activity. Many models perform similarly to each other, with the CNN achieving the highest R-
squared and lowest RMSE. We observe improvement in the linear regression on log-transformed 
data compared to linear regression without transformation, suggesting there are non-linear 
relationships that are presumably captured by more complex models. Random forest on one-hot 
encoded DNA performs worse than random forest on 6-mer frequencies, in line with the heuristic 
that random forests are not well suited to categorical features.  
 
Overall, the CNN performs best in both classification and regression, although simpler models 
have some predictive power and have the benefit of much faster training times. However, all of 
these models together provide evidence that the problem of prediction, even for a simple model 
organism, remains challenging. We attempt here to highlight several different approaches to the 
problem with models of varying complexity. This is a starting point for future work for further 
optimization and utilizing other types of models. 
 
DISCUSSION 
The promoter as described by Jacob and Monod was a distinct unit of the operon with elegant 
but ultimately simple components. Looking back at over 50 years of research, the definition of a 
promoter has evolved dramatically to encompass their incredible flexibility and complex roles in 
genetic regulation. In this work, we use a multiplexed reporter assay to isolate promoter activity 
from extraneous mechanisms of genetic regulation and characterize hundreds of thousands of 
sequences spanning the E. coli genome. Our genomic screen identifies 3,321 and 3,477 active 
promoters in rich and minimal glucose media, respectively, and find many intragenic and 
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antisense promoters. We present evidence that antisense promoters have a profound impact on 
global transcript levels and shows the quantitative relationship between antisense promoter 
activity and repression. Our analysis of codon usage within intragenic promoter suggests that 
codon usage has adapted to enable promoter activity within genes while still navigating the 
constraints of protein coding space. Amongst these intragenic promoters, there is a significant 
enrichment of rare codons in these regions. Furthermore, we perform scanning mutagenesis of 
2,057 previously identified TSS-associated promoters and identify 7,293 encoding regulation 
within these promoters, of which 2,583 have not been previously annotated. 
 
A critical question to reflect upon is: Have we finally identified all promoters encoded in the E. 
coli genome? Considering the dramatic rearrangement of promoters between rich and minimal 
glucose media, it is likely that interrogating other conditions will reveal many other condition-
dependent promoters. Furthermore, we are skeptical to make the claim that we’ve definitively 
identified all promoters even in the conditions tested in this work. Here we defined sequences 
as promoters based on empirically derived thresholds, however, this method is somewhat 
arbitrary and likely underestimates the actual number of promoters. Perhaps promoter 
sequences cannot be defined in such a binary manner and are actually a quantitative trait 
inherent to all sequences in the genome. This quantitative perspective is consistent with the 
incredible amounts of ‘spurious’ transcription observed by RNA-seq studies. Moreover, it is 
consistent with the observation that a surprising number of random sequences exhibit promoter 
activity54. To reaffirm this observation, we used our platform to characterize 1,000 random 150 
bp sequences, with over 3% of sequences surpassing our empirically derived threshold (Figure 
3.S6), although as many as 10% of random 100 bp sequences have been previously reported to 
be active promoters. On the other hand, there may be other mechanisms within E. coli that 
allow the genome to distinguish transcription from promoter sequences vs non-promoter 
sequences, similarly to what has been observed in the suppression of transcription from tss-
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RNA promoters35. More sensitive techniques to study promoter activity of sequences near 
activity thresholds will be necessary to clearly state whether promoter activity is a general trait of 
all sequences in the genome or a binary identity that is encoded within specific sequences in 
genomes. 
 
We designed a scanning mutagenesis library of previously identified 2,057 TSS-associated 
promoters and identified 7,293 regulatory sequences, including 2,583 that have not been 
previously reported17. We identified “scrambled” variants that significantly altered expression 
(compared to wild-type) and compared these motifs to known TFBS annotations in RegulonDB. 
The majority of our significant scrambles contained no corresponding annotation in RegulonDB, 
and for those that overlapped known sites, an appreciable proportion disagreed with the reported 
effect. There could be several explanations for this disagreement and the discovery of these 
missing annotations. First, it could be that the predictions of TFBSs in RegulonDB are actually 
false positives due to promiscuous binding events. Second, some transcription factors may 
possess condition-dependent behavior and the conditions tested in our study do not capture the 
full scope of their regulatory program. Finally, it is plausible that a portion of the sites we identify  
represent true functional sites that are missing from current annotation and should be interesting 
targets for further dissection, such as identifying which transcription factors operate at these 
motifs. Further studies to determine which sequences within a promoter contribute to regulation 
may aid efforts towards predicting promoter sequence-function relationships. 
 
We leveraged our unique and large datasets of quantitative promoter activity across multiple 
libraries to train machine learning models to predict whether a promoter was active or inactive 
(classification) and the precise level of activity (regression). We implemented models of varying 
complexity, from simple linear regression models based on a handful of biological features, to 
convolutional neural networks trained on raw sequence alone. Even with the large training set, 
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the performance of these predictive models is limited. Why does this problem remain challenging? 
First, it is likely quite challenging to develop a single generalizable model for all promoters as 
there are several families of sigma factors with various consensus motifs. Therefore, models that 
are sigma-factor specific may be more tractable. Second, although the range of our MPRA is quite 
dynamic, accurate predictive models may require techniques with even greater quantitative 
resolution, especially in the noise regime of the assay where most observations fall. Finally, high 
performance models may require even larger and more narrowly focused training sets. For 
example, one could create a library design to parameterize the binding motifs for various sigma 
factors, allowing greater exploration of the vast sequence space than possible with the limited 
sites present in the genome. In previous work, we designed a “minimal” promoter with various 
combinations of the core σ70 promoter motifs embedded in a constant background and developed 
accurate predictive models using the identities of core motifs as features29. These types of 
approaches could be better suited for the prediction task because they use functional promoter 
sequences as a foundation to expand further into sequence space. There has been recent similar 
work from other groups9, and our MPRA would be a powerful tool to further refine biophysical 
models. 
 
As genome sequencing technologies continue to evolve, our ability to discover genomes has far 
surpassed our ability to characterize them. While recent technological advances have made it 
possible to rapidly determine gene functions within bacterial genomes55, we lack similar genome-
scale approaches to dissect the regulation of these genes. Understanding the regulation of genes 
can help place these functions within their appropriate context, which is paramount to 
understanding how they contribute to the behavior and plasticity of cells. This work marks a 
notable leap in our understanding of genetic regulation by promoters in E. coli. Although we only 
characterize the promoter landscape of E. coli, we believe this approach can be utilized for any 
genetically tractable bacteria amenable to the transformation of relatively large libraries of 
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sequences (~106 clones) and RNA-Seq of expressed barcodes. Similar approaches have been 
utilized in a number of bacterial species to identify functional promoter sequences56. Therefore, 
the approaches we present here will enable researchers to rapidly screen bacterial genomes for 
active promoter sequences and determine how promoter activity is encoded within genomes. 
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METHODS 
 
Strains 
All experiments were performed in the E. coli MG1655 background.  
 
TSS library design 
 The TSS library incorporates all TSSs from the RegulonDB database28 (Version 8.0, 
genome version U00096.2) and those identified in two recent genome-wide TSS mapping 
studies15,16. We synthesized each TSS embedded in its local sequence context -120 to +30 
relative to the TSS, capturing most of the cis-regulatory elements. Recent work provides 
evidence that most regulatory motifs fall within 100 bp upstream of the TSS30 and the initial 
transcribed region (+1 to +20) can also influence gene expression. There were 23,798 unique 
TSSs across all three sources, many of which were a few base pairs away from each other. We 
minimized redundancy and collapsed together TSSs within 20 bp and selected the most 
upstream TSS for our library, yielding 17,635 TSSs for the final synthesized library. Additionally, 
we included 500 negative controls from the E. coli genome that are assumed to have minimal 
regulatory activity. We randomly selected 150 bp sequences that are more than 200 bp from a 
TSS (on either strand), and many fall within coding regions. We included a set of 112 short 
synthetic positive controls that were previously characterized57,58 and span a wide range of 
expression.  
 
TSS library barcoding and cloning 
The TSS library was synthesized by Twist Biosciences and delivered lyophilized as a 26 pmol 
pool. The library was resuspended in 100 uL of TE pH 8.0 and 1 uL was amplified for 12 cycles 
using GU72 and GU116 with NEB Q5 High-Fidelity 2x Master Mix (#M0492L). Unless otherwise 
stated, all amplifications were performed using this polymerase mixture. This product was then 
ran on a 2% TAE agarose gel and approximately 200 bp amplicons were extracted using a 
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Zymoclean Gel DNA Recovery Kit (#D4008). For barcoding, 1 ng of this eluate was amplified for 
9 cycles using primers GU72 and GU73. Following cleaning using a Zymo Clean and 
Concentrator Kit (#D40140), the library was digested using NEB’s SbfI-HF and XhoI. 
  
The plasmid backbone, pLibacceptorV2 (Addgene #106250 was digested using SbfI-HF and 
SalI-HF with the addition of rSAP (NEB #M0371S). The digested library was ligated into 
pLibacceptorV2 using T7 DNA Ligase (NEB #M0318S), cloned into 5-alpha Electrocompetent E. 
coli (NEB #C2989K), and plated on LB + kanamycin (25 ug/mL) yielding approximately 2.3 
million colonies estimated by plating concomitant dilution plates. After allowing for 24 hours of 
growth on plates, the library was scraped and resuspended in LB, and then 800 million cells 
(based on OD600) were inoculated in 450 mL LB + kanamycin (25 ug/mL) overnight. Unless 
stated otherwise, all plasmids were isolated using a Qiagen Plasmid Plus Maxiprep Kit (#12963) 
and concentrated using a Promega Wizard SV Gel and PCR Clean-up System (#A9281). 
 
In order to clone the RiboJ::sfGFP reporter construct, the library was digested using NEB’s 
BsaI-HF and NheI-HF with the addition of rSAP. The reporter construct was digested using 
NEB’s BsaI-HF and NcoI-HF. Similarly to the previous cloning step, the reporter was cloned into 
the library using T7 DNA Ligase, cloned into 5-alpha electrocompetent E. coli, and plated on LB 
+ kanamycin (25 ug/mL), yielding 6.8 million colonies. The completed plasmid library was 
isolated as stated above. 
 
Isolation of genomic fragment library 
To isolate genomic fragments, 10 ug of E. coli MG1655 gDNA was sheared using a Covaris . 
The settings used were as follows: Duty factor was set to 10%, Intensity was set to 4, 
cycles/burst was set to 200, and time was 60 seconds. The sheared gDNA was ran on a 3% 
TAE agarose gel and fragments between 200 and 300 bp were extracted using a Zymoclean 
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Gel DNA Recovery Kit and eluted in 18 uL water. All 18 uL of the extracted fragments were end 
repaired using Enzymatics End Repair Mix (Part # Y9140-LC-L) following manufacturers 
protocols, cleaned using 45 uL (1.8x volume) of Agencourt AMPure XP Beads (#A63880), and 
eluted in 20 uL of water. The 20 uL eluate was A-tailed following the New England Biolabs 
protocol:  
 
Reaction: 
20 uL End-repaired DNA 
5 uL NEB Buffer 2 (10x)\ 
0.5 uL dATP (10mM) 
3 uL Klenow Fragment (3’ -> 5’ exo-) (Enzymatics #P7010-HC-L) 
21.5 uL Nuclease-free water 
 
The reaction was Incubated for 30 minutes at 37ºC, then heat inactivated for 20 minutes at 75ºC 
before cleaning using 90 uL Agencourt AMPure XP beads and eluting in 20 uL water. Y-
adapters to facilitate fragment amplification and barcoding were ligated to the A-tailed fragments 
using the following reaction mix: 
 
Reaction: 
 20 uL A-tailed DNA 
 5 uL NEB T4 DNA Ligase Buffer (10x) (NEB #B0202S) 
 2 uL Y-adapter GU Y-Frag (25 uM) 
 1 uL NEB T4 DNA Ligase (NEB #M0202T) 
22 uL Nuclease-free water  
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This reaction was incubated for 20 minutes at 25ºC, heat inactivated for 20 minutes at 65ºC, 
and subsequently cleaned using 90 uL Agencourt AMPure XP beads and eluting in 12 uL 
nuclease-free water. 
 
Barcoding and cloning of genomic fragment library 
To barcode the genomic fragments, 1 uL of the processed fragments was amplified for 13 
cycles using GU72 and GU116. This product was then cleaned using a Zymo Clean and 
Concentrator Kit and eluted in 12 uL nuclease-free water. For barcoding, 1 ng of this eluate was 
amplified for 10 cycles using primers GU72 and GU73. Following cleaning using a Zymo Clean 
and Concentrator Kit (#D40140), the library was digested using NEB’s SbfI-HF and XhoI. 
 
This library was cloned following the same protocols as the TSS library. The transformation of 
the barcoded library yielded approximately 3.3 million colonies and the transformation after 
addition of the RiboJ::sfGFP yielded approximately 1.25 million colonies.  
 
Genomic promoter tiling library design 
We used a custom peak caller on the single-nucleotide resolution strand-specific expression 
pileup generated from our genomic fragment library to define “peaks” of promoter activity. Our 
peak calling method is simple and conservative, as we wanted to tile the most active regions 
and keep the library size reasonable. We defined a peak as a continuous region with expression 
above an empirically determined threshold. We considered a continuous range of thresholds 
and for each evaluated the percentage of active TSSs, from our previous library, contained in a 
peak and determined an expression level of 1.1 was sufficient and captured 90% of active TSSs 
(data not shown). We required that each peak be at least 60 bp, and merged adjacent peaks 
that were within 40 bp, yielding 1753 and 1724 peaks for the minus and plus strands, 
respectively. We tiled each peak by synthesizing 150 bp windows across the region, with no 
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overlap between adjacent tiles, yielding 48,491 peak tiles. Additionally, we included 1000 
randomly generated 150 bp sequences to test what fraction of random sequence can drive 
expression. We included the same set of positive and negative controls as described in the TSS 
library design. 
 
Genomic promoter tiling library barcoding and cloning 
The active TSS mutagenesis library was synthesized by Agilent and delivered lyophilized as a 
10 pmol pool. The library was resuspended in 100 uL of TE pH 8.0 and 1 uL was amplified for 
10 cycles using GU120 and GU121. This product was then cleaned using a Zymo Clean and 
Concentrator Kit and eluted in 12 uL nuclease-free water. For barcoding, 1 ng of this eluate was 
amplified for 8 cycles using primers GU120 and GU122. Following cleaning using a Zymo Clean 
and Concentrator Kit (#D40140), the library was digested using NEB’s SbfI-HF and XhoI. 
 
This library was cloned following the same protocols as the TSS library. The transformation of 
the barcoded library yielded approximately 1.5 million colonies and the transformation after 
addition of the RiboJ::sfGFP yielded approximately 5.2 million colonies.  
 
Active TSS mutagenesis design 
We systematically mutagenized all active TSSs from our initial TSS library to design a follow-up 
library. We used 500 negative controls to classify the TSS library into active and inactive TSSs. 
We set the active threshold at two standard deviations above the median expression for the 
negative controls, resulting in 2,670 active TSSs. We mutagenized the active sequence by 
scrambling 10 bp windows, sliding across the 150 bp at 5 bp intervals, resulting in 5 bp of 
overlap between adjacent scrambles. We scrambled the sequence using the existing 10 bp to 
preserve nucleotide content and selected the scramble that was most dissimilar to the original 
sequence out of 100 scrambling attempts. Our final library included 59,653 scrambled 
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sequences and 2,057 unscrambled sequences. We also included the same set of negative and 
positive controls as described above for the TSS library, for a total library size of 62,322. 
 
Active TSS mutagenesis library barcoding 
The active TSS mutagenesis library was synthesized by Agilent and delivered lyophilized as a 
10 pmol pool. The library was resuspended in 100 uL of TE pH 8.0 and 1 uL was amplified for 
12 cycles using GU123 and GU124. This product was then cleaned using a Zymo Clean and 
Concentrator Kit and eluted in 12 uL nuclease-free water. For barcoding, 1 ng of this eluate was 
amplified for 10 cycles using primers GU123 and GU125. Following cleaning using a Zymo 
Clean and Concentrator Kit (#D40140), the library was digested using NEB’s SbfI-HF and XhoI. 
 
This library was cloned following the same protocols as the TSS library. The transformation of 
the barcoded library yielded approximately 3.7 million colonies and the transformation after 
addition of the RiboJ::sfGFP yielded approximately 5.2 million colonies.  
 
Library Barcode mapping 
We used PCR to individually barcode each library sequence to quantitatively measure 
expression in our MPRA. Prior to genome integration, DNA-sequencing was performed to 
computationally map barcodes to sequences. A custom barcode mapper developed by Nathan 
Lubock (manuscript in preparation) was used to collapse reads into a barcode-sequence map. 
We used two filtering steps for barcode quality. First, we required a minimum number of reads 
for every barcode, assuming reads that appear once or twice correspond to sequencing errors. 
Second, BBMap59 was used to align the reads associated with a given barcode, and discarded 
barcodes that map to sequences that are too dissimilar to one another. A Levenshtein distance 
of 30 was used to discard barcodes that map to two very distinct sequences, while still allowing 
for a small number of sequence errors.  
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Library integration into specific genomic loci 
Library integration was performed as previously described.  
 
The isolated plasmid library was digested with SalI-HF and NheI-HF to eliminate incompletely 
cloned plasmid before transformation into electrocompetent MG1655 with a landing pad 
engineered in the nth-ydgR locus and plating on LB + kanamycin (25 ug/mL). Colonies were 
resuspended in LB and 800 million cells were inoculated into 
250 mL LB + kanamycin (25 ug/mL) and grown overnight. Several 2 mL frozen aliquots were 
made of this overnight culture. 
 
The library was integrated into the nth-ydgR locus as follows. A frozen aliquot of MG1655 with a 
landing pad engineered in the reverse orientation at the nth:ydgR locus was transformed with 
the library and grown overnight in 200 mL LB + kanamycin (25 ug/mL). Following overnight 
growth, 400 million cells of this culture were seeded into 250 mL LB + kanamycin (25 ug/mL) + 
.2% arabinose (g/mL) and grown for 24 hours. After integration of the library, the plasmid 
backbone was removed through heat-curing. From the 24 hour induced culture, 800 million cells 
were inoculated into 80 mL of LB + kanamycin (25 ug/mL) and grown at 42 ºC for approximately 
1.5 hours before reaching an OD 600 =.3. Upon reaching exponential growth, 200 million cells 
from this culture library were plated and grown for 16 hours at 42 ºC. Heat-cured plates were 
scraped and resuspended in LB and 400 million cells were inoculated into 200 mL LB + 
kanamycin (25 ug/mL). This culture, consisting of our integrated and heat-cured library, was 
grown overnight at 37 ºC and several frozen 2 mL aliquots were made. 
 
To test the TSS library in the essQ-cspB and ybbD-ylbG midreplichore regions, the same 
protocol was followed using strains engineered with landing pads in these intergenic regions. 
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Library growth and harvest for expression measurements 
To measure expression of all promoter libraries, libraries were grown and harvested as 
previously described29 with minor changes to culture conditions. 
 
For each library and biological replicates, a 2 mL frozen aliquot of the library was inoculated in 
200 mL LB (Source) with 25 ug/mL of kanamycin and grown at 30 ºC overnight. The overnight 
cultures were used to seed new cultures at OD600 = .0005 and grown for approximately 5.5 
hours at 30 ºC until reaching an OD600 between = 0.5 and 0.55. The genomic fragment library 
was also grown in Minimal Media (Source) with .2% glucose (g/mL) and 25 ug/mL of kanamycin 
for 10 hours at 30 ºC until reaching an OD600 between = 0.5 and 0.55. Cultures were rapidly 
cooled to 0 ºC in an ice slurry for two minutes. Three 50 mL aliquots were pelleted at 4 ºC by 
centrifugation at 13,000xg for two minutes and the supernatants were poured out before snap-
freezing the pellets in liquid nitrogen. Three 5 mL aliquots of each library were harvested using 
the same approach to be processed for genomic DNA extractions. 
 
RNA and DNA library preparation 
RNA was extracted from 50 mL library pellets using a Qiagen RNEasy Midi kit (#75142) and 45 
ug of each extract was concentrated using a Qiagen Minelute Cleanup Kit (#74204). Barcoded 
cDNA was generated from 25 ug of each concentrated RNA extract using Thermo Fisher 
SuperScript IV (#18090010) primed with GU101. The manufacturer’s protocol was followed 
aside from extending the reaction time to 1 hour at 52 ºC. The cDNA reaction was cleaned 
using a Zymo Research DNA Clean and Concentrator kit (#D40140) before amplification. 
Barcoded cDNA was amplified via PCR for 13 cycles using primers GU59 and GU102. This 
reaction was cleaned using a Zymo Research DNA Clean and Concentrator Kit and 1 uL of this 
reaction was used in a second PCR for indexing and addition of flow cell adapters. The second 
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PCR was for 8 cycles and utilized primers GU102 with either GU61, GU62, GU63, or GU64 
(which add separate 6 bp indices).  
 
gDNA was extracted from 5 mL cell library pellets using a Qiagen Gentra Puregene kit 
(#158567). Barcoded DNA was amplified from 1 ug of gDNA via PCR for 12-15 cycles using 
primers GU59 and GU60. The reaction was subsequently cleaned using a Zymo Research DNA 
Clean and Concentrator kit. To add sequencing adapters and indices to the library, 1 ng of this 
reaction was subject to a second PCR for 8 cycles using primers GU70 with either GU63, 
GU64, GU65, or GU66 (which add separate 6 bp indices). RNA and DNA sequencing libraries 
were cleaned using a Zymo Research Clean and Concentrator Kit (#D40140) before 
quantification using an Agilent Tapestation. 
 
For each library, eight separate sequencing libraries were prepared: Four sequencing libraries 
for each RNA/DNA with two biological replicates and two technical replicates of each biological 
replicate. Biological replicates originated from separately grown and harvested glycerol stocks 
of each library. For each biological replicate, two RNA/gDNA extractions and sequencing library 
preparations (technical replicates) were performed in parallel. Libraries were submitted to the 
Broad Stem Cell Research Center at UCLA for sequencing on a HiSeq2500 or to the UCLA 
Translational Pathology Core Laboratory for sequencing on a NextSeq500. Raw sequencing 
data and promoter expression measurements have been made available on NCBI’s Gene 
Expression Omnibus (GEO Accession no.******). 
  
RNA-Seq of MG1655 in M9 minimal Media 
To compare the promoter landscape to local transcriptional levels, RNA-Seq was performed on 
MG1655 grown in M9 minimal media (BD Difco #248510) supplemented with 0.2% glucose, 2 
mM magnesium sulfate, and 0.1 mM calcium chloride. Cells growth and RNA preps were 
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prepared as previously described (see methods section titled: library growth and harvest for 
expression measurements). Sample replicates, originating from the same culture, were 
prepared using an Illumina TruSeq® Stranded mRNA Library Prep (#20020594) following 
manufacturers protocols to achieve strand-specific coverage. We note that no rRNA depletion 
was performed to preserve the fully intact transcriptional landscape. Samples were submitted to 
the UCLA TCGB sequencing core and sequenced on a Hiseq 4000.  
 
Universal Promoter Expression Quantification and Activity Thresholding 
We processed all libraries using the same pipeline to facilitate comparisons between libraries 
and set a consistent activity threshold for each library. First, we use a set of 112 short synthetic 
positive controls, designed to span a range of activity57,58, to fit a linear regression with the TSS 
library as the reference. Each library is compared independently to the TSS library using the set 
of positive controls present in both libraries. Next, we determined an activity threshold for each 
library independently based on the distribution of 500 negative controls, 150bp of random 
genomic sequence at least 200bp away from an annotated TSS (on either strand). We set the 
threshold at two standard deviations greater than the median negative control. Next, we 
independently scale each library so the threshold is equal to 1 to facilitate cross-library 
comparison and modeling. These steps standardize our data so we can train jointly across all 
datasets.  
 
-10 Motif and -35 Motif characterization 
 A position weight matrix from bTSSfinder was used to identify and score the best match to the -
10 and -35 motifs within active tss-associated promoters, inactive tss-associated promoters, and 
a set of 500 negative controls. Best scores were reported regardless of position within the 
sequence. For all pairwise comparisons of active tss-associated promoters, inactive tss-
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associated promoters, and the negative controls, the distributions of motif scores were 
compared and a student’s t-test was performed to determine significance. 
 
Genomic fragment alignment and promoter landscape quantification 
To identify the coordinates of genomic fragments assayed using the MPRA, fragment 
sequences were aligned using bowtie260 (version 2.3.4.3 ). To determine nucleotide-resolution 
calculations for promoter activity, we utilize the script, frag_expression_pileup.py. This 
script outputs WIG files in a strand-specific manner with the number of fragments overlapping 
each nucleotide position.  
 
Comparison of condition-dependent promoters between rich and minimal media 
To identify condition specific promoters, genomic peaks associated with promoter activity that 
contained no overlaps between conditions were identified. Coordinates of promoter peaks were 
cross-compared between conditions using the bedtools intersect tool (bedtools v2.27.1) and 
considered unique to a particular condition if they had no overlap between conditions. 
 
Identification of condition-dependent TFBSs 
The TFBS content of promoter peaks unique to each condition was evaluated by cross-
referencing with TFBSs reported by (Salgado et al. 2013) (Release 8.8). Unique promoter peaks 
were assigned TFBSs based on overlapping genomic coordinates using the bedtools intersect 
tool (bedtools v2.27.1) with default parameters and ignoring strand assignments. Incidents of 
each TFBS overlap were quantified between conditions and hit frequencies were normalized to 
incidencies per 100,000 bp of promoter peak sequence. 
 
Determining promoter-gene associations 
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To assign genomic promoter peaks to their regulated genes, peaks were first assigned specific 
nucleotide positions by identifying the maximum activity score within a peak. Promoter peaks 
were considered intragenic if their maximum scoring nucleotide overlapped with a gene 
coordinate. For peaks whose maximum scoring nucleotides were within intergenic regions, 
regulated genes were assigned by identifying the first downstream gene within 500 bp. Once 
gene associations were identified, promoter peaks were labeled sense or antisense depending 
on whether the regulated gene shared strand orientation with the promoter peak 
 
RNA-Seq alignment and genome transcript coverage  
RNA-Seq analysis was performed using the script RNA-Seq_M9_processing.sh. This script 
trims reads using the trimmomatic software (ver. 0.36+dfsg-3) and aligned to the MG1655 
reference genome (U00096.2) using Hisat2 (Kim et al. 2015) (ver. 2.1.0-1). Genome nucleotide-
resolution coverage was determined using Samtools depth (ver. 1.7-1) and overall gene 
expression levels were calculated using bedtools multicov (2.26.0+dfsg-5). In all cases, default 
parameters were used with the exception of allowing for strand-specific quantifications. 
 
Identification of minimal promoter regions 
To identify minimal sequences necessary for promoter activity, contiguous stretches of active 
promoter peak tiles were grouped and the minimal shared overlapping region was identified. 
Peak tiles above the expression threshold were identified and grouped together if they shared 
an overlap of at least 110 bp of their 150 bp total length. The minimal region necessary for 
promoter activity was found by determining the overlap of the outermost sequences within a 
contiguous stretch of active peak tiles. 
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Amino acid and codon bias within intragenic promoters 
Amino and codon usage was characterized within intragenic promoters and compared to all  E. 
coli coding regions. To identify intragenic promoters, minimal regions necessary for promoter 
activity were identified by cross referencing genomic coordinates to reported genes. Reported 
gene coordinates were acquired from (Salgado et al. 2013) (Version 8.0). Once intragenic 
promoters were identified, nucleotide triplets were extracted while conserving the reading frame 
of the overlapping gene. Similarly, nucleotide triplets were extracted from all reported E. coli 
coding regions after filtering out sequences which did not have lengths of a multiple of three. For 
these extracted sequences, codon frequencies were normalized to the total number of 
occurrences of the encoded amino acid. Amino acid frequencies were normalized to the total 
number of amino acids within each group of sequences. Significantly enriched or depleted 
codons were identified by performing a chi-squared test within each amino acid group and 
adjusting the p-value using FDR. Significantly enriched or depleted codons were identified by 
performing a chi-squared test for each amino acid relative to the total pool of amino acids and 
adjusting the p-value using FDR. 
 
Identification of statistically significant scrambling promoter variants  
We identified scrambling promoter variants that significantly altered expression compared to the 
wild-type (WT) variant in the script scramble_ttest.Rmd. We considered each scramble and 
barcode combination as an independent observation, rather than summarizing expression as an 
average across all barcodes. A two sample two-sided Student’s t-test (t.test) was performed to 
test for a significant difference in mean expression levels between barcodes for a scrambled 
variant and barcodes for the corresponding WT variant. We performed multiple testing 
correction and identified 1,885 scrambles that increase expression and 5,408 that decrease 
expression relative to the WT variant, at a false discovery rate of 1%.  
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Next, bedtools merge was used to merge overlapping adjacent scramble variants to produce 
“merged” scrambles. These merged sites correspond to a continuous scrambled region that 
induced significant changes in expression. We identified 1,414 merged scrambles that 
increased expression and 1,903 merged scrambles that decreased expression, and scrambles 
were merged separately based on effect. 
 
Comparison of identified regulatory regions to RegulonDB annotations 
We compared our identified merged scramble sites to existing RegulonDB annotations. We 
used bedtools intersect and required that 10% of the TFBS overlapped with a merged scramble 
site to count as an overlap. Next, we assessed whether the expression effect seen in our MPRA 
agreed with the direction of effect of the TFBS as indicated in RegulonDB. A merged scramble 
site was marked as “concordant” if any of the component scrambles agreed with existing 
annotation, and not concordant otherwise. 
 
Machine learning models 
We implemented several machine learning models, independently trained for both classification 
and regression. All reproducible code is provided in the Github and we will briefly describe each 
model and the appropriate parameters or implementation details.  
Data processing 
We standardize all datasets as detailed above in “Universal Promoter Expression Quantification 
and Activity Thresholding”. Next, we split our data, using custom scripts, into 75%/25% for 
training/testing based on genomic location, ensuring the splits are equidistant from the origin, to 
avoid overfitting (define_genome_splits.py). Briefly, we split the genome into eight “chunks”, 
with the first and last chunk adjacent to the origin of replication. We designated the second and 
 
 
 
 133 
seventh chunk as the test set and remaining chunks as training set. This splitting maintains 
roughly the same distance from the origin between the training and test sets to avoid any 
potential effects of genome location. Many of our library designs include high overlap between 
adjacent positions in the genome. Splitting by genome location mitigates inflated performance 
due to highly similar sequences present in both train and test sets. Across the three libraries 
(TSS, peak tiling, scramble) there are 87,164 training samples and 30,392 test samples.  
 
We trained models for both regression and classification. Our data is skewed toward negative 
examples, with many samples near our determine threshold. For classification, we created a 
buffer around the threshold and only include sequences with expression <= 0.75 as negatives 
and >= 1.25 as positives and labeled sequences as active or inactive. Our training set is 
reduced to 53,326 samples and testing set to 18,567 samples. 
 
We specify classification models to predict probabilities, instead of the class, for precision-recall 
curves. 
Simple model with promoter features 
For the models in this section we created features only for the TSS library because it is closest 
to endogenous sequence and is a smaller dataset. The training and test sets were split by 
genomic location, as described above, with 13,118 training samples and 4549 testing samples. 
 
We created a simple model which incorporates four features related to promoter function. We 
calculated the maximum position weight matrix (PWM) score using motifs from  bTSSfinder61 for 
both the -10 and -35 core promoter motifs. We scanned the -10 and -35 PWM individually and 
took the max score at any position using scoring functions from the Bioconductor package 
Biostrings62. Next, we scanned the sequence with -10 and -35 PWM jointly, allowing either 16, 
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17, or 18bp spacing in between the PWMs, reflecting common spacer lengths between core 
motifs. We assigned the “paired” max score as the max score at any position in the sequence 
across the three length options. Finally, we calculated the GC content (percentage) as this has 
been shown to be negatively correlated with promoter strength56. We constructed models in R 
with these four features and fit 1) a linear regression (lm), 2) a linear regression on the log-
transformed expression values (lm) , and 3) a logistic regression (glm, family = ‘binomial’, type = 
‘response’). 
 
We trained the gapped k-mer SVM (gkm-SVM63) model on only the TSS dataset because the 
model is suited for training sets < 20,000. The training and test sets were split by genome 
position as described above. We specified a word length = 10 with 8 informative columns (L = 
10, K = 8). 
K-mer frequencies and simple models (linear regression, logistic regression, partial least 
squares regression, partial least squares discriminant analysis) 
All of the models described in the remaining sections were trained using all three combined 
datasets, as described above. 
 
We created a feature set based on k-mer frequencies, with k-mers ranging in length from 3 to 6-
mers. We generated feature sets and trained models in python. For simpler models we 
performed an additional feature selection step using custom scripts 
(kmer_feature_generator.py).  
 
We trained four models:  
● linear regression (statsmodel.api.OLS) 
● logistic regression (sklearn.linear_model.LogisticRegression()) 
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● partial least squares regression (sklearn.cross_decomposition.PLSRegression()) 
● partial least squares discriminant analysis 
(sklearn.cross_decomposition.PLSRegression() on binary dependent variable) 
 
For each k-mer, we computed the frequency in a set of random genomic sequences, the same 
length and size of the training set. We include a k-mer if the absolute correlation with expression 
is greater than the “random” k-mer frequency, resulting in 4800/5440 filtered k-mers. We chose 
partial least squares regression because it projects the input features onto a new space and is 
better equipped to handle a large number of features with high collinearity. 
Random forest regression and classification  
Next, we trained a random forest, for both regression 
(sklearn.ensemble.RandomForestRegressor()) and classification 
(sklearn.ensemble.RandomForestClassifier()). We train on one-hot encoded DNA as a 
comparison to the neural network model, although random forest is not well suited to categorical 
input features. To compensate for this, we trained the random forest using frequencies of all 6-
mers and observed improved performance. 
Multi-layer perceptron and neural networks 
We trained a multi-layer perceptron for both regression 
(sklearn.neural_network.MLPRegressor()) and classification 
(sklearn.neural_network.MLPClassifier()). MLPs are a class of feedforward artificial networks 
and are “vanilla” neural networks consisting of an input layer, hidden layer, and output layer. We 
used two different feature sets: frequency of all 3- to 6-mers and frequency of only 6-mers. 
Feature sets were standardized with sklearn.preprocessing.StandardScaler() to remove mean 
and scale to unit variance. We trained all four models with the following parameters: alpha = 
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0.005, hidden_layer_sizes=(800, 30), solver = ‘lbfgs’, random_state=1, max_iter=10000, 
early_stopping=True, learning_rate=’adaptive’, tol=1e-8.  
 
We trained a convolutional neural network (CNN) on one-hot encoded DNA sequence for both 
regression and classification. We performed hyperparameter tuning and training using 53, a 
toolkit for working with CNNs built on keras. We performed a random hyperparameter search for 
a three layer CNN for 100 combinations and the optimal parameters are listed below. 
 
Regression: 
● Dropout: 0.1340735187802852 
● Pooling width: 16 
● Convolutional filter width (for each layer): 16, 17, 18 
● Number of filters (for each layer): 19, 39, 54 
 
Classification: 
● Dropout: 0.45541334972592196 
● Pooling width: 7 
● Convolutional filter width (for each layer): 8, 29, 29 
● Number of filters (for each layer): 99, 87, 60 
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SUPPLEMENTAL INFORMATION 
 
 
A) 
B)  
 
Figure 3.S1, related to Figure 3.1) TSS-associated promoters are represented by multiple 
barcodes and provide replicable measurements between genomic positions. A) Distribution 
of the number of barcodes measured per TSS-associated promoter (Median = 61 barcodes). B) 
Comparison of TSS-associated promoter measurements when integrated into distant regions of 
the E. coli chromosome. 
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Figure 3.S2, related to Figure 3.2) TSS-associated promoters are represented by multiple 
barcodes and provide replicable measurements between genomic positions. A) Distribution 
of the lengths of genomic fragments assayed for promoter activity. B) Comparison of fragment 
expression measurements between biological replicates C) Comparison of 50,000 randomly 
sampled single-nucleotide measurements between biological replicates. D) Distribution of the 
lengths of genomic regions exhibiting significant promoter activity.  
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Figure 3.S3, related to Figures 3.3 and 3.4) Quality control for peak tiling and scrambled 
TSS libraries. A) Distribution of the number of barcodes per variant within the peak tiling library 
B) Comparison of peak tiling variant measurements between biological replicates. C) Distribution 
of the number of barcodes per variant within the scrambled TSS promoter library. D) Comparison 
of scrambled TSS variant measurements between biological replicates. 
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Figure S4, related to Figure 3) A) Distribution of the size of promoter regions identified 
from the genomic fragment screen separated by their number of distinct minimal promoters. 
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Figure S5, related to Figure 5) Global identification of E. coli regulatory motifs by scanning 
mutagenesis. A) Distribution of the effects of scrambling mutations on regulatory regions. B) 
Distribution of significant scramble lengths after merging contiguous regions. C) Relative change 
in expression from merged scrambles by length. D,E) Agreement between RegulonDB TFBS 
annotations and effects of scrambling the overlapping region of the promoter for D) Repressors 
and E) Activators  
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Figure 3.S6) An appreciable number of random 150mer oligos encode promoter activity. 
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Table 3.S1. Primers used in this study 
 
Primer Sequence (5’ à 3’) 
GU59 CATGTTGTCCACTCCAATCGGTGATGGTCCTG 
GU60 GTAATAGCTAAATCCCACCCGATGCCTGCAGG 
GU61 CAAGCAGAAGACGGCATACGAGAT ACTGTG CATGTTGTCCACTCCAATCG 
GU62 CAAGCAGAAGACGGCATACGAGAT AGCCAT CATGTTGTCCACTCCAATCG 
GU63 CAAGCAGAAGACGGCATACGAGAT ATCTCG CATGTTGTCCACTCCAATCG 
GU64 CAAGCAGAAGACGGCATACGAGAT CAGTGT CATGTTGTCCACTCCAATCG 
GU70 AATGATACGGCGACCACCGAGATCTACACGTAATAGCTAAATCCCACCCGA TGC 
GU72 ACCTGTAATTCCAAGCGTCTCGAG 
GU73 TCGTATCCCTGCAGGNNNNNNNNNNNNNNNNNNNNGCATGTGAGACCGGATG CTAACTAAACACCGCTAGC 
GU79 CGTGCATAGTGCCATGTTATCCCTGAAGTCGAG  
GU82 CAAGCAGAAGACGGCATACGAGATATCTCGCGTGCATAGTGCCATGTTATC 
GU83 CAAGCAGAAGACGGCATACGAGATAGCCATCGTGCATAGTGCCATGTTATC 
GU101 AATGATACGGCGACCACCGAGATCTACACGTAATAGCTAAATCCCACC CGATGCCTGCGG 
GU102 AATGATACGGCGACCACCGAGATCTACAC 
GU116 GGATGCTAACTAAACACCGCTAGC 
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CHAPTER FOUR 
Conclusion and Future Directions 
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Summary of Novel Technology and Findings 
 
In this work I discuss two different projects aimed at dissecting sequence-function relationships 
in two different biological systems. The first project, discussed in Chapter 2, focuses on the  
impact of sequence variants on exon recognition in human cell lines. The Multiplexed Functional 
Assay for Splicing using Sort-Seq (MFASS) is a novel technique that enables functional 
screening of tens of thousands of variants, both intronic and exonic, integrated at a fixed 
genomic location at single copy. It leverages a intron-exon-intron mini-gene inserted into a split-
GFP reporter, followed by flow cytometry sorting into distinct populations, and finally next-
generation sequencing to quantitatively measure the level of exon skipping for each designed 
sequence. This is powerful tool that can be used to assess the functional impact of variants of 
unknown significance, arising in both clinical applications and computational predictions. We 
used MFASS to determine that a previously under-appreciated proportion of rare variants cause 
large-effect splicing changes, and occur at locations other than the canonical splice sites. This 
suggests an under-studied source of variants that may be implicated in complex diseases 
caused by aberrations in splicing.  
 
The second project, discussed in Chapter 3, dissects various aspects of transcriptional 
regulation in E. coli. We developed a massively parallel report assay that clones a 150bp 
designed synthetic DNA sequence upstream of a GFP reporter and short 20bp molecular 
barcode and use next-generation sequencing to quantitatively measure the level of promoter 
activity. We functionally annotate the genome in a systematic fashion for regions capable of 
driving expression in both rich glucose media and minimal media. We designed multiple 
synthetic libraries to understand which sequences are responsible for regulation and develop 
machine learning models based on these datasets. 
 
 
 
 
 
 152 
Future Directions 
The ultimate goal of sequence-function relationships is to develop a model that can accurately 
predict the level of activity for a given sequence based on the sequence alone. The work 
presented here is an important first step in generating training data for future machine learning 
models. We hope our work enables future research in frameworks such as active learning or 
Bayesian experimental design, methods which formally maximize the expected utility of an 
experimental outcome. One can envision designing synthetic libraries that are optimally 
designed to be the most valuable for predictive modeling. For example, a biophysical model of 
promoter function could be further refined with libraries that systematically vary the potential 
sequence space for those parameters, exploring beyond what exists in natural sequence. This 
feature-driven design can more effectively probe the massive parameter space of individual 
features at a level of variation that is impossible from natural sequence alone, whether 
promoters or splice sites. One could also design libraries containing sequences that would 
behave differently under competing models, potentially guiding model selection and establishing 
causality. This Bayesian experimental design could be conducted in an iterative fashion – each 
experiment will further refine previous models, act as test sets for previous models, guide model 
selection, and inform the next best set of experiments. Using the approach outlined above, it 
could be possible to distinguish between multiple hypotheses and discover the true underlying 
biological mechanism. Ultimately, the focus of predictive modeling in biology should not solely 
be accuracy, but on interpretability and uncovering true biological insights. 
 
 
 
 
 
